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ABSTRACT 




The publication of the European Paediatric Regulation (EC No. 1901/2006) in January 
2007 brought the issue of taste assessment of medicines to the forefront. This 
regulation requires the early submission of a paediatric investigation plan (PIP).In most 
cases the applicant is required to provide an overview of planned measures / 
performed studies of which taste masking and assessment are of particular relevance. 
Therefore, there has been an increased interest in the development of objective taste 
assessment methods. 
 
The first area in this thesis focused on investigating and understanding the mechanism 
of detection of the Insent® electronic tongue TS 5000Z. Within this area, sensor 
responses to molecules possessing similar structures were analysed. In addition, 
metformin hydrochloride, paracetamol and ibuprofen were also analysed. 
 
In the development of objective taste assessment methods, such methods have to 
correlate with human taste perception. To this end, the second area investigated the 
correlation of taste assessment between an untrained human taste panel (n=24) and 
the electronic tongue. The human taste panel were presented with extemporaneously 
prepared amlodipine suspension which they graded in a visual analogue scale (VAS). 
These scores were compared to those obtained from the electronic tongue. 
 
It is widely accepted that hot melt extrusion is useful for generating solid dispersions 
that have taste masking capability. However there are limited reports in the literature 
that assess taste masking efficacy using electronic tongues. The third area of this 
thesis focuses on generating solid dispersion of Eudragit®EPO and quinine 
hydrochloride dihydrate. 
 
Overall, three key messages are concluded from the work detailed in this thesis. Firstly, 
the detection mechanism is dependent on the ionic / ionisation of the molecule under 
investigation. Secondly, strong correlation is shown between taste scores from the 
human panel and those obtained from the electronic tongue. Lastly, melt extrudates 
with 30% and 50% of quinine hydrochloride released less than 10% of drug in the first 
three minutes of dissolution therefore showing taste masking via both UV 
spectrophotochemical and electronic tongue analysis. 
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CHAPTER 1 – INTRODUCTION 
 
The taste of medicine is an important determinant of patient compliance with treatment 
regimens. The issue of unpleasant taste is particularly important in paediatric and 
geriatric populations. Generally, bitter taste is masked using solid dosage forms such 
as tablets or capsules. However, these are becoming increasingly inappropriate for 
both patient groups. In paediatrics, tablets and capsules are only recommended by the 
World Health Organisation (WHO) for children (6-12 years) and adolescents  
(12-18 years). Oral liquid dosage forms such as suspensions, syrups and oral drops 
are universally recommended for neonates (0-30 days), infants (1 month – 1 year) and 
young children (2-6 years). Among the elderly, there is an increase in the incidence of 
dysphagia (a swallowing disorder resulting from neurological / physical impairment of 
oral pharyngeal or oesophageal mechanism). 1.1 million people in England  in 2013 
are living with effects of stroke; the Royal College of physicians estimates that 40% of 
those surviving stroke have a swallowing difficulty (Royal et al. 2012). 50-75% of 
nursing home residents have some degree of dysphagia (O'Loughlin et al. 1998). 
These numbers are set to increase with the increasing ageing population. Therefore, in 
these patient groups it is necessary to use liquid dosage forms where they are 
commercially available. Taste masking is more difficult (or impossible) in liquid dosage 
forms especially if the drug is highly soluble. In addition, liquids have a high propensity 
to interact with taste buds because they spread all over the tongue and oral cavity, 
which means taste becomes more apparent to the patient.  
 
During formulation development, the poor taste of a medicine does not become known 
until late into clinical studies. At this point, if the taste is noticeable and resulting in 
aversion then it may be necessary to find a different salt of the active pharmaceutical 
ingredient (API) which has a better taste profile or in the worst case scenario, an 
alternative candidate is selected. It would be valuable to be able to screen molecules 
and /or salt forms early in the development phase (preferably at the pre-candidate 
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stage), to enable formulators to work with the optimum API in terms of taste amongst 
other parameters. To perform this screening in humans has numerous limitations, of 
which the most important is ethics. Participants in such studies would be exposed to 
several new chemical entities (NCE) for which the toxicology data are limited or 
unknown. Hence, there is a need for other techniques for selecting candidate APIs at 
the pre-clinical stage. Such method(s) would also benefit formulators when designing a 
taste masking strategy for the NCE at a very early stage of development, which would 
ultimately be timely and cost effective. In order to develop such in vitro methods, it is 
important to understand the basic physiology of taste and taste transduction in 
mammals. 
 
1.1 HUMAN PERIPHERAL GUSTATORY SYSTEM 
 
Taste perception serves as a primary gatekeeper, controlling voluntary ingestions of 
substances in mammals. The peripheral gustatory system has two distinct functions, 
which are believed to be evolutionary in origin i.e. to detect nutritionally beneficial 
compounds and distinguish them from those that are potentially toxic of harmful.  Taste 
is often confused with flavour (McBurney et al. 1979). The latter is a combination of 
different sensory signals, namely taste and aftertaste (gustatory system) and 
somatosensory modalities such as appearance (vision), texture (touch), smell 
(olfactory) and temperature (Chaudhari et al. 2010). The brain integrates these signals, 
the outcome of which is explained as flavour (Boltong et al. 2013). In this thesis, taste 
refers to the output obtained from the gustatory system alone. Signals from the 
olfactory system (nose) are only detected if the ingested substance is also volatile; this 
is not normally the case for most pharmaceuticals products therefore for the purposes 
of this research focus will be diverted from the taste-smell interaction under the 
assumption stated above. 
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1.1.1 FUNCTIONAL ANATOMY AND PHYSIOLOGY OF THE GUSTATORY SYSTEM 
Spatial testing has dismissed the historical myth of the tongue map illustrated in  
Figure 1.1. This stated that the four basic tastes are spatially distributed such that 
sweet tastes are only detected on the anterior section of the tongue, while sour and 
salty are detected on the lateral section and bitter on the posterior. In fact, taste 
detection not only occurs on the tongue but throughout the oral cavity. 
 
FIGURE 1. 1 THE TONGUE MAP (HTTP://FACULTY.ETSU.EDU/MILLERH/TONGUE/TONGUE4.GIF) 
 
This is because taste recognition in mammals is mediated by specialised epithelial 
cells called taste receptor cells (TCR) that are arranged in taste buds on the tongue 
and throughout the oral cavity. Humans have taste receptors in several fields within the 
oral cavity including: all edges of the tongue, soft palate and in the pharyngeal and 
laryngeal regions of the throat. These cells are made up of gustatory cells, transitional 
cells and supportive basal cells and exhibit a rapid turnover; their average lifespan is 
about 10 days (Beidler et al. 1965). Taste receptor cells are not neuronal cells. Rather, 
they are specialised epithelial cells that share the same properties as neuronal cells but 
they lack an axon. The cells bodies of these taste fibres occur within the sensory 
ganglia of cranial nerves VII, IX and X. TRC predominately reside within multicellular 
rosette clusters labelled as “taste buds”. 
 
Each taste bud contains approximately fifty to one hundred taste receptor cells 
collected together in a spherical structure that is 20-40µm in diameter and 40-60µm in 
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length. Taste buds are distributed throughout the oral cavity in the lingual and extra-
lingual locations. Two thirds of these taste buds are localised on the tongue in three 
specialised structures known as fungiform, foliate and circumvallate papillae. 
Circumvallate papillae, found in the posterior region of the tongue can contain 
thousands of taste buds. Foliate papillae, are distributed most densely at the tip and on 
the edges of the tongue. Fungiform papillae which are located in the anterior third of 
the tongue only contain a few taste buds (Roper 1992, Breslin et al. 2006, 
Chandrashekar et al. 2006) 
 
Taste buds display some similarity regardless of their location within the oral cavity. 
The individual taste receptor cells within the taste buds are diverse and as such they 
are classified into four cell types of which three are shown in Figure 1.2. Type I cells 
are also known as dark cells. They are the predominant cell type in taste bud 
consisting  about 55-75% of all the cells (Finger 2005). Type II cells are considered the 
light cells and are distinguished by the presence of electron-lucent cytoplasm and large 
oval nuclei. Furthermore, they have smooth endoplasmic reticulum and constitute 20% 
of all cells in a taste bud. Type III are intermediate cells largely similar to type II cells 
but differ in that they have numerous dense-core vesicles particularly in their basal 
portions. Their unique feature is their unequivocal synaptic connections to afferent 
nerve synapses. Type IV cells, which are located at the basal parts of the taste bud, 
are a pool of undifferentiated precursor cells devoted to replacing the other cell types 
throughout life (Chaudhari et al. 2010). 




FIGURE 1. 2 THE THREE MAJOR CLASSES OF TASTE RECEPTOR CELLS. THE CLASSIFICATION 
INCORPORATES ULTRA-STRUCTURAL FEATURES, PATTERNS OF GENE EXPRESSION AND FUNCTIONS OF EACH.  
(CHAUDHARI ET AL. 2010) 
 
1.1.2  CELLULAR MECHANISMS OF TASTE TRANSDUCTION 
The qualitative range of human taste is not yet fully established. Traditionally, the 
majority of taste research has presumed the existence of five basic taste attributes 
namely: sweet, sour, bitter, salty and umami. These are illustrated in Figure 1.3. 




FIGURE 1. 3  FIVE RECOGNISED TASTE ATTRIBUTE I.E. SWEET, SOUR, BITTER, SALTY AND UMAMI, TASTE 
RECEPTOR THAT DETECT THEN AND EXAMPLES OF STIMULI (CHAUDHARI ET AL. 2010) 
 
Data are accumulating that suggest that other sensory qualities such as fatty 
(Gilbertson 1998, Mattes 2011), astringency (Schiffman et al. 1992) and metallic  
(Lawless et al. 2004) are also carried by taste nerves. Thus, while the terms sweet, 
sour, salt, umami and bitter maybe familiar and have linguistic relevance, they do not 
describe the entire range of tastes perceived by humans.  
 
As illustrated in Figure 1.3, each taste attribute has a specific coding mechanism which 
is mediated by specialised taste receptor. T2R family of G-protein coupled receptors 
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(GPCR) for bitter; T1R GPCRs for sweet and umami taste; ion channels candidate 
receptors for salt and sour. Figure 1.4 shows a schematic of the taste signal 
transduction pathways of the five basic taste attributes. Essentially, bitter sweet and 
umami are triggered by the activation of TCR on the tongue and palate. Tastant 
molecules bind to and activate a phosphoinositide pathway that elevates cytoplasmic 
Ca2+ and depolarises the membrane via a cationic channel, Trpm5. The combined 
action of the elevated Ca2+ and membrane depolarisation opens the large pores of the 
gap junction hemi-channels, likely composed of panx1, resulting in adenosine tri-
phosphate (ATP) release. This thesis will focus on bitter taste transduction which is 










FIGURE 1. 4  SCHEMATIC OF TASTE SIGNAL TRANSDUCTION PATHWAYS OF EACH OF THE FIVE BASIC TASTE 
QUALITIES.(KOBAYASHI ET AL. 2010) 
 
1.1.3 BITTER TASTE 
The bitter taste is generally known as an aversive taste. It warns mammals to avoid the 
ingestion of potentially harmful compounds. Since some APIs are developed from plant 
alkaloids or animal toxins they have a bitter taste; therefore the understanding of the 
taste transduction of bitterness is crucial.  Bitter taste does not originate from one 
single type of chemical agent but a diverse range of substances. These are transduced 
by GPCR and at present 25 bitter taste receptor genes and 11 pseudo-genes have 
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been identified in humans. These bitter receptors were named T2Rs (also termed 
Tas2Rs). At present, a focused search for ligands that activate the 25 human T2Rs is 
underway, with at least nine bitter-taste receptors and their ligands already been 
identified. These have been highlighted in Table1.1.  
 
TABLE 1. 1 BITTER RECEPTORS CURRENTLY IDENTIFIED TOGETHER WITH THEIR CORRESPONDING 
LIGANDS (ADAPTED FROM (REED ET AL. 2006) 
Receptor Ligand Reference 
hTaSR16 Salicin (Bufe et al. 2002) 
hTaS2R38 Phenythiocarbamide, polythiouracil (Bufe et al. 2005) 
hTaS2R43 High concentration saccharin and 
acesulpham K 
(Kuhn et al. 2004) 
hTaS2R44 High concentration saccharin and 
acesulpham K 
(Kuhn et al. 2004) 
hTaS2R46 Absinthin, strychnine, denatonium (Sakurai et al. 2010) 
hTaS2R4 Denatonium, PROP (Chandrashekar et al. 
2000) 
hTaS2R10 Strychnine (Bufe et al. 2002) 
hTaS2R14 Broadly tuned (Behrens et al. 2004) 
hTaS2R61 6-nitro-saccharin (Kuhn et al. 2004) 
 
The precise signal transduction pathway that results in bitter taste sensation is not yet 
fully understood. However, studies on the subject so far allude to the following second 
messenger signal transduction process. Tastant molecules bind to the GPCR activating 
the hetero-trimeric GTP-binding proteins. Upon ligand binding, the Gβγ subunits are 
freed from the taste GPCR and interact functionally with a phospholipase PLCβ2, which 
in turn stimulates the synthesis of IP3. This is followed by the IP3R3 ion channels on the 
endoplasmic reticulum open resulting in the release of Ca2+ into the cytosol of the 
receptor cells. The elevated intracellular Ca2+ appear to have two targets in the plasma 
CHAPTER 1  INTRODUCTION 
35 
 
membrane: a taste-selective cation channel TRPM5 and a gap junction hemi channel, 
both found in taste receptor cells. The Ca2+ dependent opening of TRPM5 produces a 
depolarisation potential in receptor cells. In summary, two signals are elicited by tastant 
molecules: strong depolarisation and increased Ca2+. These are both integrated by gap 
junction hemi channels resulting in ATP and possible other molecules are secreted 
through hemi channel pores into the extracellular space surrounding the activated 
receptor cell. 
 
1.1.4 FACTORS AFFECTING TASTE 
NATURE OR NURTURE 
Parents provide genes and, especially during the early years of a child’s life, they 
create the child’s eating environment, making it difficult to separate genetic and 
environment factors (Plomin et al. 1993). To ask the question “nature or nurture” has 
become obsolete. The question has become how genes expressed in differing 
environmental contexts produce particular phenotypes. Taste preferences are 
phenotypic behaviours that result from genes, genetic polymorphism and environment 
interactions (Birch 1999). 
 
The genetic basis of taste is exemplified by studies into the ability of certain individuals 
to taste phenylthiocarbamide (PTC) and its chemical relation 6-n-propythiouracil 
(PROP). These investigations date back to a serendipitous accident in Fox’s laboratory 
in 1931. Synthesised PTC blew into the air and a nearby colleague complained of a 
bitter taste that Fox himself could not perceive. To date, literature has concluded that 
PTC tasting is produced by dominant allele (T). Individuals that are homozygous 
recessive (tt) are non-tasters, while heterozygotes (Tt) are medium tasters and 
homozygous dominant (TT) are super tasters. Polymorphisms in a single gene 
hTaS2R38 have been shown to account for most (60-85%) of the variation in 
PTC/PROP sensitivity among individuals. Unfortunately the question of genetic 
variation in bitterness has primarily focused on the PTC/PROP phenomenon. It is 
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understood that supertasters find quinine and caffeine bitterer when compared to non-
tasters (Tepper et al. 1997), however the taste preferences (phenotypic behaviours) of 
raft of pharmaceutical agents has not been fully elucidated.   
AGE 
In humans, specialised taste cells first appear around the seventh or eighth week of 
gestation and structurally mature taste buds are recognisable at thirteen to fifteen 
weeks (Cowart 1981).  The foetus engages in episodic swallowing of amniotic fluid 
which changes composition throughout gestation. However, there is no direct evidence 
relating to the gustatory sensitivity in utero to behaviours in neonates or subsequent 
years of development.  What is clear is that children are not merely miniature adults. 
Their responses to certain tastes differ markedly from adults. They exhibit heightened 
preferences for sweet-tasting and greater rejection of bitter-tasting substances  
(Mennella et al. 2003).  
 
It is well established that taste acuity diminishes with increasing age. Changes in taste 
threshold increase after the age of 70 (Cowart 1981, Stevens et al. 1993, Schiffman 
1997, Ng et al. 2004). Such changes include ageusia (absence of taste), hypogeusia 
(diminished sensitivity to taste) and dsygeusia (distortion of normal taste). Research 
and clinical studies indicate that hypogeusia and dsygeusia commonly occur in the 
elderly population, whereas ageusia is relatively rare. At present there is anecdotal 
evidence to suggest that it is not uncommon for the elderly to exhibit both hypogeusia 
and dsygeusia. This evidence suggests that it may be challenging to predict taste 
perception in the elderly population given that the loss or alteration of taste can differ in 
intensity and magnitude even between the basic taste senses. 
 
Studies comparing an elderly population (n=24, mean age = 75± 6.0),  and young 
adults (n=24, mean age = 28±3.4) showed that the elderly population judged caffeine 
(bitterness stimuli) and citric acid (sour stimuli)  as tasting less intense than did the 
young adults. The same study illustrated that the aging effects on suprathreshold taste 
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perception were greatest for bitter, marginal for sour and least for sweet and salty 
stimuli  (Hyde et al. 1981). In another study, detection thresholds in the elderly were on 
average 4.7 times higher than those of the younger population (Schiffman 2009).  
 
Age related decrease in taste sensitivity was once thought to be a result in decrease in 
the number of taste buds whereas more recent studies have found no significant 
decrease in numbers with age. Since taste receptor cells have a life span of 
approximately 10 days, it has been suggested that an increase in the taste receptor 
cell’s life span results in the deterioration of taste cell responses (Fukunaga et al. 2005). 
 
MEDICINES AND DISEASE 
A range of medical conditions have been reported to affect the sense of taste. However, 
in most of these reports, the patients who were evaluated for taste perception were 
also being treated with medications for their medical conditions, so, it is impossible to 
determine the relative contribution of the disease state or the medicines to the taste 
alteration. Cancer is a classic example. It is a chronic condition in which patients are 
vulnerable to taste disorders. Taste receptor cells are rapidly dividing cells so therefore 
in theory they can be targeted by chemotherapy agents. This implies that it is not clear 
that taste distortion can only be attributed to the chemotherapy agents alone because 
disease progression is some cancers also affects taste perception. It is important to 
note that of those medicines where taste alteration has been identified, in most cases 
the nature of the taste alteration is not clearly identified and whether the taste alteration 
is transient or permanent is also not generally established. Therefore further 
investigation is required.  
 
1.2 TASTE ASSESSMENT METHODS 
A comparative summary of the most commonly used taste assessment methods is 
given Table 1.2 and Table 1.3; however, each of the methods has been described in 
brief below. 
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1.2.1. HUMAN TASTE PANEL STUDIES 
At present, human taste trials also known as gustatory sensation studies or taste trials 
remain the “gold standard” for taste assessment (Anand et al. 2007) The International 
Organisation of Standardisation (ISO) provides a series of standards that safeguard the 
running of efficient and safe human taste panels. In such studies, trained healthy adult 
volunteers are used typically to evaluate the taste of formulations in statistically 
designed analysis. Evaluation of the formulation is usually performed on an objective 
scale, such as a visual analogue scale (VAS), which panellists use to evaluate a 
particular property of the formulation. Although taste trials are the gold standard, they 
are not without their limitations. The recruitment, training and retention of panellists are 
difficult and running these trials is costly. Furthermore, ethical and /or safety 
considerations often limit taste trials e.g. for cytotoxic agents, it would be deemed 
unethical to expose panellists to medicines that may cause potentially harmful side 
effects. Whilst such studies are designed to reduce bias, panellists remain subjective. 
Taste trials conducted in adults are not representative of paediatric taste preferences. 
These trials are also time-consuming and laborious, which leads to inaccurate taste 
evaluation from fatigued assessors. In view of highlighted limitations of the taste trials, 
researchers have focused on other methods to evaluate taste. A number of 
technologies have been proposed for screening APIs and their formulations. Most of 
them require the API to be in solution for testing, so they cannot address the issue of 
mouth feel. However, they give valuable insight into other aspects of the APIs taste 
profile.  
 
1.2.2 ELECTROPHYSIOLOGICAL STUDIES  
In these studies, the use of isolated tongue models from animals is employed  
(Oakley 1985). Electrodes are implanted in the chorda tympani nerve bundle or 
glossopharyngeal nerve; tastant solutions are passed over the tongue for a controlled 
period. Electrophysiological recordings from the nerve fibres provide a means of 
directly measuring dose response curves of taste stimuli. However, use of these 
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studies is limited due to involvement of surgery, capital investment on equipment. The 
low throughput is low due to the limited life isolated tongue. These studies are rife with 
difficulties in data analysis and interpretation. Animal ethical considerations also remain 
an issue. 
 
1.2.3 IN-VITRO DRUG RELEASE STUDIES 
These studies are commonly used to measure the effectiveness of taste masking. They 
are an indirect method of assessing taste because they offer no contribution to the 
evaluation of the taste of the API. Pharmacopeia release tests have been modified in 
recent years by altering the chemical component of dissolution media or reducing the 
volume of the dissolution media (Preis et al. 2013). Taste masking is achieved when, in 
the early times points for 0-5mintues; the API is either not detected or detected in 
amounts below the API’s detection threshold. Drug content is analysed 
spectrophotochemically or using high performance liquid chromatography (HPLC). 
 
1.2.4 IN-VITRO ASSAY METHODS 
In these studies, e.g. cell based assays, taste receptor cell lines are cultured to 
maturity (which in itself is difficult), then they are exposed to tastant molecules while 
gustducin / transducing release is measured.  Cell lines used include human 
enteroendocrine NCI-H716 cells and STC-1 cells (Hui et al. 2012). These methods are 
generally specific to bitterness but are only useful if bitterness response is gastducin / 
transducing dependant (Ruiz-Avila et al. 2000). 
 
1.2.5 ANIMAL TASTE PREFERENCE STUDIES  
Two commonly used models include the two bottle taste preference and the brief-
access taste aversion (BATA) model. Typically, rats, mice, cats or dogs are used in 
these studies. In the two bottle preference study animals are given free access to two 
bottles, one which contains water and another containing an equal volume of tastant 
solution. The volume missing from each bottle after the test period (typically between 
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twenty four and forty eight hours) is measured and a preference ratio of tastant solution 
to water consumed is calculated  (Danilova et al. 2006). In the BATA model, animals 
are mildly water deprived and therefore are motivated to sample from one of the 
multiple spouts that are presented one at a time through a port, usually in random order, 
in an apparatus called the Davis Rig, or “lickometer” (Boughter et al. 2002).  Each 
bottle contains only a few millilitres or either water or tastant solution. The animals only 
have a short period to sample (lick) a solution. The time period should be short enough 
to allow animals enough time to lick but not too long so as to alleviate the animal’s 
thirst such that they lose motivation to continue licking. Therefore, this is generally 
limited to fifteen seconds. Typically, a thirsty mouse will emit thirsty to fifty licks of water 
per five second period. Lick rates are diminished by a highly aversive tastant e.g. 1mM 
quinine hydrochloride (Glendinning et al. 2002). These studies tend to be qualitative, 
have low throughput and involve animal ethical issues and as such their use is limited 
(Devantier et al. 2008). 
 
1.2.6 BIOMIMETIC TASTE SENSING SYSTEMS  
These are also known as electronic tongues, e-tongues, taste sensors, taste chip and 
electronic sensor array systems. They are analytical sensor array systems which are 
able to detect specific substances by means of different artificial membranes and /or 
electrochemical techniques. The principle of detection of the electrodes can generally 
be divided into: potentiometric, voltammetric, impedimetric, optical and mass sensors. 
Potentiometric sensors are among the most popular sensors adapted for electronic 
tongues. This is illustrated in Table 1.2 which shows electronic tongues in development. 
Furthermore, the two commercially available electronic tongues are based on this 
principle. In potentiometry, a potential across a working electrode is measured when an 
equilibrium state is reached, corresponding to a state where the net current is equal to 
zero. The most significant advantage of potentiometry is the availability of a large 
number so different, both specific and less specific membrane material available such 
as glass, solid crystals, ionophores and lipid membranes. In voltammetry, a potential is 
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applied to a working electrode, and the resulting current obtained when redox active 
species are reduced or oxidised on the electrode surface. Voltammetric analytical 
systems include cyclic, stripping and pulse voltammetry. The latter is used most often. 
It can either be large amplitude pulse voltammetry (LAPV) and small amplitude pulse 
voltammetry (SAPV). An extensive review on the different voltammetric systems and 
the basic principles is described by (Winquist 2008). It is therefore not discussed any 
further because this research focuses on the potentiometric electrodes. Impedimetric 
sensors take the voltage-current ratio at a particular frequency as the detection signal 
and simultaneously another important interfacial property, capacitance, can also be 
detected. Impedence sensors have been widely used for taste assessment and have 
proven to be a feasible and effective methods due to their cross-selectivity, high 
sensitivity and reproducibility (Pioggia et al. 2007a, Pioggia et al. 2007b). Optical and 
mass electrodes have not been discussed in this context as there are currently no 
mentions in the literature of the development of electronic tongue which use these two 
principles. 
 
As previously mentioned, there are currently two commercially available models of the 
electronic tongues available on the market i.e. AlphaMoss Astree2 and Insent TS5000Z.  
The latter, which is investigated in this thesis, is discussed in detail in section 1.3 
whilst the former is discussed below in brief. The Astree2 is equipped with a seven-
sensor probe, an Ag/AgCl reference electrode and an auto sampler with sixteen to forty 
eight possible sample positions. There are three types of sensor sets available i.e. food 
analysis, pharmaceutical analysis and bitterness intensity measurement for new 
chemical entities. The underlying sensor technology is based on chemically modified 
field effect transistor technology (ChemFET) which is similar to the ion selective FET 
technology. The ChemFET sensors are composed of two highly conducting 
semiconductor regions: a source and a drain. These regions are surrounded with an 
insulator. A sensitive layer (coated membrane) is deposited above the insulator 
between the source and the drain. The composition and nature of the coat remains 
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undisclosed by the manufactures however it is suggested that it is able to form  
Van der Waals or hydrogen bonds with tastant molecules. There are also other 
electronic tongues in various development phases, a summary of which is given in 
Table 1.2. Thus far several reviews have been published in the literature, a selection 
that focus on commercially available electronic tongues have been highlighted 
(Kobayashi et al. 2009, Savage 2012, Tahara et al. 2013). This thesis will focus on the 
commercially available Insent TS 5000Z, which was developed and manufactured by 
Intelligent Sensor Technology Co. Ltd.(Insent®) in Japan. 
 
1.3 ELECTRONIC TONGUE INSENT® TS5000Z 
1.3.1 DEVELOPMENT OF INSENT® ELECTRONIC TONGUE 
Research into so called “electronic tongue” was first recorded in the literature in the 
1980s; Toko et al applied for a patent for their taste sensor in 1989  
(Hayashi et al. 1990). They then developed a taste sensor equipped with multichannel 
electrodes using a lipid/polymer membrane for a transducer thus commercialising the 
first version of the electronic tongue TSS SA 401 (Toko et al. 1994). This taste sensor 
was considered to be an electronic tongue with “global selectivity”. Toko defined global 
selectivity as the decomposition of the characteristics of a chemical substance into 
those of each type of taste and their quantification, rather than the discrimination of 
individual chemical substances (Toko 1996). Essentially, Toko suggested that these 
taste sensors were able to describe a chemical substance in terms of its taste 
composition (based on five basic tastes) and furthermore quantify each of these taste 
attribute. This was based on the fact that in human taste transduction which is 
described in sections 1.12 and 1.1.3, humans recognise taste attributes rather than 
individual chemical substances. This was a departure from previous work in the 
literature which sort to discriminate individual chemical substances. Other models of 
the electronic tongue include the TSS 402 and the TSS 402B which were 
commercialised in 1996 and 2000 respectively.  
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It was found that the sensors used in the SA401 model had low taste selectivity, thus 
causing difficulties in the evaluation of sample with unknown taste qualities. In order to 
improve selectivity and sensitivity of taste sensors, the developers modulated the 
electrical charge density and the hydrophobicity of the membrane surface. This was 
achieved by incorporating varying amounts of lipid in the membrane.  For example, in 
the development of the bitter sensor AN0, developers focused on the adsorption of the 
bitter molecule on the surface of the membrane. In this case the researchers focused 
on Log D, which is known to be correlated to hydrophobicity. With this in mind, taste 
sensors with eight plasticisers of different hydrophobicity were examined for sensitivity. 
The study showed that sensors with bis(1-butylpentyl) adipate (BBPA), bis(2-
ethylhexyl) sebacate  (BEHS), phosphoric acid tris(2-ethylhexyl) ester  (PTEH) and 
tributyl o-acetylcitrate (TBAC) were selective to quinine hydrochloride and the selection 
of the eventual composition of the sensor was based on the polymer – lipid 
composition that gave the highest voltage reading (Kobayashi et al. 2009). Similar 
methods were applied in the development of the other sensors. Sensor composition 
and fabrication is discussed in further detail in section 1.3.2. 
 
The SA402 and SA402B models needed improvement in the automation of the robotic 
arm and software for operating the electronic tongue and proceeding data analysis. 
The automation of the electronic tongue is not discussed any further in this thesis 
because this was outside the scope of the objectives presented for this research. 
However, data analysis is an integral part of the results obtained from the electronic 
tongue therefore attention is given to this issue in chapter 2 (which explains the basic 
principles of principle component analysis). In chapters 3, 4 and 5 a practical 
application and interpretation of the data analysis is described.  
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An image of the TS 5000Z which was used in this research is given in Figure 1.5 
 
FIGURE 1. 5 IMAGE OF ELECTRONIC TONGUE INSENT® TS 5000Z, SHOWING THE POSITIONING OF 





Robotic arm moves 
automatically 
according to procedure 
 
“Touch Panel” 
Measurement can be 
performed simply via 
panel just by following 
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TABLE 1. 2 A COMPARATIVE SUMMARY OF THE CURRENT IN VITRO AND IN VIVO TASTE ASSESSMENT METHODS – PART 1. 
Methods Description Applications limitations 
Taste panel studies Sensory Analysis of tastants in 
trained healthy human volunteers 
Well established and standard 
method for the taste assessment 
of drugs and drug products 
Extensive training, subjectivity, toxicity, low 




Response of tastants from 
glossopharneal or chordi tympani 
nerve 
Screening of new molecules by 
assessment of taste difference 
Involvement of surgery, capital investment on 
equipment, low throughput, difficulties in data 




Animal taste behaviour 
methodology to obtain data that 
parallels physiological 
investigations 
Screening of new molecules by 
assessment of animal preference 
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TABLE 1. 3 A COMPARATIVE SUMMARY OF THE CURRENT IN VITRO AND IN VIVO TASTE ASSESSMENT METHODS – PART 2 
Methods Description Applications limitations 
In vitro drug 
release studies 
Study of release of tastant from 
pharmaceutical formulations 
Formulation development tool, quality control not applicable in case of liquid 
medicines namely solutions 
In vitro assay 
method 
Biochemical assay involving 
measurement of activation of 
gustducin  and /or transducin 
Rapid-throughput of bitterness and bitterness 
inhibitors, determination of molecular mode of action  
Not applicable in 
gustducin/transducin 




Electrochemical sensors coupled 
with chemometric methodologies for 
qualitative and quantitative analysis 
Rapid-throughput screening of tastants and taste –
masking agents, formulation development and 
optimisation, benchmark analysis, buccal dissolution 
simulation and quality control. 
Require completely dissolving or 
suspending of the oral medicine 
in water. 
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TABLE 1. 4 SUMMARY OF EXPERIMENTAL TONGUES IN DIFFERENT STAGES OF DEVELOPMENT -ADAPTED FROM (WOERTZ ET AL. 2011D) 
Sensor type No. of sensors Measurement 
principle  
Where developed Reference 
2 x chalcogenide glass membrane with 
pronounced redox sensitivity or plasticised PVC 
cation / anion sensitivty 
27 potentiometric Chemistry department, University of St 
Petersburg, Russia 
(Legin et al. 2004, 
Rudnitskaya et al. 2013) 
Ion selective electrodes 8 potentiometric Warsaw University of Technology, 
Department of Chemistry, Warsaw, Poland 
(Ciosek et al. 2007) 




Faculdade de Ciencias e Technologia, 
UNESP, Sao Paulo, Brazil 
(Aoki et al. 2008) 
Lipid membrane sensors 8 potentiometric School of Pharmaceutical Sciences, 
Universiti Sains, Penang, Malaysia 
(Ahmad et al. 2006) 
Ion selective electrode coated PVC membranes 1/drug potentiometric Department of Physical Chemistry, Kyoto 
University, Kyoto, Japan. 
(Funasaki et al. 2006) 
Electrodes composed of gold, iridium, palladium, 
platinum and rhodium 
5 voltammetric Swedish Sensor Centre, Linkӧping 
University, Linkӧping, Sweden 
(Winquist 2008) 
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1.3.2 SENSOR COMPOSITION AND FABRICATION 
Various amounts of lipids and plasticisers were mixed for one hour in 10ml of 
tetrahydrofuran (THF). The mixture was dried in a petri dish at room temperature for 
three days to form a transparent layer (artificial membrane) which is about 200µm thick. 
The membrane is attached to the sensor platform using a solution of 800mg polyvinyl 
chloride (PVC) in 10ml of THF(Kobayashi et al. 2010). The sensor platform is illustrated 
in Figure 1.6. The sensor membrane is mounted on the part of the plastic tube, which 
has a hole, such that the inner part of the cylinder is isolated from the outside. The end 
of the cylinder is sealed with a stopper that holds the Ag/AgCl electrode. The lipids and 
plasticisers used are detailed in Table 1.4. The purpose of the plasticiser is to increase 
hydrophobicity of the lipid membrane which is the case of basic bitterness increases 
the adsorption of quinine hydrochloride dihydrate. In contrast the saltiness sensor has 
a higher lipid concentration and subsequently a lower plasticiser concentration 
therefore increasing the hydrophilicity of the sensor therefore allowing formation of 
electrostatic interactions with ions. The structures of the lipids and sensors used in the 
fabrication of the sensors are given in Figure 1.7. 





FIGURE 1. 6 IMAGE SHOWING A TYPICAL SHOWING. THE PIN JACK ELECTRODE TERMINAL PLUGS INTO THE 
SENSOR HOLDER. THE LIPID MEMBRANE DIFFERS DEPENDING ON THE SENSOR. ALL THE HANDLING OF THE 
SENSOR IS DONE VIA THE SENSOR BODY.(INSENT® TASTE SENSING SYSTEM MANUAL 2010). 
Sensor body 
Pin jack type electrode 
terminal for taste sensor 
Artificial lipid membrane 
Ag/AgCl electrode 
Internal solution (3.33M 
KCl) 
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Tetradodecylammonium bromide and  
2-Nitrophenyl octyl ether 















CT0 saltiness Tetradodecylammonium bromide n-
Tetradecyl alcohol and phosphoric acid di-
n-decyl ester 
CA0 sourness phosphoric acid di-2-ethylhexyl)  ester, 
oleic acid, Triomethylammonium chloride  
and dioctyl phenylphosphonate 
AAE umami phosphoric acid di-2-ethylhexyl)  ester, 
Triomethylammonium chloride  and dioctyl 
phenylphosphonate 
BT0 sweetness Tetradodecylammonium bromide, 








FIGURE 1. 7  FIGURE OF STRUCTURES OF LIPIDS AND PLASTICISERS USED IN THE FABRICATION OF TASTE 
SENSOR ELECTRODES FOR THE INSENT® TASTE SENSING SYSTEM (KOBAYASHI ET AL. 2010)
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1.3.3 MECHANISM OF DETECTION 
The mechanism of detection as described by the developers of the electronic tongue is 
illustrated in Figure1.8. Essentially, it is based on the Gouy Chapman theory, which 
states that when a lipid-based membrane is immersed in an aqueous solution, an 
electrical double layer (stern and diffuse layers) is formed at the membrane surface as 
shown in Figure 1.8A. The double layer is a result of dissociation of acid group of lipid 
molecules hence causing a membrane potential. The Stern layer either positive or 
negative comprises of ions adsorbed directly onto the membrane due to chemical 
interactions. The diffuse layer is composed of ions attracted to the surface charge via 
Coulombic force, electrically screening the Stern layer.  The membrane potential can 
be calculated using the Poisson – Boltzmann equation which is a differential equation 
that describes electrostatic interactions between molecules in ionic solutions. The 
addition of a drug i.e. HCl (sour - Figure 1.8B), NaCl (salt - Figure 1.8C) and quinine 
(bitter – Figure 1.8D) to the aqueous solution can affects the membrane potential. In 
the case of an acid, the protons (H+) prevent dissociation of the acid groups. In the 
case of a salt e.g. NaCl, the Na+ cation provides a screening effect leading to a change 
in membrane potential. Quinine however, is believed to adsorb onto the surface of the 
lipid membrane therefore changing the membrane potential (Kobayashi et al. 2010). It 
is important to note that when the considering the Gouy-Chapman stern theory, the 
charge density of the solute, the concentration and charge of the ion are important 
determinants of the electrostatic interactions.  While determining the responsiveness of 
the artificial membranes used on the electronic tongue the manufacturers make no 
reference to investigating molecules /ions which have the same charge at the same 
concentration with a view of explore the effect of these variables on responsiveness of 
sensors.
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As previously mentioned, during the development of the electronic sensor, Toko 
suggests that these sensors possessed global selectivity, a term already defined in 
section 1.3.1. Essentially, an assumption is made that it is not necessary to detect the 
precise molecule in the formulation but however it is the overall taste quality of the 
formulation that is important, which in some respects describes taste synergy. Caution 
should be taken when accepting this assumption.   The cellular mechanisms described 
in literature and summarised in section 1.1.2 suggests that in human each molecule is 
detected but the overall taste quality depends on the processing in the brain centres.  
How this processing occurs in the brain remains unclear. Although taste synergy is 
important, it is equally important to understand the basic taste detection and quality of 
each molecule in the formulation before addressing the issue of taste synergy. This is 
because in order to establish synergistic or suppressive taste effects, it is important to 
establish the detection of each molecule before investigating their effect in combination.  
 
FIGURE 1. 8  PICTORIAL REPRESENTATION OF MECHANISM OF DETECTION OF HCL, NACL AND QUININE 
WITH THE CORRESPONDING CHANGES IN MEMBRANE POTENTIAL (KOBAYASHI ET AL. 2010). 
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The issue of molecule detection by the taste sensor has also been investigated in two 
studies (Woertz et al. 2011c, Guhmann et al. 2012). The former suggested that cationic 
and anionic molecules were easier to detect compared to neutral molecules, while the 
latter described successfully distinguishing diclofenac acid from its sodium and 
potassium salts, suggesting that differentiation observed was largely due to the 
presence of different cations. Woertz et al suggested that the underlying measurement 
principle is potentiometric and is best explained using Nernst Equation (Equation 1.1). 
𝐸 = 𝐸0 + (
𝑅𝑇
𝑧𝐹
) ln 𝑎𝑖 
EQUATION. 1.1 
where, E = electrode potential, Eo = standard electrode potential, R = universal gas 
constant, T = temperature (oK), z = ionic valence of substance, F = Faraday constant, 
𝑎𝑖 = activity of substance. 
The potentiometric response (mV) of the chemical sensors depends logarithmically on 
the activity of the substance ai (Equation 1.2) 
𝑎𝑖 = 𝑓𝑐𝑖 
EQUATION. 1.2 
where, 𝑓 = activity coefficient of substance, 𝑐𝑖 =   concentration of substance. 
 
Application of these formulae suggests that, in the case of detection of diclofenac, the 
differences observed were largely due to the different cations. This observation raises 
the question that, are the sensors on the taste sensor  detecting the leaving group 
cations i.e. H+, Na+, K+ and not the parent diclofenac molecule. This therefore suggests 
that the resultant taste quality observed relates to the cation and not the parent 
diclofenac molecule which is the active ingredient.  
 
Furthermore, questions still remain as to whether the detection process is a function of 
concentration or a function of intrinsic bitterness of the molecule in question. It is 
necessary to understand whether the bitterness described by the electronic tongue is 
attributed to the underlying bitterness of the API or its concentration in the formulation. 
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Also of interest to be investigated is the issue of how the physical characteristics of the 
molecule i.e. solubility in water, extent of ionisation in solution (pKa) and salt 
dissociation profile affect the detection of the molecule by the electronic tongue. 
1.3.3 PHARMACEUTICAL APPLICATION 
Reports in literature have established the utility of the electronic tongues in validating 
various taste masking strategies.  A study evaluated the bitterness of clarithromycin 
which was coated with an aminoalkyl methacrylate polymer using the spray congealing 
technique (Uchida et al. 2003). An electronic tongue was used to confirm that the 
polymer was successful in almost completely masking the bitter taste of clarithromycin.  
Taste masking efficiency of quinine pellets produced via extrusion-spheronisation and 
coated with Eudragit® EPO was evaluated using the Astree 2 electronic tongue 
(Kayumba et al. 2007).  They demonstrated taste masking ability of this formulation. 
The evaluation of ibuprofen suspensions using the Insent TS500Z  in a top down 
fashion with the aim of developing a taste masked generic formulation has been 
successfully demonstrated in a recent study (Woertz et al. 2010b). The Astree 2 was 
used to illustrate the taste masking efficiency of hot melt extruded paracetamol 
granules containing Eudragit® EPO or Kollidon® VA64. The best taste masking effect 
was observed with VA64 at 30% paracetamol loading (Maniruzzaman et al. 2012). In 
another study, the Astree 2 was used to evaluate taste masking efficiency of 
paracetamol powder formulations. The powders were produced via spray drying of 
aqueous paracetamol dispersions containing sodium caseinate and lecithin. The 
“coating” containing sodium caseinate and lecithin had a significant role in decreasing 
the release of drug in the first 2 minutes and therefore was able to mask the bitterness 
of paracetamol (Thia et al. 2012). Orodispersible films containing dimenhydrinate and 
cyclodextrin / maltodextrin prepared using the solvent casting method where 
investigated for taste masking efficacy using both the α-Astree and the TS-5000Z. In 
both cases, taste masking effect of the excipients was demonstrated (Preis et al. 2012). 
In another study, the α-Astree2 was used to evaluate the bitterness of eight 
antihistamines namely: cetirizine dihydrochloride, diphenhydramine hydrochloride, 
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chlorphenamine maleate, epinastine hydrochloride, ketotifen fumarate, olopatidine 
hydrochloride, fexofenadine hydrochloride and azelastine hydrochloride. The 
antihistamines were compared to quinine hydrochloride and water. The Euclidean 
distances between API and quinine / water were calculated. However, it was not 
possible to establish a bitterness scale as the main sensor response was acidity (Ito et 
al. 2013). With the exception of Uchida et al (2003) and Ito et al (2013), all the other 
studies highlighted here did not attempt to illustrate correlation between the taste 
masking efficiency shown on the electronic tongue with a human taste panel study. In 
addition, again with the exception of Ito et al (2013), all the studies did not use known 
comparators like quinine hydrochloride or water in proving taste masking efficacy of 
their new formulations. With this in mind this thesis will aim to describe the correlation 
of taste prediction / perception between a human taste panel and the Insent® 
electronic tongue.  
 
1.4 TASTE MASKING 
There are three general taste masking strategies, namely; the use of physical barriers, 
chemical or solubility modification and solid dispersions.  Table 1.6 gives a list of the 
different techniques currently used for taste masking. Physical barrier methods are 
described in brief because they are the most common method. Solid dispersion 
strategies are discussed in further detail as one of these strategies is going to be used 
in this thesis. 
TABLE 1. 6 SUMMARY OF CLASSIFICATION AND EXAMPLES OF TASTE MASKING STRATEGIES 
Taste Masking Strategies 
Physical Barriers Chemical modification Solid dispersion 
Fluidised bed coating Chemical derivitisation Melt granulation 
Micro-encapsulation Complexation Spray congealing 
Supercritical fluids  Melt extrusion 
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1.4.1 PHYSICAL BARRIERS 
The simplest and most common method to taste mask a bitter API, especially 
chewable and liquid formulation is via physical barriers.  A barrier coated onto the API 
could successfully provide a palatable oral dosage form, as sometimes such barriers 
prevent early dissolution of API in the oral cavity.  
FLUIDISED BED COATING 
This technology is commonly used to apply a continuous coat around the core particle. 
Generally coating can be achieved using polymeric solutions or molten material. The 
atomisation of polymeric systems dispersed as solutions/suspensions in volatile 
organic solvent(s) and/ or aqueous vehicles are used to apply the film coat. While the 
use of organic solvents is generally fast with simplified film formation processes due to 
the dissolved nature of the polymer, the use of aqueous systems remains the preferred 
option. Aqueous systems are advantageous because of the absence of solvent toxicity, 
increase process safety and lower production costs. Despite these benefits, cases still 
remain where aqueous systems are inappropriate namely: API sensitivity to water 
resulting in degradation and migration of water leading to compromised quality of 
product (Bose et al. 2007). Alternatively, a solvent free process i.e. the atomisation of 
molten materials commonly known as melt coating has been adopted. This process 
requires application of low melting point materials maintained at temperature of about 
40 – 60oC above the melting point of the wax or polymeric component. When fatty 
acids or glycerol ester or low melting polymers such as polyethylene glycols are 
applied; the melt coating is performed in  fluid bed coater with the aid of heating 
systems for atomised air to provide a molten spray plume (Cerea et al. 2008). A study 
has reported the preparation of diclofenac sodium granules with Eudragit L30 D-55® 
by fluidised bed system. The subsequent dissolution studies confirmed the 
effectiveness of fluidised bed for applying enteric coated on diclofenac granules  
(Silva et al. 2006).  




Microencapsulation is defined as a process by which small discrete solid materials, 
liquid droplets or gases are completely enveloped within an intact membrane. Taste 
masking is often achieved by applying an encapsulating barrier around an API. The 
barrier remains intact while the dosage form in administered. Following administration, 
the barrier allows API release either immediately or in a modified fashion. Ethyl 
cellulose microcapsules containing theophylline exhibited modified release 
performance. It was reported that the microcapsules demonstrated excellent taste 
masking properties (Golzi et al. 2004). This is because the API was released slowly. 
Therefore an insufficient amount was release into the mouth to trigger a taste response 
prior to swallowing. There are several methods to achieve microencapsulation. The 
most common include: temperature-induced phase separation, emulsion solvent 
evaporation, solvent evaporation, film coating, non-solvent addition and spray drying. A 
very comprehensive review is described by Rogers et al (2011). The authors describe 
microencapsulation in terms of background and materials used (Rogers et al. 2011a), 
techniques used to make microcapsules (Rogers et al. 2011b) and applications 
(Rogers et al. 2011c). 
 
SUPERCRITICAL FLUIDS 
This is a rather limited approach which involves the use of supercritical fluids (SCFs). It 
is a one step process. The supercritical state is defined as a state where both the 
pressure and temperature of a substance are greater than its critical pressure (Pc) and 
critical temperature (Tc). The thermal and physical properties of SCFs fall in between 
pure liquids and pure gases. In a critical isotherm (between Tc and 1.2Tc), the density, 
viscosity, diffusivity and other physical properties, such as solvent strength and 
dielectric constant, can be varied in a range from gas like to liquid like with small 
changes around the critical pressure (0.9 – 2.0Pc) (Subramaniam et al. 1997). Carbon 
dioxide is one of the most commonly used supercritical solvents because of its 
relatively low critical temperature and pressure (Tc = 31.1
oC, Pc= 78.3bar) 
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(Bose et al. 2007). In this technique, essentially, the drug and polymer are dissolved in 
an organic solvent and then sprayed into a high pressure chamber filled with 
supercritical carbon dioxide (scCO2). Rapid expansion supercritical solution (RESS) is 
the most common supercritical fluid process in pharmaceutical applications. The 
coating agent is solubilised in scCO2 in a high pressure vessel. The API is dispersed in 
the SCF. The suspension is rapidly expanded by passing through a heated nozzle at 
supersonic speed. By so doing, the solvent power of carbon dioxide is reduced. This 
results in the coating material precipitating onto the particle of drug dispersed in the 
medium (Thies et al. 2003, Moribe et al. 2008). SCFs offer considerable promise for 
taste masking through the formation of micro-particles. However, this technique is not 
widely used because of its expensive running costs, limited polymer /drug solubility in 
carbon dioxide and insufficient drug loading in some cases. 
 
1.4.2 SOLID DISPERSION 
MELT GRANULATION 
This process involves the dispersion of the API into a molten mixture of highly water 
soluble sugars e.g. mannitol and xylitol. The mixture is heated above the eutectic 
temperature and then rapidly cooled to form a glassy solid. In some cases, solvents 
such as methanol, ethanol and polyethylene glycol are used to facilitate lower melting 
temperatures. The solvents are removed via cooling and solidification. In cases where 
the API is heat sensitive, a low melting point polymer can be used. 
 
SPRAY CONGEALING 
This method is used to change the structure of a material with the aim of obtaining free 
flowing powders. Generally, the API is allowed to melt, disperse or dissolve in a hot 
melt of an inert polymer and other additives. This molten mixture is sprayed into an air 
chamber where the temperature is below the melting point of the formulation 
components, the product of which are spherical congealed pellets which usually range 
from 0.25 to 2.0mm in size (Yajima et al. 2003). Spray congealing presents noticeable 
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advantages including the absence of solvent evaporation which makes the pellets non-
porous, strong and remain intact on agitation. It is also a single step continuous 
process. However, the high temperature exposure of the API presents a problem for 
APIs that are thermally labile. If amorphous / anhydrous forms of the API are generated 
this alters the dissolution behaviour and by extension the release profile. Furthermore, 
coated particles maybe perceived as gritty in the mouth due to the fact that water-
insoluble polymers remain intact in the mouth after all the other excipients have 
disintegrated or dissolved.  
 
PRECIPITATION AND DRYING 
This is a method of preparing stable dispersions of poorly soluble APIs in the presence 
of one or more stabilisers free of any toxic solvents. Initially, the poorly water soluble 
API is dissolved in a suitable solvent. This solution is added to another solution 
containing at least one surface stabiliser to form a second solution. The formulation is 
precipitated by adding an appropriate non solvent usually a polymer. The API is 
entrapped within the polymer matrix by in-situ complexation which eliminates the bitter 
taste and provides a good mouth feel. Any salt formed is removed by dialysis or 
filtration and concentrations of the dispersion by conventional means. Although 
precipitation can be applied to several APIs, in some cases, it is necessary to use 
harmful solvents. In addition, increased polymer-drug ratios are necessary to mask the 
bitter taste, resulting in a slow release profile. 
 
MELT EXTRUSION 
Melt extrusion is a well-known, solvent free approach which is generally accepted as a 
method to enhance the dissolution characteristics of poorly water soluble drugs. In 
taste masking, melt extrusion is performed by mixing API with an extrudable material 
e.g. Eudragit®. The process and pharmaceutical application of melt extrusion are 
described in detail in section 1.5 
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1.5 HOT MELT EXTRUSION (HME) 
Hot melt extrusion technique was first invented for the manufacturing of lead pipes at 
the end of the 18th century. Since then, it has been widely used in plastic, rubber and 
food manufacturing industries. The technology has proven to be a robust method of 
producing drug delivery systems, via the production of solid dispersions. Put simply, 
extrusion can be described as conveying raw materials with a rotating screw under 
controlled temperature and pressure through barrel. The output (extrudates) are of 
uniform shape and density (Breitenbach 2002).  
 
An extruder is composed of a control panel, inlet feeding hopper, steel barrel with 
different heating zones, screws for extrusion, a die attached to the end to specifically 
shape the product, a cooling system and downstream processing machinery. Two 
types of pharmaceutical grade extruders are available, ram and screw. The latter is 
available as single and twin screw types. The single screw has a long history but may 
not provide sufficient mixing of different materials if the screw is not long enough 
(Crowley et al. 2007). Single screw extrudates showed streaks and shaded areas 
indicating incomplete mixing whereas materials processed using twin-screw extrusion 
was homogenous. 
 
The vast majority of extruders manufactured for pharmaceuticals needs are twin-screw 
types. The screws can be oriented in a number of configurations depending on the 
desired level of shear and speed operation. Depending on required intensity of mixing, 
the two screws can be designed to rotate in the same direction (co-rotating) or in 
opposite (counter rotating). Co-rotating screws are primarily used in pharmaceutical 
formulation. 
1.5.1 PROCESSING 
Theoretically, HME can be divided into five steps, namely: feeding, melting and 
plasticising, conveying and mixing, flow through the die, stripping and downstream 
processing. These are illustrated in Figure 1.9. 




FIGURE 1. 9 HOT MELT EXTRUSION ILLUSTRATED. HTTP://WWW.PARTICLESCIENCES.COM/IMAGES/TB/HOT-
MELT-EXTRUSION-PROCESS.JPG 
 
Each of these steps affects the properties of the final extrudate. In brief, the material to 
be extruded is introduced into the feed section via a hopper. It is essential that the 
angle of the feed hopper always exceeds the angle of repose of the feed material in 
order to ensure good flow properties of the feedstock and avoid formation of solid 
bridges at the throat of the hopper which often results in erratic flow. The feed section 
has flights of greater pitch as illustrated in Figure 1.10. As the material is conveyed 
along the screw to the mixing zone, the flight depth decreases gradually. This 
increases the pressure on the material (through a squeezing effect) that, when 
combined with the external heating to the barrel and increased shear causes the 
material to melt. The final metering point zone has the smallest depth but is held 
constant to provide and even flow of material to the die (Wilson et al. 2012). 




FIGURE 1. 10  SCREW DIMENSIONS SHOWING FLIGHT/ CHANNEL DEPTH, AXIAL CHANNEL WIDTH, PITCH, 
AXIAL FLIGHT WIDTH AND HELIX ANGLE (BREITENBACH 2002). 
  
The processing parameters play a key role in determining the properties of the final 
extrudate. Some of the most commonly adjusted parameters include screw speed, 
processing temperature and feeding rate (Henrist et al. 1999). As HME is a non-
ambient process, often high temperatures are required to facilitate extrusion and as 
such plasticising agents play a pivotal role in providing acceptable drug delivery 
systems. They can be used to lower the processing temperature required therefore 
preventing the thermal degradation of the API. In some cases, interactions between the 
drug and the polymer may be used to this effect. However, certain minimum 
temperatures are required in order to reduce the torque needed to rotate the screws. 
Typically, the temperature of the melting zone is set to 15 – 60oC above the melting 
point of the semi-crystalline polymer or the glass transition of an amorphous polymer 
(Repka et al. 2008). 
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Torque is directly proportional to the viscosity of the molten feedstock  
(Repka et al. 2007). This relationship can be expressed using the Arrhenius equation 
(Equation 1.3) 
𝜂 =  𝐾′  ×  𝑒𝑅𝑇
𝐸𝑎 
EQUATION 1.3 
where, η = viscosity of polymer melt, 𝐾′ is a constant dependant on the structure and 
molecular mass of polymer. 𝐸𝑎 is the activation energy of the polymer for the flow 
process and is constant for the same type of polymer while 𝑅 is the gas constant and 𝑇 
is the temperature (oK). 
 
The screw speed and feeding rate are also related to shear stress, shear rate and 
mean residence time, which will affect the dissolution rate and stability of the final 
products. Although heat conduction from the electrical bands on the barrel contributes 
to the melting process, heat is also generated by shearing of the polymer melt. 
“Viscous heat generation” is the process of transforming energy from shearing into 
thermal energy (Li et al. 2013). The rate of heat generation per unit volume due to 
viscous heat dissipation follows Equation 1.4 
𝐸 = 𝑚 × 𝛾𝑛+1 
EQUATION 1.4 
where, 𝑚 is a constant, 𝛾 is the shear rate and 𝑛 is the power law constant. 
 
The materials used in the production of hot melt extruded dosage forms are similar to 
those used in traditional dosage forms. However, as already eluded above, thermal 
stability of the individual components is a pre-requisite for the process. It is noteworthy 
that the short processing time afforded by using HME does not entirely limit thermo-
labile compounds.in addition to the API. Other materials include carrier molecules, 
plasticisers, release modifying agents and/or other functional excipients. Carriers used 
in hot melt extrusion are broadly classified as either polymeric or non-polymeric. 
Needless to say, that the selection of the carrier compound is important in the 
formulation and design of hot melt extruded dosage forms. This is because the 
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properties of the carrier material often dictate the processing conditions necessary for 
the production of the dosage unit. These properties also often modulate the release of 
the active from the final dosage form. Some examples of carries used in the 
pharmaceutical industry include Eudragit®, Kollidon® and Soluplus®, these will be 
discussed further when considering the pharmaceutical application of HME in  
section 1.5.3. 
 
Plasticisers are sometimes necessary in order to improve the processing conditions or 
to improve the physical and mechanical properties of the final product. They are 
typically low molecular weight compounds capable of softening polymers thus making 
them more flexible. Plasticisation of a polymer is generally attributed to the 
intermolecular secondary valence forces between the plasticiser and the polymer. 
Therefore plasticisers are able to decrease the glass transition temperature and the 
melt viscosity of a polymer by increasing the free volume between polymer chains 
(Aharoni 1998). Release modifying and other functional excipients have not been 
discussed in this thesis due to the fact that there were not used in the formulation 
design and therefore deemed not relevant to this discussion. 
 
1.5.2 PHARMACEUTICAL APPLICATIONS 
HME stands out in the pharmaceutical industry because it is associated with increased 
throughput, efficient mixing and material modification during processing. Furthermore, 
HME presents a highly versatile technology capable of producing a wide range of 
different drug-delivery products, including pellets, controlled release tablets, fast 
dissolving systems, transdermal/ trans- mucosal delivery systems and implants. 
Several comprehensive reviews covering this issue are available in the literature 
(Breitenbach 2002, Repka et al. 2008, Jones et al. 2010).  
 
Although it is widely accepted that HME is useful in taste making, there are limited 
reports where this has been evaluated using the taste assessment techniques 
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described in Section1.2. Instead, reports in the literature have detailed the 
mechanisms and dissolution profiles of solid dispersions created via HME  
(Qi et al. 2008a, Qi et al. 2010b, Jijun et al. 2011). Other reports in the literature have 
focussed on the analytical techniques to characterise such solid dispersions (Qi et al. 
2008b, Yang et al. 2013). In other reports, the mechanical properties of hot melt 
extrudates were investigated (Campbell et al. 2009).  Reports in the literature detailing 
the taste masking efficacy of hot melt extrusion following taste assessment using the 
electronic tongue are both reported by Douromis’ working group. In the first report, they 
produced hot melt extruded paracetamol formulations using Eudragit® EPO and 
Kollidon VA64 as carriers. The taste masking efficacy was evaluated using a panel of 
six untrained volunteers and the α-Astree electronic tongue. The best taste masking 
effect was observed for Kollidon VA64 at 30% paracetamol loading. The authors 
reported good correlation between in-vivo and in-vitro taste assessment methods  
(Maniruzzaman et al. 2012). In another study, the same group produced hot melt 
extrudates of cetirizine hydrochloride and verapamil hydrochloride with various grades 
of Eudragit L100 and Eudragit L100-55. Taste assessment was carried out in similar 
fashion to their previously reported work. This study concluded that HME was able to 
mask the bitter taste of drug by enhancing the drug polymer interactions 
(Maniruzzaman et al. 2014). The work detailed in this thesis seeks to add to this limited 
pool of evidence by describing the taste masking effects of hot-melt extrudates using 
the Insent® electronic tongue for which there are currently no reports in the literature. 
 
1.6 DISSOLUTION TESTING OF TASTE MASKED SOLID DOSAGE 
FORMULATIONS 
Historically dissolution testing has been used to assess taste masking efficiency 
because it allows the researcher to make a prediction of the taste masking capability of 
the formulation by estimating the likely release in the oral cavity. The British 
Pharmacopoeia (BP) has recommended dissolution tests for delayed release dosage 
forms, however, these are not appropriate for taste masked particles as they are 
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designed to mimic the stomach and the small intestine with the use of an acid stage 
followed by a buffer stage. This does not give consideration of the oral cavity because 
the oral cavity solvent composition (saliva), volume and residence time is considerably 
different.  
 
Natural saliva is a complex aqueous solution containing 99% water and a diverse 
spectrum of inorganic ions, small organic molecules and proteins. The inorganic ions 
include bicarbonate and phosphate which contribute to the buffer capacity of the saliva. 
Electrolytes such as sodium, potassium, magnesium, zinc, calcium, chloride, fluoride, 
iodide, thiocyanate and nitrates are present. In addition, small molecules such as 
steroid hormones, amino acids, glucose, creatinine and urea have been identified. The 
proteins present include immunoglobulins, mucins (which contribute to the viscosity of 
saliva), enzymes including lingual lipase and amylase, growth factor, and antimicrobial 
factors such as lactoferrin and lysozyme (Gibson et al. 1994). It is clear that the 
complexity of natural saliva renders it challenging to prepare artificially in the exact 
composition of natural saliva. Saliva is generated in the oral cavity by three salivary 
glands namely: parotid, submandibular and sublingual, which together produces 90% 
of total saliva. Studies have shown that unstimulated saliva flow rate range between 
0.05 – 2.87mlmin-1, with mean values between 0.37 and 0.56mlmin-1 (Rudney et al. 
1995, Aframian et al. 2006). Other studies have reported that the volume of saliva 
present in the oral cavity ranged from 0.09 – 1.86ml, with a mean or median values in 
the range of 0.37 – 0.70ml and only approximately 30% of saliva is swallowed in each 
unforced swallow (Lagerlöf et al. 1984, Müller et al. 2010). In addition, the pH of saliva 
has been shown to range from 5.45 – 7.8 (Kalantzi et al. 2006, Shpitzer et al. 2007). 
 
Ideally, dissolution testing of taste masked solid dosage form should mirror the oral 
cavity environment. Few studies have been reported in the literature relating to the 
modelling of the oral cavity. Lee at al evaluated coated nanohybrid particles of 
sildenafil at neutral pH in de-ionised water for 2 minutes as a model of the oral cavity 
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(Lee et al. 2012). However, this test was carried out using 900ml of media and a 
paddle dissolution apparatus. Such a large volume is not representative of the volumes 
found in the oral cavity. Smaller volumes were used in a study evaluating polymer 
coated diclofenac particles in 50ml of simulated salivary fluid which was comprised of 
potassium dihydrogen phosphate (12mM), sodium chloride (40mM), calcium chloride 
(1.5mM), sodium hydroxide (to pH 7.4) (Guhmann et al. 2012). Several examples of 
modelling the oral cavity are discussed in a review by Gittings et al (2014). What is 
clear from this review is that more research is needed into the development of an in-
vitro dissolution model that mimics the oral cavity in terms of media composition, 
volume, agitation and residence time (Gittings et al. 2014). 
 
This inappropriateness of traditional dissolution testing  was initially highlighted by the 
International Pharmaceutical Federation (FIP) and American Association of 
Pharmaceutical Scientists (AAPS) who jointly issued guidance on dissolution testing of 
novel dosage forms (Siewert et al. 2003b). Although these guidelines cover 
formulations such as suspensions, orally disintegrating tablets, chewable tablets, 
transdermal patches and suppositories, it also highlights the need for more research 
for powders and granules and micro particulate formulations. To this end, the research 
presented in this thesis also demonstrates a proof of concept study for dissolution 
testing of taste masked powders produced via hot melt extrusion.  
 
1.7 RESEARCH OBJECTIVES 
The overall aim of the research detailed in this thesis was to further the understanding 
of the electronic tongue (Insent® TS-5000Z) and how it can be used for taste 
assessment during or after the formulation process. The work detailed in this thesis is 
composed of three main areas. 
 
The first area concerns the analysis of sensor responses to different molecules in 
solution with the view to gain further understanding of the mechanism of detection. 
CHAPTER 1  INTRODUCTION 
69 
 
Within this area, the first objective was to address the issue of detection of molecules 
with similar structure. To this end methylxanthines, namely caffeine, theobromine and 
theophylline were investigated. This work detailed in Chapter 3, Section 3.2 
highlighted the need for using sensor response curves in order to establish whether 
molecules were being detected. The second objective (based on results from Chapter 
3, Section 3.2) was to investigate a series of molecules for which detection had been 
previously reported. The work described in Chapter 3, Sections 3.3 and 3.4, led to 
identification of factors that influenced the detection of the molecules, i.e. the 
interaction between detecting sensor and ions, extent of dissociation / ionisation of 
electrolyte, concentration and the effect of solvent. The relevance of these factors is 
discussed in detail in Chapter 3, Section 3.5. 
  
The second area of this thesis has three objectives. The first objective which is 
described in Chapter 4, Section 4.3.1 was to investigate the utility of the electronic 
tongue in predicting which salt of amlodipine had the best taste profile. For the second 
objective, three extemporaneous formulations of amlodipine were investigated in order 
to compare their taste masking efficiency if any, with a view to provide objective data 
that could potentially influence decision making for clinicians when it comes to which 
extemporaneous formulation to use. The final objective in this area was to investigate 
the correlation in taste prediction of the electronic tongue to the perception of a human 
taste panel. This would further validate the use of electronic tongues for development 
of pharmaceutical formulations. 
 
The third area addressed in this thesis was to evaluate the taste masking efficacy of 
formulation prepared using hot melt extrusion. Within this area (detailed in Chapter 5, 
Section 5.3), the first objective was to produce a hot melt extruded formulation using 
Eudragit® EPO as a polymeric carrier and quinine hydrochloride dihydrate as the 
model drug. The second objective was to characterise this formulation by performing a 
series of thermal, spectroscopic and X-ray diffraction techniques. The third objective in 
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this area was to evaluate the taste masking efficacy of this formulation. Two methods 
were employed in this objective: i) electronic tongue ii) modified dissolution apparatus 
with spectrophotochemical analysis, with a view to demonstrating a proof of concept for 
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CHAPTER 2 – MATERIALS AND METHODS 
2.1 MATERIALS 
All materials used were of analytical grade. Caffeine, theobromine, theophylline, 
quinine, quinine (Qn) hydrochloride dihydrate (QHD), quinine hemisulphate 
monohydrate (QhS), maleic acid and benzenesulfonic acid were obtained from Sigma-
Aldrich UK and used as received. L-(+)-tartaric acid, absolute ethanol (≥99.8%) and 
tannic acid were also obtained from Sigma-Aldrich UK. Potassium chloride (KCl) was 
obtained from Lancaster UK. Monosodium glutamate (MSG) and iso-α-acid was 
supplied by Insent® Japan. Eudragit® EPO was kindly donated by Evonik Industries 
AG, Darmstadt Germany. Amlodipine maleate, amlodipine mesilate and amlodipine 
besylate tablets were purchased from AAH Pharmaceuticals UK. The electronic tongue 
sensors were purchased from Insent ® Japan as used as received. 
 
2.1.1 EUDRAGIT® EPO 
Eugradit ® EPO is a cationic polymer with the chemical name poly (butyl methacrylate- 
co- (2-dimethylaminoethyl) methacrylate-co-methacrylate (1:2:1). The monomer 
structure is given in Figure 2.1. It has an approximate molecular weight of 
47,000g/mole and a glass transition temperature (Tg) of 45
oC ±5oC. It is naturally 
amorphous. It is presented as a white powder with a characteristic amine like odour. 
Eudragit® EPO is soluble in gastric fluid up to pH 5 and swellable and permeable at pH 
values above 5.  It is routinely used in film coating, due to the dimethyl aminoethyl 
group forming a swellable and permeable coat at pH 5 or higher but also rapidly 
dissolving by forming salts at acidic pH values lower than pH 5. Even very thin film 
coats of approximately 10µm are effective. It is ideal for taste masking because it is 
insoluble in saliva which has a pH values ranging between 6 and 7. However, due to its 
swellable and permeable nature, it is possible for drug release to occur in the 
oromucusal cavity. 
 




FIGURE 2. 1 CHEMICAL STRUCTURE OF EUDRAGIT®EPO 
 
Besides coating, granulation and melt processes have been applied to taste masking 
using Eudragit® EPO. In these techniques, complexes are reversibly formed when an 
anionic API interacts with large cationic Eudragit ® EPO at a molecular level. This API-
polymer composite prevents the API directly interacting with taste receptor cells in the 
oral cavity, thus achieving taste masking (Douroumis 2007). Recently, Eudragit® EPO 
was used in amorphous solid dispersions to increase the dissolution of poorly water 
soluble drugs (Feng et al. 2012, Sathigari et al. 2012). Additionally, the phase 
behaviour of Eudragit® EPO in amorphous solid dispersion has been studied  
(Qi et al. 2008b, Qi et al. 2010a). In these studies, it is reported that the drug-polymer 
solid solubility is drug dependent and as such different drugs formulated with the same 
polymer can present significantly different physical stability. The efficacy of Eudragit® 
EPO in taste masking has been studied using ondansetron (Khan et al. 2007), 
donepezil (Yan et al. 2010) and paracetamol (Maniruzzaman et al. 2012). All three 
studies reported successfully taste masking of API using Eudragit® EPO. This polymer 
was chosen for this project due to the fact that there is some interest on physical 
stability of the API in a solid dispersion of this polymer, and more importantly interest in 
its taste masking ability. 
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2.1.2 MODEL DRUGS 
2.1.2.1  CAFFEINE 
 
FIGURE 2. 2 STRUCTURE OF CAFFEINE 
Caffeine is a naturally occurring xanthine derivative that is similar in structure to 
theobromine and the bronchodilator theophylline. It is found in coffee, black tea and 
milk chocolate at concentrations of 350µg/ml, 217µg/ml and 5µg/ml respectively. Its 
chemical name and formula are 1, 3, 7-trimethyl-2, 3, 6, 7-tetrahydro-1H-purine-2, 6-
dione and C8H10N4O respectively.   It is used a central nervous system (CNS) stimulant, 
mild diuretic and respiratory stimulant (in neonates with premature apnea). It 
antagonises the A1 and A2 subtypes of the adenosine receptor which results in 
stimulation of the respiratory centre, this increases minute ventilation, and decreases 
response to hypercapnia. It also increases muscle tone, metabolic rate and oxygen 
consumption while decreasing diaphragmatic fatigue and threshold to hypercapnia. 
Often, it is combined with analgesics in various all-in-one formulations for treating colds 
and flu symptoms particularly headaches. A study with ergotamine alkaloids indicate 
that the enhancement effect by the addition of caffeine may also be due to improved 
gastrointestinal absorption of ergotamine when administered with caffeine  
(Schmidt et al. 1974). Depending on the formulation, caffeine or caffeine citrate can be 
used. Citrated caffeine is generally used for orodispersible tablets or solutions due to it 
being more soluble than caffeine. Their respective solubilities at 20oC are 18.7g/L and 
95g/L. Caffeine citrate solution is currently available unlicensed in UK and US for the 
treatment of neonatal apnoea.  
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It is well understood that caffeine is bitter and as such it has been used as a model 
drug in research to elucidate the physiology of bitter taste transduction  
(Koyama et al. 1972b, Kurihara 1972). Caffeine has also been the subject of a 
significant amount of research on taste masking strategies (Warmke et al. 1993, 
Schiffman et al. 1994, Schiffman et al. 1995, Zheng et al. 2006, Woertz et al. 2011a). 
 
2.1.2.2  THEOBROMINE 
 
FIGURE 2. 3 STRUCTURE OF THEOBROMINE 
 
Contrary to its name, theobromine contains no bromine; its name is derived from the 
theobora, the name of the genus of the cocoa tree. Its chemical name and formula are 
3, 7 – dimethyl-1H-purine-2, 6-dione and C7N8N4O2 respectively. Theobromine is 
generally recognised as safe (GRAS) by the Food and Drug Administration (FDA). 
Human metabolism of caffeine produces theobromine as a metabolite. It is present in 
coffee, black tea and milk chocolate at concentrations of 17µg/ml, 12µg/ml and 
21µg/ml respectively. Historically, the bitter taste of cocoa beans was attributed to the 
presence of theobromine (1.5%) and caffeine (0.15%) (Pickenhagen et al. 1975, Stark 
et al. 2005). However, Stark et al (2005) revealed that besides theobromine and 
caffeine, the flavan -3-ols epicatchin, catechin, polycynadin B-2, procyanidin B-5, 
procyanidine C-1, epicatechin – (4β→8)3 and epicatechin – (4β→8)4 were among the 
key compounds contributing to the bitter taste as well as the astringent mouthfeel upon 
consumption of roasted cocoa. 
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Theobromine was shown to be effective as a diuretic as well as in the treatment of 
angina pectoris. However, patients  experienced severe nausea and heartburn when 
large doses were given in an attempt to achieve sufficient diuresis  
(Riseman et al. 1941). Therefore, there are currently no licensed medicinal products in 
the UK, US or European markets.  Theobromine is found in a wide range of food 
products including beverages, yoghurt drinks, powdered fruit flavoured tea, coffee and 
chocolate. 
 
Theobromine stimulates medullary, vagal, vasomotor and respiratory centres, 
promoting bradycardia, vasoconstriction and increased respiratory rate. This action 
was previously believed to be due to increase intracellular cyclic 3’5’-adenosine 
monophosphate (cAMP) following the inhibition of phosphodiesterase. It is now thought 
that xanthines such as theobromine and caffeine act as an antagonist at the adenosine 
receptors within the plasma membranes of cells.  Since adenosine acts as an autocoid, 
inhibiting the release of neurotransmitters from the presynaptic sites but augmenting 
the actions of norepinephrine or angiotensin, antagonism of adenosine receptors 
promotes neurotransmitter release (Knox et al. 2011).  
2.1.2.3  THEOPHYLLINE 
 
FIGURE 2. 4 STRUCTURE OF THEOPHYLLINE 
 
Theophylline has the chemical name 1, 3-dimethyl-2, 3, 6, 7-tetrahydro, 1H-purine-2, 6-
dione and molecular formula C7H8N4O2; it is found in trace amounts (<10
-7 µg/ml) in tea, 
coffee or milk chocolate (Bispo et al. 2002).  Like the other two methylxanthines 
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already discussed, theophylline is also known to be bitter. It has been used in the 
literature as a model drug for comparing taste masked formulations  
(Burleson et al. 1978), and novel taste masking strategies (Pearnchob et al. 2003). 
 
The mechanism of action of theophylline remains unclear. Traditionally, it was 
classified as a bronchodilator; however the ability of theophylline to control chronic 
asthma is disproportionately greater than its relatively small degree of bronchodilator 
activity. In fact, it is believed that theophylline has immune-modulatory, anti-
inflammatory and bronco-protective effects that potentially contribute to its efficacy as a 
prophylactic anti-asthmatic drug.  Several mechanisms of action have been suggested 
including:  
 Inhibition of phosphodiestarase enzyme leading to raised cAMP levels 
 Antagonism of adenosine receptors 
 Inhibition of intracellular release of calcium 
 Stimulation of catecholamine 
 Anti-inflammatory action possibly involving the inhibition of submucosal action. 
 
Although these mechanisms have been proposed to explain action of theophylline, 
inhibition of phosphodiesterase isoenzymes and non selective antagonism of specific 
cell-surface receptors for adenosine are the only ones known to occur at clinically 
relevant drug concentrations. Theophylline increases intracellular concentration of 
cyclic nucleotides in airways smooth muscle and inflammatory cells by inhibiting 
phosphodiesterase mediated hydrolysis of these nucleotides. Non-specific antagonism 
of adenosine receptors appears to be the mechanism of action by which theophylline 
increases ventilation during hypoxia, decrease fatigue in diaphragmatic muscles and 
decreases adenosine stimulated mediator release from mast cells  
(Weinberger et al. 1996). 
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2.1.2.4  QUININE  
 
FIGURE 2. 5 STRUCTURE OF QUININE 
 
Quinine (Qn) has the chemical name (R) -6- methoxyquinolin -4-yl) ((2S, 4S, 8R) -8- 
vinylquinuclidine –2-yl) methanol and molecular formula (C20H24N2O4). It is an alkaloid 
derived from the cinchona bark. It is used mainly as an anti-malarial agent. The precise 
mechanism of action of quinine remains unclear but current literature suggests that it 
may interfere with lysosome function or nucleic acid synthesis in the malaria parasites 
(Golenser et al. 2006). It is a rapidly acting blood schizontocide with activity against 
Plasmodium faciparam, P vivax, P ovale and P malariae. It has activity against 
gametocytes of P malariae and P vivax, but not mature gametocytes of P falciparam. 
Quinine is also used to treat nocturnal cramps as it has effects on the motor end-plate 
of skeletal muscle and therefore prolong the refractory period (El-Tawil et al. 2010). 
Quinine is also used as sodium channel blocker and as such as local anaesthetic and 
both anti and pro-arrhythmic activity. In this study, quinine (base), and its hydrochloride 
and sulphate salts are investigated. Table 2.1 gives a summary of the physical 
characteristics of the quinine and its salts. Quinine hydrochloride dihydrate is used in 
intravenous injections for the treatment of malaria, while its less soluble counterpart 
quinine sulphate is used in the treatment of nocturnal muscle cramps in film coated 
tablets. Quinine has two pKa values i.e. 4.1 and 8.5; it is neutral at pH 10, 
monoprotonated at pH 6 and diprotonated at pH 2. 
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The bitter taste of quinine is well recognised in the literature and evidenced by the fact 
that the elucidation of bitter taste transduction pathways used quinine as the standard 
of bitterness (Koyama et al. 1972a, Price 1973). Subsequently, there is significant 
interest in the literature on taste masking of quinine. Reid at al (1956) used cocoa 
syrups to mask the bitter taste of quinine.  A series of studies formulated taste masked 
quinine sulphate in pellets and tablets for the treatment of malaria in Rwanda 
(Kayumba et al. 2007, Kayumba et al. 2008, Kayitare et al. 2010).  Another study used 
sucrose, aspartame and sodium chloride  as taste masking agents for quinine 
hydrochloride (Nakamura et al. 2002). Finally, quinine has been used as a bitterness 
standard when comparing taste assessment strategies (Woertz et al. 2011a). 
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TABLE 2. 1 BASIC PHYSICAL CHARACTERISTICS OF QUININE AND QUININE SALTS 















324.42 173-175 Slightly 
soluble 









396.91 115-116 Soluble  (Reid et al. 1956, Schiffman 









391.47 225 Slightly 
soluble 
(Kayumba et al. 2007, 
Kayumba et al. 2008) 







FIGURE 2. 6 STRUCTURE OF PARACETAMOL 
 
Paracetamol (acetaminophen) has the chemical name N-(4-hydroxyphenyl) acetamide 
and molecular formula C8H9NO2, is one of the most popular and widely used drugs in 
the treatment of pain and fever. In the UK there are over 200 licensed paracetamol 
containing preparations. Although paracetamol has been used clinically for more than a 
century, its mode of action has remained unclear until recently. Data have been 
published in the literature demonstrating that the analgesic effect of paracetamol is due 
to the indirect activation of cannabinoid CB1 receptors. In the brain and spinal column, 
paracetamol, following deacetylation to its primary amine (p-aminophenol) is 
conjugated with arachidonic acid to form N-arachidonoylphenolamine, a compound 
already known (AM404) as an endogenous cannabinoid. This suggests that 
paracetamol acts as a pro-drug with active metabolite AM404 formed in the brain by 
action of the fatty acid amide hydrolase (Bertolini et al. 2006). 
 
The bitter taste of paracetamol is well recognised in the literature. Most of the 
paracetamol oral suspension products currently licensed in the UK market contain 
varying concentrations of sweetening agents such as maltitol liquid, sorbitol liquid and 
sodium saccharin. Strawberry, orange or cherry flavour is also used in these 
formulations. Furthermore, the orodispersible preparations also contain some of the 
sweetening agents listed above.  Paracetamol has also been the subject of 
investigation for taste masking strategies (Miyazaki et al. 2005, Zheng et al. 2006, 
Maniruzzaman et al. 2012, Thia et al. 2012). 
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2.1.2.6  IBUPROFEN 
 
FIGURE 2. 7 STRUCTURE OF IBUPROFEN 
 
Ibuprofen has the chemical name 2-[4-(2-methylpropyl)phenyl] propanoic acid and 
molecular formula C13H18O2 is a commonly used non-steroidal anti-inflammatory drug 
(NSAID) with analgesic and antipyretic effects. The exact mechanism of action is not 
fully understood, however, it is believed to be a non-selective inhibitor of the cyclo-
oxygenase (COX) enzyme, which is involved in prostaglandin synthesis via the 
arachidonic acid pathway. The pharmacological effects are believed to be due to the 
inhibition of COX-2 which decreases the synthesis of prostaglandins involved in the 
mediation of inflammation, pain, fever and swelling. Antipyretic effects are thought to 
be due to the action on the hypothalamus, resulting in an increased peripheral blood 
flow, vasodilation and subsequent heat dissipation. 
 
The taste of ibuprofen is described in the literature as “peppery” and as such all the 
liquid formulations available commercially are taste masked. For example, a popular 
brand of ibuprofen suspension, Nurofen® is taste masked with maltitol syrup, glycerol 
and orange flavour. 
 
2.1.2.7  METFORMIN HYDROCHLORIDE 
 
FIGURE 2. 8 STRUCTURE OF METFORMIN HYDROCHLORIDE 
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Metformin has the chemical name 1-carbamimidamido-N,N-dimethanimidamide and 
molecular formula C4H11N5 is a biguanide anti-hyperglycaemic agent used for treating 
type 2 diabetes formally called non-insulin dependent diabetes mellitus. It is 
recommended as first line therapy by the National Institute for Health and Care 
Excellence (NICE) in patients who are overweight and  for whom dietary management 
and exercise alone has not achieved adequate glycaemic control (NICE 2009). 
Metformin lowers both basal and postpradial plasma glucose. It does not stimulate 
insulin secretion and as such does not induce hypoglycaemia. The following 
mechanisms have been proposed for the mode of action of metformin: 
 Reduction of hepatic glucose production by inhibiting gluconeogenesis and 
glycogenolysis 
 In muscle tissue, increasing insulin sensitivity, improving peripheral glucose 
uptake and utilisation 
 Delaying intestinal glucose absorption 
 Stimulating intracellular glycogen synthesis by acting on glycogen synthase 
 Increasing the transport capacity of all types of membrane glucose (GLUTs) 
known to date. 
The bitterness of metformin is not clear in the literature. The manufactures of 
metformin hydrochloride report a taste disturbance as a common side effect i.e. 1/100 
≥ n ≤ 1/10 (where n = proportion of patients taking drug). This takes the form of a 
metallic taste which is believed to decrease over time, taking anything from one to 
twelve weeks of taking metformin. The current thinking suggests that the metallic taste 
is caused by the accumulation of metformin in saliva. The mechanism by which this 
happens is still unclear.  Metformin tablets on the market in the UK are film coated with 
hypromellose and macrogol. The film coat was applied to aid taste masking and 
making the tablet easier to swallow (Hetal 2014). Both metformin suspensions currently 
available commercially are taste masked using liquid maltitol, caramel, peppermint and 
peach flavours. 
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2.1.2.8  AMLODIPINE 
 
FIGURE 2. 9 STRUCTURE OF AMLODIPINE 
 
Amlodipine has the chemical name, (R, S)-3-ethyl 5-methyl 2-[(2- amoniethoxy) methyl] 
-4-(2-chlorophenyl)-6-methyl-1, 4-dihydropyridine, 3-5-dicarboxylate. It is commonly 
used for the treatment of hypertension, chronic stable angina pectoris and vasospastic 
angina. It is a long acting dihydropyridine calcium channel blocker that exerts effect by 
blocking the trans-membrane influx of calcium (Ca2+) into cardiac and vascular smooth 
muscle tissues. It also reduces vascular resistance and lowers BP by causing a direct 
vasodilation in peripheral arteries of vascular smooth muscle. Amlodpine is used to 
treat high blood pressure in both paediatric and adult populations.  Its therapeutic 
action on angina is thought to be through the decrease in peripheral resistance and 
inhibition of coronary spasms (vasospastic angina). 
 
The taste of amlodipine is assessed in a study which compared children’s taste 
perception of pulverised amlodipine to lercanidipine. Both tablets were crushed and 
presented to the participants with no attempt to taste mask the powders.  This study 
demonstrated that children aged 4-7 years and 8-11 years both preferred crushed 
lercanidipine tablets over amlodipine (Milani et al. 2010). The generic manufacturers of 
amlodipine tablets including Aurobindo®, UK, Discovery Pharmaceuticals®, UK and 
Actavis®, UK did not have any information regarding the taste of amlodipine. 




 2.2.1 INSENT TS5000Z ELECTRONIC TONGUE MEASUREMENT PROCEDURE 
A schematic of the measurement procedure is illustrated in Figure 2.10. To start, the 
sensors are washed in the reference solution twice, each wash lasting 120s. The 
reference solution is composed of 30mM KCl + 0.3mM tartaric acid has no taste and is 
designed to mimic human saliva. Between four and ten pairs of reference solution are 
available and a different pair is used for each rinse.  The two rinsing steps are followed 
by the stabilising step in which the sensor is dipped into a separate reference solution 
and voltage reading is recorded. Essentially the voltage difference is expected to 
remain constant when the sensor is placed in the reference solution (Vr). If sensor 
recordings are not constant the stabilising process is repeated up to twenty times, until 
a constant is reached. A sensor is deemed to be stable if the value of the membrane 
potential becomes less or equal to the previous value recorded. If after twenty readings 
(Vr), and the recordings are not constant, then the sensors is deemed unstable and 
therefore cannot be used. Once stabilisation is complete, the sensors move on to the 
first sample (position designated A), were the sensors are immersed in the sample for 
30 seconds and the voltage difference is recorded (Vs). Therefore Vs – Vr gives the 
voltage reading for the initial taste.  The sensors are then briefly washed twice in two 
different reference solutions. Each wash lasts only three seconds. The sensors are 
then immersed in another reference solution where another voltage reading is recorded 
(Vr’). Vr’ – Vr then denotes the after taste or change in membrane potential after 
adsorption (CPA).  Finally the sensors are rinsed in positive or negatively charged 
washing solution for 90 seconds. 
 




FIGURE 2. 10 SCHEMATIC OF ONE CYCLE OF THE MEASUREMENT PROCEDURE ON THE ELECTRONIC 
TONGUE TS5000Z (WOERTZ ET AL. 2011A) 
 
2.2.1.1  SENSOR CHECK 
Prior to commencement of each measurement cycle a sensor check was carried out. 
This is not strictly recommended by the manufacturer but however it was performed 
nonetheless before every measurement. During the sensor check, the sensors are 
washed thoroughly in the positive and negative washing solutions for 2 x 120s. This 
was followed by a 90s wash in the reference solution. There are four to eight pairs of 
reference solutions which can be used. Following the 90s wash, the sensors are 
immersed in a different reference solution. The voltage readings for each sensor are 
displayed as shown is Table 2.2. This is repeated up to twenty times until the sensor 
reads the required voltage reading on three consecutive occasions. If after twenty 
attempts, the desired voltage reading is not recorded the sensor is deemed to be 
defective. It is possible for sensors to pass the sensor check and fail the maintenance 
measurement (discussed in section 2.4.3) therefore routine maintenance measurement 
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is required. At this junction it is worth noting that the sensor types and the reasoning 
behind choice of sensor types will be discussed in each chapter. The sensors currently 
available from the manufactures have already been described in detail in chapter 1, 
section 1.3.2. 
TABLE 2. 2 VOLTAGE READINGS FROM EACH SENSOR DURING SENSOR CHECK 
Sensor Voltage reading (mV) 
AN0 -63 ± 2.0 
AC0 -65 ±2.0 
C00 47± 2.0 
AE1 119± 2.0 
 
2.2.1.2  MAINTENANCE MEASUREMENT 
The maintenance measurement was carried out once a month as recommended by the 
manufacturers and at all times when sensors were changed. In this measurement the 
sensors are exposed to standard solutions whose composition is given in Table 2.3. 
Put simply, each sensor is expected to only respond to the taste attribute for which it is 
designed. For example, the astringency sensor (AE1) is expected to respond only to 
the astringency sample during maintenance. If any of the sensors respond to a 
standard solution for which they are not designed to, they are deemed as defective and 
need replacing.  
 
2.2.1.3  PREPARATION OF STANDARD SOLUTIONS 
All standard solutions were adapted from Insent TS5000Z (2008) manual and the 
composition of each is given in Table 2.3. The method of preparation of each of the 
solution is described in Appendix A1 
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TABLE 2. 3 COMPOSITION OF STANDARD SOLUTIONS USED IN MAINTENANCE MEASUREMENT. 
Sample Composition 
Reference  30mM KCl + 0.3mM tartaric acid 
Salty  300mM KCl + 0.3mM tartaric acid 
Sour 30mM KCl + 3.0 mM tartaric acid 
Bitter (+) 30mM KCl + 0.3mM tartaric acid + 0.1mM quinine hydrochloride 
Bitter (-) 30mM KCl + 0.3mM tartaric acid + 0.01% vol iso-α-acid 
Astringency 30mM KCl + 0.3mM tartaric acid + 0.05mM tannic acid 
2.2.1.4  PREPARATION OF SAMPLE SOLUTIONS 
Details of sample preparation are given in the chapters where the samples are 
investigated.  
 
2.2.1.5  DATA ANALYSIS – PRINCIPLE COMPONENT ANALYSIS (PCA) 
Principle components analysis finds the principle components in a given data set. In 
other words, this statistical method aims to find linear combinations of original variable 
which account for maximal amounts of variation in the data set. The principle 
components are the underlying structure of the data set. They encompass both the 
direction of the greatest variance and extent to which the data is spread out. This 
underlying structure is defined by eigenvectors and eigenvalues. Eigenvectors which 
exist in pairs describe the direction of variation while the eigenvalues describe how the 
data is spread out. Therefore, the eigenvector with the highest eigenvalue is the first 
principle component (PC1). It follows that the second principle component (PC2) is the 
eigenvector with the second highest eigenvalue which is calculated disregarding data 
that has already been included in calculating PC1. By convention, data is plotted as a 
two dimensional (2D) scatter plot. PC1 is plotted on the x-axis while PC2 is plotted on 
the y-axis.  PCAs main strength lies in its ability to reduce dimensions i.e. it reduces 
data down into its basic components, while stripping away any unnecessary 
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information. Figure 2.11 illustrates the use of PCA in evaluating the taste of a cola soft 
drink. 
  
FIGURE 2. 11  PCA PLOT SHOWING TASTE ASSESSMENT OF COMMERCIALLY AVAILABLE COLA DRINKS. 
ABBREVIATIONS: PEPSI CLASSIC (PC), PEPSI LIGHT (PL), PEPSI LIGHT TWIST (PLT), PEPSI TWIST (PT), COCA-
COLA CLASSIC (CC), COCA-COLA ZERO (CZ) AND COCA-COLA PLUS (CP) (BUENO L. 2012)  
 
In this study, principle component analysis was used to identify which sensors were 
responsible for the data recorded on each sample. By so doing, biplots are plotted 
(illustrated in Figure 2.11); this was used to draw conclusions regarding the taste on 
the samples under investigation. In essence, the first principle component dictates 
which sensor gives the most response and equally so the second principle component 
will provide the second sensor. Therefore, the samples are described by their 
association with the principle components. In addition, the samples are grouped by 
similarity using hierarchical agglomerative cluster analysis which for ease of 
explanation has been described in chapter 4, section 4.3.2. Combining both sets of 
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analyses allows interpretation of not only taste attribute as described by sensors but 
also allowing comparison and contrasting of sample under investigation. 
 
2.2.1.6  DATA ANALYSIS – ANALYSIS OF VARIANCE (ANOVA) 
Analysis of variance (ANOVA) is a parametric method for means comparison of several 
groups and it is also an extension of the independent sample t-test. However it differs 
from an independent sample t-test in that ANOVA allows for analysis across more than 
two data sets whereas independent sample t-test is limited to only two. The essence of 
ANOVA lies in testing the hypothesis that for a given data set, the means are equal. 
This hypothesis is tested under the assumption that  a) the observation are random 
and independent, b) the distribution of the data set from which the samples are 
selected is normal, c) the variances of the distribution in the data are equal. If after 
hypothesis testing p ≤ 0.05, then the hypothesis is true and the means are equal, if  
p ≥ 0.05 then the hypothesis is false and the means are not equal. A ONE-WAY 
ANOVA is so named because only one variable (x) across the data sets is analysed. 
Multiple factors can also be analysed for example, two way ANOVA analyses two 
factors (x,y) and three way ANOVA analyses three factor (x,y,z). One way ANOVA is 
used in chapters 3 and 4 to demonstrate the statistical difference if any between the 
data under investigation. The data set is question is integral data i.e. measurement in 
mV, and independent. It is normally distributed (testing for normality will be illustrated 
when one way ANOVA is reported). In this instance the assumption that variances are 
equal was made. 
 
2.2.2   HOT MELT EXTRUSION (HME) 
Invented in the 18th century for the manufacturing of lead pipes, HME is now widely 
viewed in the pharmaceutical industry as an efficient technique of producing drug 
delivery systems (Jones et al. 2010). Extrusion is defined as a process of converting a 
raw material into a product of uniform shape and density by forcing it through a die 
under controlled conditions. The principle and pharmaceutical applications of HME 
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have been described in detail in Chapter 1 section 1.5. In this study all Eudragit® 
EPOQHD melt extrudates were prepared using a Thermo Scientific Process 11 twin 
screw extruder (Thermo Scientific UK) with co-rotating screws. The advantages of 
using a twin screw over a single screw barrel have been discussed in Chapter 1, 
section 1.5. However, to recap, twin screw barrels allow for betting mixing of the raw 
material therefore extrudates are characterised by a more even distribution of API in 
the polymeric carrier. The barrel temperature was set as follows: heating zones 2 and 3 
were set at 120oC while the rest of the zones were set at 140oC. This temperature 
setting was selected because as previously mentioned in section 2.3.4 the melting 
point of quinine hydrochloride is given as 115-116oC, therefore as suggested by Repka 
et al (2008) the processing temperature was set to 15-60oC above the melting point of 
the crystalline material or the glass transition of amorphous polymer (Repka et al. 
2008). The glass transition of Eudragit®EPO has already been given in section 2.2. 
Therefore the processing temperature used in this was above the melting point of 
quinine hydrochloride and the glass transition of Eudragit®EPO. 
 
Aside from the processing temperature, other process parameters play a key role in 
determining the properties of the final extrudate (Henrist et al. 1999). The screw speed 
and feeding rate are related to shear stress, shear rate and mean residence time which 
in turn affects dissolution rate and stability of the final products (Li et al. 2013). In the 
study, the feeding rate was set at 10rpm; this was selected because at this rate no 
solid bridges were formed therefore suggesting uniform mixing. It is important to note 
that Eudragit®EPO has poor flow properties. Rotation speed was set at 100rpm unless 
otherwise stated. The processing parameters adapted from a study by (Xin et al. 2007). 
However, modifications were made i.e. feed rate was decreased to 10rpm because at 
60rpm the powder that contained 10 and 30% quinine hydrochloride formed bridges 
therefore reducing the feed rate solved this issue. The screw speed was adjusted to 
torque. Excluding the 70% drug loading, all other concentrations were processed at 
100rpm screw speed. However, at 70% drug loading, using screw speed of 100rpm 
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resulted in torque running up to 100% which meant that the screws could not rotate; as 
such screw speed was reduced to 50rpm. It is also worth pointing out that, increasing 
the screw speed meant reduction in residence time. The significance of the residence 
time has already been pointed out in chapter 1. 
 
2.2.3 MILLING 
In the pharmaceutical industry milling is primarily used to reduce particle size. In this 
study, it was used to obtain powders from Eudragit®EPO QHD melt extrudates. There 
are several types of commercial mills available and these can be classified according 
to their mechanical processes. These include: cutting, compression, impaction, attrition 
and combined methods (Aulton 2007). For cutting mills, a series of knives attached to a 
horizontal motor which act against a series of stationery knives to generate high shear 
rates. Size reduction by compression can be carried out on a small scale in the 
laboratory using a pestle and mortar. Samples are pulverised through the friction from 
the weight of the pestle compressing the sample against the mortar. Impact methods 
such as hammer mills consist of a series of four or more hammers hinged on a central 
shaft. These swing out rapidly creating an angular velocity which produces strain rates 
of up to 80s-1. The rates are so high that most of the particles undergo a brittle fracture. 
As size reduction continues, the inertia of particles hitting the hammers decreases 
remarkably and subsequent fracture is less probable. Attrition mills such as roller mills 
use horizontally mounted rollers which rotate at different speeds such that the material 
is sheared as it passes through the gap and is transferred from slower to faster rollers. 
 
Ball mills such as the one used in this study combine both impaction and attrition of 
particles. They consist of a hollow cylinder mounted such that it can be rotated on its 
horizontal longitudinal axis. The cylinder contains balls that occupy 30-50% of the total 
volume. These balls move with the cylinder until the forces of gravity exceed frictional 
forces and balls slide back to the base of the cylinder. At high angular velocities, the 
balls are thrown against the walls of the cylinder.  To ensure that the material is 
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subjected to attritional and impaction forces often two or more cylinders are mounted 
onto a turntable which enable two modes of rotation.  
 
In this study milled samples of Eudragit®EPO – QHD melt extrudates were prepared in 
a pulverisette 5 planetary ball mill (Fritsch) at a rotational speed of 350rpm for 30 
minutes. The agate grinding chamber had a capacity of 500ml, with four 20mm agate 
grinding balls. The pulverisette 5 contains four sample chambers to enable 
simultaneous milling. Approximately 15g of melt extrudate was placed in two of the four 
chambers during processing. The samples were allowed to cool for 30 minutes when 
the milling process was completed, before being removed from the chamber, sieved 
and stored in three different temperature and humidity conditions which will be 
discussed in chapter 5. 
 
2.2.4   DIFFERENTIAL SCANNING CALORIMETRY (DSC) 
Differential scanning calorimtery (DSC) is a technique that measures difference in the 
heat flow between a sample and an inert reference as a function of time and 
temperature when subjected to a specified  control program (temperature, time, 
atmosphere and pressure). This gives both qualitative and quantitative information 
such as crystallisation kinetics and identification of structural relaxations. There are two 
forms of DSC namely: heat flux (the most common) and power compensation. The 
former is described in detail as it is used in this study.  
 
Heat flux DSC (illustrated in the schematic shown in Figure 2.12 consists of sample (S) 
and reference (R) pans placed symmetrically in a furnace. Both pans share a common 
heat source (the thermo electric disc) and are heated at the same rate. The 
temperature difference between the two pans is measured and resultant signal is 
converted to heat flow.  The differential heat flow measured during a DSC experiment 
can be expressed using the thermal equivalent of Ohm’s law: 














 is the heat flow (Q is heat energy and t in time), ΔT is the temperature 
difference between the sample and the reference and R is the thermal resistance in the 
heat flow path between the furnace and the sample. 
 
 
FIGURE 2. 12 SCHEMATIC OF HEAT FLUX DSC CELL SET UP. (TAKEN FROM 
HTTP://WWW.ANASYS.CO.UK/LIBRARY/DSC1_3.GIF) 
 
During heating of a material, the heat flow signal is determined by the heat capacity 
(Cp) of the material. Heat capacity is defined as the amount of heat required to raise 
the temperature of one gram of the material by one degree Celsius. Hence, heat 









Where Q is the heat energy and 
𝑑𝑡
𝑑𝑇







A schematic of a typical DSC plot is shown in Figure 2.13. The data is usually 
presented as a plot of heat flow against temperature. Identical heat capacities for the 
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sample and the reference result in the heat flow signal appearing as a horizontal line 
on the abscissa. Changes in the heat capacities between sample and reference result 
in the displacement of the horizontal baseline. Endothermic and exothermic processes 
are displayed and troughs and peak respectively.  These are characterised according 
to position, size and shape. The size of peak represents the amount of material and 
energy of the reaction, while the shape points to the kinetics of the process. 
 
FIGURE 2. 13 SCHEMATIC OF TYPICAL DSC PLOT. TG REPRESENTS GLASS TRANSITION, TC IS 
RECRYSTALLIZATION AND TM IS MELTING TEMPERATURE. (TAKEN FROM 
HTTP://WWW.PSLC.WS/MACTEST/IMAGES/DSC08.GIF) 
 
DSC measurements were performed on TA instruments DSC Q2000 with a refrigerated 
cooling system (RCS) attached. The purge gas, oxygen free nitrogen, was used at a 
flow rate of 50ml/min. All DSC experiments and calibration were performed using 
PerkinElmer 40µl, 0.15mm aluminium pans. Samples were accurately weighed directly 
into the pans using a Mettler Toledo XS205 dual range balance. The sample mass 
used was between 3-5mg. The samples were equilibrated to 25oC before heating to 
250oC at a heating rate of 10oC/min. Each set of DSC experiments was repeated three 
times to ensure reproducibility. Further details on pan types and variation heating rates 
are outlined within the relevant experimental section.The instrument was calibrated 
monthly or every time experimental parameters were changed to ensure optimal 
performance. The routine calibrations performed included the instruments baseline, 
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temperature and cell constant. High purity indium (Tm, 156.60
oC), benzoic acid (Tm, 
122.37oC) and n-octadecane (Tm, 28.24
oC) were used as temperature calibrants. 
 
2.2.5  POWDER X-RAY DIFFRACTION (PXRD) 
X-rays were discovered by Wilheim Röntgen in 1895. The powder diffraction methods 
which use conventional X-ray sources were devised independently in 1916 by Debye 
and Scherrer in Germany and in 1917 by Hull in the United States. In PXRD 
experiments, X-rays are generated by a cathode ray tube which is directed towards the 
sample. Diffraction is governed by Braggs law given in Equation 2.4, which occur when 
the crystalline material interacts with the focused X-ray beam.  
nλ = 2dsinθ 
EQUATION. 2.8 
 
where n is the order of the diffracted beam, λ is the wavelength of the incident X-ray 
beam, d is the distance between adjacent planes of atoms (the d-spacing) and θ is the 
angle of incidence of the X-ray beam. By altering θ during scanning, different d-spacing 
can be obtained. A plot of the beam intensity against the angle of emergence produces 
a diffractogram with peaks seen corresponding to lattice spacing this providing an 
insight into the orientation and molecular arrangement within a sample. Materials 
exhibiting long-range order (i.e. crystalline) produce XRPD diffractograms containing 
clearly defined sharp peaks of varying intensities which corresponds to the uniform 
lattice spacing, arrangements and orientation of molecules within the crystal.   
 
Applications in the pharmaceutical industry include: determining the crystal structure 
(Evans et al. 2004)  and degree of crystallinity of a material (Grisedale et al. 2011), and 
the recognition and quantification of amorphous content in partially crystalline mixtures 
/ solid dispersions (Wulff et al. 1996). X-ray powder diffraction analysis of quinine 
hydrochloride dihydrate and Eudragit EPO® extrudates and physical mixtures were 
performed at ambient temperature using the Rigaku miniflex 600 equipped with a 
copper X-ray tube (1.54Å). Samples were exposed to an X-ray beam with a voltage of 
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40kV and a current of 15mA. The PXRD patterns were recorded using diffraction 
angles (2θ) from 2o to 70o at scan rate of 3o/min. Resultant data was exported into 
Microsoft excel 2010® for analysis. 
 
2.2.6 SCANNING ELECTRON MICROSCOPY (SEM) 
Scanning electron microscopy (SEM) differs from standard light microscopy in that it 
uses electrons instead of light waves to magnify the surface of a sample. This enables 
samples to be examined at higher magnification and resolutions than light microscopy.  
SEM has three major benefits namely: upper magnification of about 250 000X, a large 
depth of field and lateral spatial resolution better than 3nm. A schematic diagram of a 
SEM set up is shown in Figure 2.14. Briefly, a beam of electrons is emitted from a 
cathode which is maintained under a very high vacuum to keep it stable and minimise 
beam scatter caused by electrons colliding with gas molecules. Electrons are 
accelerated using high voltage. As the electron beam collides with the sample, 
electrons and x-rays are emitted and detected by an array of detectors that are 
positioned a few millimetres away. The sample can be moved in X, Y and Z directions, 
rotated or tilted to allow creation of 3-dimensional images. The transfer of energy to the 
sample as the electron beam decelerates can cause localised heating which may 
degrade or melt material under observation. Hence, coating the sample with a 
conduction metal can help dissipate heat and reduce beam damage.  
 




FIGURE 2. 14 SCHEMATIC DIAGRAM OF A SEM SET UP. (TAKEN FROM 
HTTP://WWW4.NAU.EDU/MICROANALYSIS/MICROPROBE-SEM/IMAGES/SEM_SCHEMATIC.JPG) 
 
In this study, SEM images were taken using a FEI Quanta 200F (Eindhoven, The 
Netherlands). The samples were mounted on aluminium stubs with double sided 
carbon sticky pads and then coated with gold in order to protect the samples from heat 
generated by the electron beam. 
 
2.2.7  HOT STAGE MICROSCOPY (HSM) 
HSM is also known as thermo-microscopy. It is the combination of microscopy and 
thermal analysis to enable the study and physical characterisation of materials as a 
function of temperature and time. Sample changes upon controlled heating can be 
visually observed through a microscope which is attached to a computer where footage 
can be recorded as well as images captured. It is very useful tool for rapidly 
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distinguishing between crystalline and amorphous forms of pharmaceutical materials. 
When used in conjunction with other thermal techniques, hot stage microscopy can 
provide useful insight into thermal events seen.  
 
In this study, a LeicaDM2700M  microscope with a 10X magnification lens was 
connected to a FP82HT  Mettler Toledo instruments heating stage unit and a FF90 
Mettler Toledo instruments central processor unit. Samples were heated from 30oC to 
250oC at a heating rate of 10oC/min. Studio4 design capture software was used to 
record and capture thermal events in real time. 
 
2.2.8 THERMOGRAVIMETRIC ANALYSIS (TGA) 
Thermogravimetric analysis (TGA) is a technique in which weight change(s) of a 
material are measures as a function of increasing temperature or isothermally as a 
function of time under a controlled atmosphere. A typical TGA instrument consists of a 
sample holder, a sensitive electro balance, furnace and a recorder. The balance 
operates on a null balance principle. At the point zero or “null” position equal amounts 
of light shine on the two photodiodes, at which point a current is applied to the meter 
for movement to return the balance to the null position. The amount of current applied 
is proportional to the weight loss or gain. The furnace is purged with a gas such as air 
or nitrogen in order to maintain a controlled atmosphere surrounding the sample and to 
rapidly remove any evolved volatiles. The temperature within the furnace is monitored 
by a thermocouple located close to the sample and is used to control the furnace 
temperature.  
 
Weight changes can occur in any material and may be caused by decomposition, 
oxidation or dehydration. The moisture content within a sample is an important quality 
control parameter as it can affect long-term stability and effectiveness as well as short 
term processability. Free surface water and bound water are present in most 
formulations. Free water refers to water that is absorbed from the environment and is 
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not chemically attached to materials while bound water(s) of hydration that are 
chemically bound to the surface. TGA was used in this study to detect water content of 
samples immediately after HME processing as well as after storage of melt extrudates 
in differing humidity conditions. It is important to measure the water content in solid 
dispersions since water can act as a plasticiser that can increase molecular mobility of 
amorphous drugs and compete against drugs in forming hydrogen bonds with 
polymers. This increases the physical instability of solid dispersions. This technique 
was also used to generate anhydrous forms of QHD and QhS.  
 
TGA was carried out using a TA instruments Hi Res 2950 thermogravimetric analyser. 
The thermobalance was calibrated monthly using the melting transition of an indium 
standard. The magnitude and linearity of the balance were calibrated using milligram 
masses as per the manufactures instruction manual. Samples weighing 3- 5mg were 
placed in tarred aluminium pans on the sample holder. Oxygen free nitrogen was used 
as the purge gas. The flow rate through the furnace and TGA head were 60mlmin-1 and 
40mlmin-1 respectively. Weight changes were recorded over a temperature range from 
30oC to 250oC with a heating rate of 10oCmin-1. Data obtained was analysed using 
Universal Analysis 2000 software for Windows 2000/XP/Vista version 4.5A  
(TA instruments). 
 
2.4.9  DISSOLUTION TESTING 
The basic premise of taste masking is to deter the interaction between the API and the 
taste receptor cells in the oral cavity. The different types of taste masking strategies 
have been discussed in chapter 1 (section 1.4). The release of the API in the oral 
cavity is critical in taste masking. An analysis of the release profile of the API, i.e. 
dissolution testing, is therefore essential to confirm taste masking. However, there are 
no set pharmacopeial standards for dissolution testing of taste masked particles. 
Guidance published jointly by the Federation International Pharmaceutique (FIP) and 
the American Association of Pharmaceutical Sciences (AAPS) for orally disintegrating  
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tablets (ODT) recommends the use of neutral medium where the drug should have 
typically less than or equal to 10% drug dissolved in 5 minutes to achieve taste 
masking (Siewert et al. 2003a). However, this criterion is heavily dependent of the 
bitterness and human detection threshold of the API. Highly bitter APIs have lower 
acceptable limits of release and vice versa, thus there is no set limit of acceptable drug 
release for all drug candidates. More importantly, this criterion is limited to APIs for 
which bitterness intensity and detection threshold have been identified. 
 
The British Pharmacopoeia (BP) has recommended dissolution tests for immediate and 
delayed release dosage forms; however these are not appropriate for taste masked 
particles. This is because the tests aim to mimic the stomach and the small intestine 
and no consideration is given for the oral cavity. The lack of appropriate 
pharmacopoeial standard dissolution test for taste masked particles has led to a wide 
variety in dissolution methods being adopted. The challenge revolves around selection 
of dissolution media, the volume of dissolution media and agitation of sample if 
necessary.  
 
In this study, dissolution studies have been designed to give a near representation of 
the oral cavity in terms of type of dissolution media, its volume and agitation time of 
tastant sample. 90ml of deionised water was used as dissolution media. The samples 
were agitated using an incubated shaker (Incu Shaker mini XHWY series, Shropshire, 
UK), temperature was set at 37oC and shake speed of 50rpm was used. Samples were 
withdrawn at time intervals (3min, 30 minutes and 3 hours), filtered using a Millex GP 
filter unit (0.22µm) then analysed spectrophotochemically on the Jenway 6305  
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CHAPTER 3- MECHANISM OF DETECTION 
3.1 BACKGROUND 
At the time of the study presented here, studies into the responsiveness of the 
electronic tongue Insent®TS500Z had not investigated the responsiveness of the taste 
sensor to caffeine and its salts or quinine and its salts in comparison to water. 
Comparison of caffeine and caffeine citrate was briefly addressed in a study where the 
authors reported logarithmic dose response to caffeine citrate and no such response 
for caffeine (Woertz et al. 2011a). The same group also compared two salts of quinine 
namely, hydrochloride and sulphate. They reported that both salts recorded high 
responses to bitterness in comparison to quinine benzoate and sodium benzoate. 
However, in both cases, it is not clear from the literature reports as to whether negative 
controls i.e. de-ionised water was used. The objective of the work detailed in this 
section was to understand the responsiveness of taste sensor to different salts of the 
same molecule with the aim of explaining the precise mechanism by which objective 
taste measurement is achieved using the taste sensor. Another objective was to 
establish the extent to which the dissociation profile and other physical properties i.e. 
solubility and electrolyte behaviours of the drug affects its detection by the TS5000Z 
electronic tongue. 
 
3.2 PRELIMINARY WORK 
3.2.1 STUDY OBJECTIVES 
In this study, the responsiveness of four sensors, namely AC0, AN0, C00 and AE1, 
(which collectively make up the bitter drug sensor set), were explored. For ease of 
explanation, sensor AC0 will be referred to as basic bitterness1, sensor AN0 is referred 
to as basic bitterness2, sensor C00 is referred to as acidic bitterness and sensor AE1 
is referred to as astringency.  The composition of these sensors has been discussed in 
Chapter 1, Section 1.3.2, and Table 1.5. Sensor response was evaluated using 
increasing concentrations of aqueous solutions of methylxanthines i.e. caffeine and 
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caffeine citrate, theobromine and theophylline with the aim of describing sensor 
response and sensitivity to molecules with similar structure. The increasing 
concentrations of the methylxanthines were each compared to de-ionised water 
(negative control).  
 
3.2.2 GENERAL METHODOLOGY 
Solutions of the methylxanthines (MX) were prepared by the addition of the required 
quantity of MX powder gently into the vortex created by the action of a magnetic stirrer 
in the deionised water. The stirring was continued until all the powder had dissolved. 
With the exception of theobromine, all solutions were stirred for 15 minutes. All 
solutions were prepared at room temperature on the day of testing.  In the case of 
theobromine which did not dissolve after 15 minutes, dissolution was aided by using 
sonicator. A volumetric flask containing undissolved powder of theobromine and de-
ionised water where placed in a sonicator for 30 minutes at 25oC. The concentrations 
used in this study were all within the maximum solubility of each methylxanthine i.e. 
only solutions were used. 
 
3.2.3 RESULTS 
Concentrations ranging from 0.5 – 25mM of caffeine were investigated using the bitter 
drug sensor set and sensor response curves were plotted in Figure 3.1. These 
concentrations were adapted from a study by Woertz et al (2010). De-ionised water 
was used as a placebo for comparison. The plot in Figure 3.1 shows that there was no 
difference in the sensor response values between placebo and increasing 
concentrations of caffeine. A one-way ANOVA (p = 9.9 x 10-12) showed that there was 
no statistical difference between the sensor responses of caffeine and those observed 
for de-ionised water (shown on the zero point concentration data point). 




FIGURE 3 1 RELATIVE SENSOR RESPONSE FOR CAFFEINE SHOWING THE RESPONSES OF FOUR SENSORS 
WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A FUNCTION OF CONCENTRATION (N=9, ?̅?± SD) 
 
In order to understand why there was no difference between de-ionised water and 
caffeine it was necessary to investigate concentrations of caffeine ranging from 0.05 to 
1.0mM (lower concentrations). The rationale for this was that the concentrations 
already investigated could have been too high therefore saturation effect on sensors 
would have led to no difference being observed. The response curve for the 
investigation of the lower concentrations is illustrated in Figure 3.2. It is noteworthy that 
mV recorded at the lower concentration were similar to recordings presented in  
Figure 3.1, which were also similar to those observed for deionised water. A one-way 
ANOVA (p=0.001) revealed that there is no statistical difference between the readings 
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FIGURE 3. 2  RELATIVE SENSOR RESPONSE CURVE FOR CAFFEINE (LOW CONCENTRATIONS), SHOWING 
THE RESPONSES OF FOUR SENSORS WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A 
FUNCTION OF CONCENTRATION (N=9, ?̅?± SD) 
 
Investigations thus far have focused on concentrations ranging from 0.1 to 25mM. 
However, it was necessary to investigate sensor response to higher concentrations, 
right up to maximum solubility of caffeine in water, with a view to establish whether the 
smaller concentrations were below the minimum detection threshold of the taste sensor. 
Figure 3.3 shows sensor response curves of high concentrations of caffeine. Similar to 
Figures 3.1 and 3.2, a one-way ANOVA (p= 0.001) showed that there is no statistical 
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FIGURE 3. 3  RELATIVE SENSOR RESPONSE CURVE FOR CAFFEINE (HIGH CONCENTRATIONS), SHOWING 
THE RESPONSES OF SENSORS AS A FUNCTION OF CONCENTRATION (N=9, ?̅?± SD) 
 
In summary, investigation of sensor response (mV) of caffeine concentrations ranging 
from 0.01 to 110mM has revealed no difference with deionised water. The results 
observed suggest that caffeine was not being detected by the taste sensor. 
Furthermore, increasing concentration of caffeine did not affect the detection of 
caffeine.  Also noteworthy is that the relative sensor response for acidic bitterness 
increases between each measurement cycle i.e. in the case of water, in Figure 3.1 and 
3.2 the relative sensor response was approximately -52mV however this increased to 
approximately -31mV in Figure 3.3. A comment will be made on this phenomenon in 
section 3.5.Theobromine is slightly soluble in water i.e. < 0.1g /100ml therefore 
concentrations ranging 0.05 – 2.5mM were used. Interestingly, results obtained for 
theobromine illustrated in Figure 3.4 are similar to those already observed for caffeine. 
A one-way ANOVA (p= 2.09x10-14) showed that  no statistical difference was observed 
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FIGURE 3. 4  RELATIVE SENSOR RESPONSE CURVE FOR THEOBROMINE, SHOWING RESPONSES OF 
SENSORS AS A FUNCTION OF CONCENTRATION (N=9, ?̅?± SD) 
 
The investigation of theophylline at concentrations ranging from 0.5 – 25mM revealed 
results similar to caffeine and theobromine. The sensor response curves are shown in 
Figure 3.5. There was no statistically significant difference between relative sensor 
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FIGURE 3. 5  RELATIVE SENSOR RESPONSE CURVE FOR THEOPLHYLLINE, SHOWING RESPONSES OF FOUR 
SENSORS AS A FUNCTION OF CONCENTRATION (N=9, ?̅?± SD) 
 
Following investigations of caffeine (Figures 3.1, Figure 3.2 and Figure 3.3), 
theobromine (Figure 3.4) and theophylline (Figure 3.5) at varying concentrations it 
became apparent that these three methylxanthines were not being detected by the 
electronic tongue. Furthermore, variations in concentrations across the 
methylxanthines did not change detectability by the taste sensor. There are no reports 
in the literature suggesting that theophylline or theobromine is detectable on the 
electronic tongue. 
 
The detection of a caffeine salt i.e. caffeine citrate, which had already been described 
in literature as being detectable, was then investigated. Concentrations of caffeine 
citrate investigated were derived from literature reports but also matched the range that 
was used for caffeine in order to facilitate a direct comparison at equimolar 
concentrations (Woertz et al. 2010a). Reports in the literature suggest a concentration 
dependent relationship for caffeine citrate; a similar relationship was illustrated in 
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sensor response values with increasing concentration. However, there is no further 
increase in relative sensor response after 60mM. The acidic bitterness sensor shows a 
sharp increase in relative sensor response values between 0.5mM and 1.0mM, 
following this there is a gradual decrease in values which also level off after 50mM. 
The astringency sensor response values decrease gradually and then levelling off at 
60mM. Overall, a one-way ANOVA (p=0.57) reveals that there is a statistical difference 
between response values of caffeine citrate and de-ionised water. Furthermore, sensor 
response values change with increases in concentration. 
 
FIGURE 3. 6  RELATIVE SENSOR RESPONSE CURVE FOR CAFFEINE CITRATE, ILLUSTRATING SENSOR 
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Various concentrations of caffeine revealed no difference in response patterns 
between deionised water and caffeine; however, caffeine citrate illustrates 
concentration dependence. At this juncture it was necessary to investigate citric acid 
(Figure 3.7), in order to give an indication as to which species is responsible for 
response identified with caffeine citrate. Interestingly, sensor response patterns for 
citric acid were similar to those observed for caffeine citrate. This suggests that the 
citrate in caffeine citrate could be responsible for the response patterns observed. 
 
 
FIGURE 3. 7  RELATIVE SENSOR RESPONSE CURVE FOR CITRIC ACID, SHOWING SENSOR RESPONSE 
PATTERNS AS A FUNCTION OF CONCENTRATION (N=3, ?̅?± SD). 
 
Woertz et al (2010) reported that caffeine was detectable on the taste sensor although 
the report also stated that the results were inconclusive as only a few sensors showed 
ranges of linearity. The authors go on to add that the responses were quite small and 
not incongruent with the whole shape of the concentration curve. The work reported 
here contradicts this finding in that caffeine was not detectable using this sensor set.  
Therefore, in order to elucidate how detection may have been observed in previous 
reports, it was necessary to investigate the effect of the solvent used. As such, caffeine 
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solutions from reference solution while Figure 3.9 illustrates caffeine dissolved in water 
but reference solution used as a blank. Figure 3.8 shows a difference in voltage is 
observed between the reference solution and increasing concentrations of caffeine for 
all sensors except astringency. This difference was only observed for concentrations 
up to 10mM for both basic bitterness sensors. After this concentration, there is no 
statistical difference in the voltage reading observed for the other sensors as shown by 
a one-way ANOVA (p= 4.05x10-5). Only the acidic bitterness sensor demonstrates 
response with different concentrations, however this does not appear to be 
concentration dependent. 
 
FIGURE 3. 8  RELATIVE SENSOR RESPONSE CURVE FOR CAFFEINE DISSOLVED IN REFERENCE SOLUTION, 
SHOWING SENSOR RESPONSE PATTERNS AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD)  
 
Figure 3.9 shows the comparison of reference solution (0.03mM tartaric acid + 0.3mM 
KCl, shown on the zero concentration data point) to increasing concentrations of 
caffeine dissolved in de-ionised water. At 0mM the voltage reading recorded i.e. 0mV is 
the reference solution. The concentrations ranging from 0.5mM to 25mM are caffeine 
dissolved in de-ionised water. Comparison of increasing concentrations of caffeine 
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reference solution and 0.5mM. However, as already observed in Figure 3.1, no 
concentration dependence is seen with increasing concentrations of caffeine. A one-
way ANOVA showed that there was no statistical difference between the increasing 
concentrations of caffeine (p= 2.89x10-14) 
 
FIGURE 3. 9  RELATIVE SENSOR RESPONSE CURVE FOR CAFFEINE DISSOLVED IN WATER AND REFERENCE 
SOLUTION (0.03MM TARTARIC ACID AND 0.3MM KCL) USED A STANDARD COMPARATOR. THIS SHOWS SENSOR 
RESPONSE PATTERN AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD). 
 
3.2.4 PRELIMINARY DISCUSSION AND CONCLUSION 
In general, there is no difference in relative sensor response between de-ionised water 
(control) and the different methylxanthines across all four sensors used to detect 
bitterness of pharmaceutical products. Furthermore, the relative sensor responses 
show no dependence to concentration. A study by Woertz et al (2011) showed that 
caffeine did not have a clear log linear relationship. The authors also report that the 
results were inconclusive as basic bitterness1 and 2 showed no response with 
increasing concentrations of caffeine. The other sensors used in the study showed 
response albeit the responses were quite small and incongruent with the whole shape 
of a concentration curve. The  authors attribute the non-detectability of caffeine by the 
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work reported here shows that caffeine has not been found to be detectable. A 
possible reason for this difference in findings is that, the work reported here uses de-
ionised a negative control therefore eliminating the possibility of false positives. This is 
the first time that theobromine and theophylline have been investigated in such a study 
and also compared to a control (de-ionised water).  
 
The results thus far point to the fact that caffeine is not being detected and furthermore 
neither are theobromine and theophylline when they are dissolved in deionised water. 
In the case of dissolving caffeine in reference solution, sensor responses were 
observed for all but the astringency sensor. It is important to note that this behaviour is 
observed at the lower end of concentrations of caffeine i.e. 0.5mM – 10mM. A possible 
explanation for this is that; caffeine is an amine; therefore, it has basic nitrogen which 
will react with a proton source. As previously mentioned in chapter 2, Table 2.3, the 
reference solution is composed of 0.3mM tartaric acid and 30mM potassium chloride. 
Hence, tartaric acid acts as a proton source. The reaction with the acid produces the 
conjugate acid (an ammonium ion) as illustrated in Equation 3.3. It is this conjugate 
form of caffeine that gives a change in membrane potential on the sensors thus it can 
be detected. However, the formation of the conjugate acid is limited by the 
concentration of tartaric acid (0.3mM). This is to say that there is a finite amount of 
caffeine conjugate that can be formed, therefore at concentrations higher than 10mM 
the concentration of caffeine exceeds that of the conjugate form, which means 
detection by the taste sensor is diminished in comparison to concentrations lower than 
10mM. The significance of these finding will become apparent in section 3.5, however 
it is worth mentioning that the solvent used has an effect on the detectability of caffeine. 




   
 
EQUATION 3.9 
The pKa values of the methylxanthines are given in Table 3.1, together with pH values 
of solutions measured. In general, the solutions used had a pH below the pKa which 
suggests that the molecules were unionised in solution therefore did not affect the 
stern layer or diffuse layers of the double electrical layer. Woertz et al (2011) 
suggested that the increased conductivity of ionic substances leads to better detection 
by the electronic tongue; hence caffeine being a neutral molecule is difficult to detect. 
However, it is not possible to explain the mechanism of detection when investigating a 
system that is not being detected. This is to say that since methylxanthines are not 
being detected, that lack of detection does not validate the theories already suggested. 
It is therefore imperative to investigate a system that has some data regarding 
detectability. 
 
caffeine caffeine conjugate acid 
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TABLE 3. 1 SUMMARY OF CAFFEINE, THEOBROMINE, THEOPHYLLINE 
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3.3 QUININE AND QUININE SALTS 
3.3.1 STUDY OBJECTIVES 
In line with preliminary work outlined in section 3.2, sensor response was evaluated 
using increasing concentrations of aqueous solutions of quinine, quinine hydrochloride 
and quinine sulphate with the aim of describing sensor response and sensitivity to 
molecules that are known to be bitter and detectable by the taste sensor. Exploring 
these molecules would give an indication as to whether the bitterness detection was 
attributed to the parent compound or the corresponding salt. 
 
3.3.2 GENERAL METHODOLOGY 
Solutions of quinine and the salts were prepared by the gentle addition of the required 
quantity of quinine or its salts into a vortex created by the action of a magnetic stirrer. 
The stirring was continued until all the powder had dissolved for 15 minutes.  
DATA MANIPULATION AND STATISTICAL ANALYSIS 
Six sensor response reading (mV) was obtained for each sample at each 
concentration; the average (?̅?) was obtained and plotted against the concentration. 
Principle component analysis (PCA) was carried out using the following formulae 
described in chapter 2. In addition, in order to establish statistical significance of 
findings, a one-way analysis of variance (ANOVA) was used. This statistical test was 




The relative sensor response patterns of all four sensors are shown in Figure 3.10. 
Both basic bitterness sensor responses are similar showing clear concentration 
dependence. In both cases, sensor response does not increase after concentrations of 
30mM. Furthermore there is no difference in magnitude of response between the two 
bitterness sensors at concentrations higher than 30mM. The astringency sensor 
response gradually decreases from approximately 120mV to 0mV with increasing 
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concentration. The relative response for acidic bitterness has a sharp increase 
between 0.1mM and 1.0mM, which was followed by a gradual decrease in sensor 
response as concentration increases. A one-way ANOVA (p= 0.06) showed that there 
was a statistical difference between the samples under investigation.  
 
FIGURE 3. 10  RELATIVE SENSOR RESPONSE CURVE FOR QUININE HYDROCHLORIDE DIHYDRATE (QHD), 
SHOWING RESPONSES OF SENSORS AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD) 
 
Figure 3.10 illustrates sensor response across concentration ranging from 0.1mM to 
50mM; however the highest rate of change was observed between 0.1mM and 1.0mM, 
therefore it was necessary to observe sensor response across these concentrations.  
The sensor response pattern in the region where highest rate of change was observed 
is illustrated in Figure. 3.11. Both basic bitterness sensors show an increase in sensor 
response with increasing concentration. This observation is also mirrored by the acidic 
bitterness sensor. The astringency sensor shows a decrease in sensor response 
magnitude with increase in concentration. Statistical analysis using a one-way ANOVA 
(p= 4.44x10-4), showed that there was no statistically significant sensor response with 
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analysis only refers to the low concentrations of quinine hydrochloride described in 
Figure 3.11. 
 
FIGURE 3. 11  RELATIVE SENSOR RESPONSE CURVE FOR QUININE HYDROCHLORIDE DIHYDRATE (LOW 
CONCENTRATIONS), SHOWING THE RESPONSES AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD) 
 
Quinine sulphate, another quinine salt was also investigated. The sensor response 
patterns are illustrated in Figure 3.12.  Both basic bitterness and acidic bitterness 
sensors exhibit a concentration dependant response to quinine sulphate. Furthermore, 
the pattern of response is similar to those observed for quinine hydrochloride at similar 
concentrations. Interestingly, the astringency sensor does not demonstrate 
concentration dependence. There is no difference in the relative sensor response value 
between de-ionised water and the quinine sulphate which is confirmed by a one-way 
ANOVA test (p= 5.57x10-7). This suggests that the astringency sensor is not detecting 
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FIGURE 3. 12  RELATIVE SENSOR RESPONSE CURVE FOR QUININE SULPHATE, SHOWING THE RESPONSES 
OF SENSORS AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD) 
 
The preliminary work demonstrated that ionic molecules were easier to detect as 
compared to neutral molecules, hence it was necessary to investigate quinine base in 
order to assess the taste sensor’s responsiveness. Figure 3.13 illustrates the sensor 
response patterns to quinine base. Similar to quinine sulphate, both basic bitterness 
and acidic bitterness sensors show a concentration dependant response. The 
astringency sensor does not show definitive concentration dependence. The patterns 
of response for quinine bear resemblance to those observed for quinine sulphate. A 
one-way ANOVA (p = 0.003) showed that there was statistically significant difference 
between the increasing concentrations of quinine base. Therefore even though quinine 
is not an ionic molecule it is still detectable. This is because quinine is ionised in water 
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FIGURE 3. 13  RELATIVE SENSOR RESPONSE CURVE FOR QUININE (QN), SHOWING RELATIVE SENSOR 
RESPONSE AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD) 
 
Quinine hydrochloride and quinine differ on a molecular level by the presence of the 
hydrochloride ion in quinine hydrochloride. Since sensor response patterns were also 
different, it was necessary to ascertain as to whether the difference was a result of the 
presence of the hydrochloride ion. Figure 3.14 demonstrates the sensor response 
patterns of hydrochloric acid which would give the same effect as hydrochloride ion in 
quinine hydrochloride. The basic bitterness sensors both exhibit concentration 
dependence. Statistical analysis using a one-way ANOVA (p=0.63), showed that there 
was a statistical difference between the sensor responses with increasing 
concentrations of hydrochloric acid. Furthermore, there is no difference in response 
between the two basic bitterness sensors, as shown by an independent sample t-test  
(p= 0.15). The acidic bitterness sensor has a marked increase between 0.1mM and 
1.0mM, which is followed by a gradual decrease in sensor response. The astringency 
sensor also illustrates a gradual decrease in relative sensor response with increasing 
concentration. In general, all four sensors show concentration dependence and 
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for hydrochloric acid are similar to those observed for quinine hydrochloride. However, 
it is noteworthy that the magnitude of sensor response is markedly different between 
quinine hydrochloride and hydrochloric acid. 
 
FIGURE 3. 14  RELATIVE SENSOR RESPONSE CURVE FOR HYDROCHLORIC ACID (HCL), SHOWING RELATIVE 
SENSOR RESPONSE AS A FUNCTION OF CONCENTRATION, (N-6, ?̅?± SD) 
 
In similar fashion to quinine hydrochloride and hydrochloric acid, quinine sulphate was 
compared to sulphuric acid. The relative sensor response patterns for sulphuric acid 
are illustrated in Figure 3.15.  Both basic bitterness sensors show clear concentration 
dependence. There is no difference in response between the two sensors. The acidic 
bitterness sensor show marked increase in response between 0.1mM and 1.0mM, 
which is then followed by a gradual decrease in relative response. The astringency 
sensor demonstrates a gradual decrease with increasing concentration of sulphuric 
acid. Interestingly, the results observed for sulphuric acid are not similar to those 
observed for quinine sulphate, however they show resemblance to those observed for 
hydrochloric acid in Figure 3.14. A one-way ANOVA (p=0.29), revealed that there was 
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FIGURE 3. 15  RELATIVE SENSOR RESPONSE CURVE FOR SULPHURIC ACID, SHOWING RELATIVE SENSOR 
RESPONSE AS A FUNCTION OF CONCENTRATION (N=6, ?̅?± SD) 
 
The magnitude of response varies between the drugs as described in Table 3.2, which 
compares the magnitude of relative sensor response at a single concentration of 
1.0mM. When considering basic bitterness sensor 1, there is no statistically significant 
difference in relative sensor response values between quinine and both its salts 
investigated. This is verified using a one-way ANOVA (p=0.02).However, a marked 
difference is observed between HCl, sulphuric acid and their quinine salts respectively 
(p=0.47). Possible explanations will be given in section 3.5.  
 
For basic bitterness sensor 2, a one-way ANOVA (p=0.009), revealed that there is no 
significant difference between quinine hydrochloride, quinine sulphate and sulphuric 
acid in terms of magnitude of response. The quinine bases’ response is significantly 
different from that of its salts (p=0.10), and similarly HCl response is different of all the 
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The acidic bitterness sensor’s values are similar between quinine hydrochloride and 
quinine sulphate, however the quinine bases’ response is significantly different from its 
respective salts. The relative sensor response magnitude for HCl and sulphuric acid 
are different from those recorded for quinine and its salts as well as from each other. In 
relation to astringency, quinine hydrochloride and quinine display statistically similar 
relative response values. The highest magnitude of response is recorded with quinine 
sulphate, however it should be noted that this response value has no difference to that 
recorded for de-ionised water.  
 


















1.0 115 51 45 74 
Quinine 
Sulphate 
1.0 110 50 45 110 
Quinine base 1.0 109 69 32 80 
Hydrochloric 
acid 
1.0 33 36 39 58 
Sulphuric 
acid 
1.0 55 57 26 73 
 
Similar to preliminary work, the responsiveness of the sensors to QHD was 
investigated when QHD was dissolved in reference solution (QHD-R). Contrary to 
response patterns observed when QHD in water (QHD-W), only basic bitterness 2 and 
acidic bitterness sensors responded. As illustrated in Figure 3.16, both these sensors 
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show an increase in sensor response with increasing concentration. However, for basic 
bitterness sensor 1 and astringency no concentration dependent behaviour is observed. 
Moreover, these two sensors appear not to detect QHD-R. The relative sensor 
response values are not statistically different from that observed for the reference as 
illustrated by a one-way ANOVA (p= 0.002). 
 
FIGURE 3. 16  RELATIVE SENSOR RESPONSE CURVE FOR QHD DISSOLVED IN REFERENCE SOLUTION 
(QHD-R), SHOWING RELATIVE SENSOR RESPONSE AS A FUNCTION OF CONCENTRATION (N=6, ?̅?±SD).  
 
SUMMARY OF RESULTS 
This section has reviewed the detection capability of the Insent® TS5000Z electronic 
tongue on quinine, quinine hydrochloride and quinine sulphate. All three molecules 
were detectable on the electronic tongue with statistical significance being shown by a 
one-way ANOVA. Hydrochloric and sulphuric acids which are comparatively 
corresponding acids to quinine hydrochloride and quinine sulphate respectively were 
also detectable, though their magnitude of detection differed from the quinine salts. 
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3.4 PARACETAMOL, IBUPROFEN AND METFORMIN HYDROCHLORIDE 
3.4.1 STUDY OBJECTIVE 
In the previous section, the detection of quinine and its hydrochloride and sulphate 
salts was described. However, in order to fully elucidate the mechanism of detection it 
was necessary to investigate the detection of other active pharmaceutical ingredients 
(API) which have been reported to be bitter in the literature. The main objective of this 
study was to investigate the nature of sensor response to paracetamol; ibuprofen and 




Solutions of the paracetamol, ibuprofen, and ibuprofen sodium and metformin 
hydrochloride were prepared by the gentle addition of the required quantity of the API 
into a vortex created by the action of a magnetic stirrer. The stirring was continued until 
all the powder had dissolved for 15 minutes.  In the case of ibuprofen, each of the 
ibuprofen solutions was stirred for 4 hours. Due to the long stirring time, solutions for 
ibuprofen were prepared 24 hours before they were used, whereas all other solutions 
were prepared on the day of testing. The concentrations used in this section matched 
those already used in previous work with quinine hydrochloride detailed in section 
3.2.2. The solutions were tested according to procedure discussed in chapter 2. 
 
3.4.3 RESULTS 
In general, there is no clear concentration dependence observed for paracetamol as 
illustrated in Figure 3.17. Both basic bitterness sensors do not demonstrate a clear 
distinction between de-ionised water and the paracetamol samples. The acidic 
bitterness sensor illustrates a difference in response between de-ionised water and 
paracetamol however no clear concentration dependence is established. The 
astringency sensor does not show a clear difference between the de-ionised water and 
concentration. Overall, these results suggest that paracetamol is not being detected. 
Woertz et al (2010) published results suggesting a linear log relationship between 
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sensor response and concentration of paracetamol; however similar results have not 
been observed despite using similar methodology. 
 
 
FIGURE 3. 17  RELATIVE SENSOR RESPONSE CURVE OF PARACETAMOL DISSOLVED IN DE-IONISED WATER, 
SHOWING SENSOR RESPONSES AS A FUNCTION OF CONCENTRATION (N=6, ?̅?±SD) 
 
In-keeping with work already reported for caffeine (section 3.2.3) and quinine 
hydrochloride (section 3.3.3), it was prudent to investigate the effect of the solvent on 
the detection of paracetamol. Dissolving paracetamol in water (Figure 3.17), has 
shown that there is no statistical difference in the sensor response values of all four 
sensors with increasing concentrations of paracetamol (one-way ANOVA, p= 0.0001). 
The sensor response patterns of paracetamol after it was dissolved in reference 
solution (0.3mM tartaric acid + 30mM potassium chloride) are shown in Figure 3.18. 
The astringency sensor shows a concentration dependent sensor response while the 
other three sensors show no significant change in sensor response with concentration 
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FIGURE 3. 18  RELATIVE SENSOR RESPONSE CURVE FOR PARACETAMOL DISSOLVED IN REFERENCE 
SOLUTION, SHOWING SENSOR RESPONSES AS A FUNCTION OF CONCENTRATION (N=6, ?̅?±SD) 
 
In Figure 3.19, which illustrates sensor responses to ibuprofen, both basic bitterness 
and acidic bitterness sensors show a slight variation with increases in concentration. 
However, the responsiveness appears to stabilise after 0.2mM.  The astringency 
sensor does not show any significant different response with water, which may suggest 
that this sensor is not detecting the molecule or ibuprofen, does not have astringency 
as a taste attribute. Ibuprofen is practically insoluble in water hence for the 
concentrations above 0.5mM ibuprofen were suspended. Reports in the literature 
suggest that detection of ibuprofen is possible when drug is in suspension  
(Woertz et al. 2011b), however since a suspending agent was not used in this study, it 
is possible that ibuprofen particles gravitated to the bottom of the vessel and as such 
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FIGURE 3. 19  RELATIVE SENSOR RESPONSE CURVE FOR IBUPROFEN, SHOWING SENSORS RESPONSE AS A 
FUNCTION OF CONCENTRATION (N=6, ?̅?±SD) 
 
The relative sensor response observed for metformin hydrochloride across all sensors 
indicates concentration dependence as shown in Figure 3.20.  A one-way ANOVA  
(p= 1.06x10-12) revealed that there was a statistical difference between the sensor 
responses with increasing concentration of metformin hydrochloride. Another 
observation was that the two basic bitterness sensors respond in the same fashion; 
there was marked increase in response up to 1.0mM after which the rate of change in 
relative sensor response decreases. This sensor response pattern is similar to that 
observed for quinine hydrochloride and hydrochloric acid. The acidic bitterness sensor 
response pattern seems to decrease initially before a gradual increase after 1.0mM. 
This response appears inverted when compared to the same sensors’ response to 
quinine hydrochloride and hydrochloric acid. The astringency sensors response also 
demonstrates concentration dependence. There is a gradual decrease in sensor 
response with increasing concentration of metformin. This pattern is similar to that 
observed with quinine hydrochloride. However, it is noteworthy that the magnitude of 
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FIGURE 3. 20  RELATIVE SENSOR RESPONSE CURVE OF METFORMIN HYDROCHLORIDE, SHOWING SENSORS 
RESPONSE AS A FUNCTION OF CONCENTRATION, (N=?̅?±SD) 
 
The relative sensor response values given in Table 3.3, paints a picture that 
paracetamol has the highest magnitude of response. However, it is noteworthy that the 
values observed for paracetamol have no statistical difference to those recorded for 
water (one-way ANOVA, p=2.28x10-4.) 
 
















Paracetamol 1.0 -116 -86 -76 111 
Metformin 
hydrochloride 
1.0 -37 -41 -76 71 
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Principle component analysis (PCA) was performed on all drugs investigated in 
sections 3.3 and 3.4. Only the first two principle components have been used for the 
biplot. This is because,  the cumulative values of the first principle component (PC1) 
and second principle component (PC2) account for approximately 97% of data 
variation (as shown in Table 3.4) therefore a two axis plot represents a statistically 
acceptable amount of data. It should also be noted that where significance level is 
greater than 0.05, there is no difference between principle components 2 and 3. 
 
TABLE 3. 4 EIGENVALUES OF THE COVARIANCE MATRIX 










1 13504.81 90.57 90.57 36.51 9 3.22 × 10−5 
2 953.53 6.39 96.96 7.74 5 0.17 
3 377.24 2.53 99.49 3.40 2 0.18 
4 76.10 0.51 100.00 0 0 0 
 
The extraction eigenvectors give the contribution of each of the sensors to each 
principle component. These have been given in table 3.5. Essentially PC1 is primarily 
related to the basic bitterness1 sensor while PC2 is composed on basic bitterness 2 
and 3. Therefore, the separation of the APIs is heavily influenced by the basic 
bitterness1 sensors on the x-axis and the basic bitterness and acidic bitterness 
sensors on the y-axis.  
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TABLE 3. 5 EXTRACTED EIGENVECTORS FOR PC1 AND PC2 
 Coefficient of 
PC1 
Coefficient of PC2 
Basic bitterness1 0.78 -0.67 




Astringency -0.10 -0.03 
 
The biplot illustrated in Figure 3.21, displays both the loading and the scores for the 
selected principle components. All the APIs under investigation are plotted as a scatter 
plot (in red dots). The APIs tested were at the same concentration i.e. 1mM. There is 
no significant difference between the predicted taste attributes between the quinine 
salts. The biplot shows that both quinine salts are close to the x-axis, which has 
loading of the basic bitterness1 sensor therefore suggesting basic bitterness for both 
quinine salts. In addition, the positioning of the two salts on the biplot overlap and 
therefore no separation between them. No significant difference was observed 
between hydrochloric acid and sulphuric acid. Interestingly, the biplot suggest both 
basic and acidic bitterness for the two acids. This is significantly different to the basic 
bitterness suggested for the quinine salts. The biplot also shows a significant difference 
between quinine and its salts. More importantly, the results suggest that the two salts 
are more bitter compared to quinine. 
 
Paracetamol, ibuprofen, metformin lie in the loading direction of the astringency sensor 
which is in the opposite direction and of less magnitude than the bitterness sensors.  
For both principle components astringency has negative contribution, which suggests 
that it has no significant contribution. Therefore paracetamol, ibuprofen and metformin 
which are close to water display insignificant response with respect to the principle 
components observed. 




FIGURE 3. 21  A BIPLOT SHOWING PRINCIPLE COMPONENT ANALYSIS COMPARISON BETWEEN WATER AND 
PARACETAMOL, IBUPROFEN, METFORMIN, QUININE, QUININE SALTS, HYDROCHLORIC AND SULPHURIC ACIDS IN 




There is no difference in sensor response to caffeine, theobromine and theophylline as 
compared to deionised water. This suggests that the methylxanthines are not being 
detected. Investigation of caffeine citrate revealed logarithmic concentration 
dependence between the relative sensor response and increase in concentration 
across all four sensors. The same relationship was observed when citric acid was 
investigated and therefore suggesting that the citrate was responsible for the 
relationship observed in caffeine citrate and this further demonstrates that caffeine was 
not being detected.  
 
Quinine, quinine hydrochloride and quinine sulphate all demonstrate statistically 
significant differences when compared with de-ionised water, which suggests that all 
three molecules are being detected. Their sensor responses showed concentration 
dependence, particularly for both basic bitterness sensors. In all the cases, the basic 





































PC1 (basic bitterness1) - 90.57%
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bitterness1 sensor and acidic bitterness sensors reveal an identical pattern. However, 
the magnitude of response differs for each molecule. With respect the basic bitterness2, 
quinine hydrochloride and sulphate have similar patterns which are different to that 
illustrated for quinine base. The astringency sensor results did not demonstrate 
conclusive concentration dependence. Astringency response to quinine hydrochloride 
appears to be concentration dependant, however this relationship is not observed for 
quinine or quinine sulphate. In fact, for the latter, the astringency sensor response is no 
different to de-ionised water. This therefore suggests that the astringency sensor has 
limited detection capability or quinine molecules have no astringency. Since this is the 
first time a study comparing the responsiveness of taste sensor to quinine and its salts 
has been reported, there were no reports in literature to compare with. 
 
No significant sensor response was observed when paracetamol was compared with 
de-ionised water. This suggests that paracetamol is not being detected by taste sensor 
Woertz et al (2011) conducted the same study on paracetamol and reported a log 
linear relationship between sensor response and paracetamol. We have not found 
similar results. This may be due to the fact that our comparison was between 
paracetamol response and water, whereas Woertz et al (2011) only looked at 
paracetamol alone which therefore could have created a false positive reading. Further. 
It is also possible that different batches of sensors used could have given different 
readings. 
 
Sensor response to ibuprofen does not demonstrate conclusive evidence to be 
different to de-ionised water. Furthermore no concentration dependence is observed. It 
can therefore be concluded that ibuprofen is possibly not being detected by the taste 
sensor. Woertz et al (2011) investigated ibuprofen in a similar fashion and suggested 
that a linear log relationship was observed but either a small slope was observed or 
only a few sensors demonstrated response. The results observed show some 
response at 0.1mM from both basic bitterness sensors, however no further response is 
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detected at concentrations higher than this. Furthermore, the astringency and acidic 
bitterness sensors do not show a difference to de-ionised water. Hence, there is 
inconclusive evidence to suggest that ibuprofen is being detected.  
 
All four sensors show clear response to metformin hydrochloride as there is a 
statistically significant difference in relative sensor responses of metformin compare to 
de-ionised water. Additionally, sensor response also appears to be concentration 
dependant. The largest rate of change in relative sensor response is observed 
between the concentrations of 0.1 to 1.0mM.  Interestingly, the general shape of the 
sensor response curves for metformin hydrochloride are similar to those observed for 
quinine hydrochloride; the magnitude of response is however different. This is the first 
time that metformin detection has been investigated using the TS; therefore we have 
no basis of comparison in the literature. 
 
Three factors have been identified that could affect the detection of a drug by the taste 
sensor, namely: 
 Interaction between detecting sensor and ions 
 Extent of dissociation / ionisation of electrolyte 
 Concentration 
 Effect of solvent 
3.5.1 INTERACTION BETWEEN DETECTING SENSOR AND IONS 
The artificial lipid sensors on the taste sensor, are designed to detect different taste 
attributes. For the purposes of this study focus will be on bitterness and astringency 
taste detection. The composition of each of the sensors used in this study is given in 
Table 3.6 which describes the lipids and plasticisers used for each sensor type. The 
structures of each of the lipids as well as the plasticiser have been presented in 
chapter 1. 
CHAPTER 3  MECHANISM OF DETECTION 
136 
 
TABLE 3. 6 COMPOSITION OF SENSORS (BITTER DRUG SENSOR SET) ADAPTED FROM THE INSENT TASTE 
SENSING SYSTEM MANUAL (2010) 
 Name of 
Taste 
Sensor 





C00 Evaluates bitterness 
and acidic bitterness 
Tetradodecylammonium 
bromide + 2-Nitrophenyl octyl 
ether 
AE1 Evaluates astringency 
and aftertaste from 
astringency 
Tetradodecylammonium 





AC0 Evaluates basic 
bitterness 
hexadecanoic acid + dioctyl 
phenylphosphonate 
AN0 Evaluates basic 
bitterness 
phosphoric acid di-n-decyl 
ester + dioctyl 
phenylphosphonate 
 
The acidic bitterness sensor has a positively charged membrane, therefore it is 
expected that when immersed in aqueous solution the stern layer is composed 
primarily of anions while the diffuse layer will be comprised of cations. This is also true 
for the astringency sensor. The basic bitterness sensors however, are both negatively 
charged therefore it is expected that the stern layer will be predominately composed of 
cations while the diffuse layer will largely contain anions. Since the membranes are 
already charged, it is also expected that the drug either dissociate (if it is an ionic 
molecule) or be its ionised form in order to create a change in membrane potential. 
 
To recap, the Gouy-Chapman- Stern theory states that when an artificial lipid based 
membrane is immersed in aqueous solution, an electrical double layer (stern and 
diffuse layer) is formed at the surface of the membrane. The double layer is a result of 
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the dissociation of the acid groups of lipid molecules hence causing a membrane 
potential. The stern layer either positive or negative comprises of ions adsorbed 
directly onto the membrane due to chemical interactions. The diffuse layer is 
composed of ions attracted to the surface charges via Coulomb force, electrically 
screening the stern layer. However, almost all the theoretical work on this theory has 
been based on the assumption that the cations and anions in question differ only in 
charge. In physical systems such as those investigated in this study, there is no reason 
to expect these symmetries. Ions are of varying dimensions and this alone can lead to 
different distances of approach. What is probably more important is that in order to 
approach the membrane surface, an ion has to penetrate the solvent. It is expected 
that different ions will behave differently in this matter. In particular, water interacts in 
an asymmetric way cations and anions so that a consistent bias is observed between 
cations and anions with regards to effective radii describing approach to the membrane 
surface.  
 
Table 3.7 describes which cation / anion is theoretically expected to be in the stern 
layer of each sensor. Looking initially at the acidic bitterness sensor, for quinine 
hydrochloride, hydrochloric acid and metformin hydrochloride, the chloride (Cl-) ion, is 
expected to be anion in the stern layer.  However a closer look at the magnitude of 
sensor response at 1.0mM reveals that hydrochloric acid has the highest magnitude of 
response, followed by quinine hydrochloride and finally metformin. This relationship is 
also observed for the astringency sensor. Although, in all the three cases the stern 
layer is expected to have the same anion, the observed results demonstrate that the 
sensor response is not just due to the anion in the stern layer. Therefore, the cations in 
the diffuse layer could be affecting the overall response.  
 
Expanding the Gouy-Chapman-Stern theory, the electrical distribution is equivalent to 
the double layer of charge i.e. stern and diffuse layers. The potential at the stern layer 
is the electro-thermodynamic (Nernst) potential (E), is defined as the difference in the 
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potential between the actual membrane surface and the electro-neutral region of the 
solution. The potential located at the shear plane (plane separating stern and diffuse 
layers), is known as the electro-kinetic or zeta (ζ). The zeta potential is defined as the 
difference in the potential between the shear plane and the electro-neutral region of the 
solution. Increasing the concentration of an electrolyte in this system increases the 
screening effect of the counter-ion thus resulting in a rapid fall in zeta potential. The 
distance of the electrical double layer decreases. It is the changes in both E and ζ 
potentials that are recorded as the sensor response. 
The extent of dissociation of each of the drugs in solution could affect the magnitude of 
sensor response.  In the case of the sulphate ion (SO4
2-), the acidic and astringency 
sensors demonstrate highest response to H2SO4 as opposed to quinine sulphate. This 
again indicates that the anion in the stern layer is not solely responsible for the sensor 
response observed. 
TABLE 3. 7 CATIONS AND ANIONS FORMING STERN LAYER FOR EACH SENSOR 





























































Qn = Quinine, Mt = Metformin 
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The basic bitterness sensors are both negatively charged, therefore the stern layer is 
expected to be comprised of cations. In the case of quinine hydrochloride and quinine 
sulphate, the quinine ion is the cation. For both sensors the higher response value is 
observed for quinine hydrochloride. However, comparing these result to hydrochloric 
and sulphuric acid where the cation become H+ revealed both acids to have a 
significantly higher response from the sensors. There are two possible explanations  
namely:1) The different radii of the cations means different distances of approach 
which in turn affects the change in membrane potential or 2) The molecules have 
different dissociation profiles which in turn affects the concentration of charges species 
in the system. The relative sensor response values for metformin hydrochloride at 
1.0mM are higher than quinine salts but lower than the acids. . 
3.5.2 EXTENT OF DISSOCIATION / IONISATION OF ELECTROLYTE 
The Arrhenius theory of electrolytic dissociation defines strong electrolytes as those 
that dissociates into ions to a high degree, and a weak electrolyte as one that 
dissociates into ions to a low degree. In this study strong electrolyte refers to HCl and 
H2SO4, while weak electrolytes are quinine hydrochloride, quinine sulphate and 
metformin hydrochloride. It is noteworthy, that a strong electrolyte can be completely 
ionised and yet incompletely dissociated into free ions, thus the solution of a strong 
electrolyte has an “effective concentration”, a.k.a. activity. In general, the activity is less 
than the actual or stoichiometric concentration of the solute, not because the strong 
electrolyte is only partially ionised but because some of the ions are effectively “taken 
out of play” by the electrostatic forces of interaction between them. In solutions of weak 
electrolytes, regardless of concentration, the number of ions is small and the inter-ionic 
attractions are correspondingly insignificant. Hence, the Arrhenius theory and concept 
of degree of dissociation are valid for solutions for weak solutions but not for strong 
electrolytes unless they are in extremely dilute solutions like those used in this study. 
The results observed in this study show that the strong electrolytes have a higher 
magnitude of sensor response compared to the weak electrolytes. Although the 
solutions being compared are at the same concentration, it is apparent that the 
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difference in sensor response is linked to the difference in degree of dissociation. The 
strong electrolytes which are completely ionised and dissociated have more ions in 
solution which interact with the electronic tongue. The opposite is true for the weak 
electrolytes.  
 
 The degree dissociation of electrolytes depends on; the nature of the electrolyte; the 
degree of dilution and temperature. In this study, the degree of dilution (concentration) 
was varied to establish concentration dependence for each drug. However, in order to 
directly compare the drug a single concentration was used (1.0mM) as shown in 
Tables 3.2 and 3.3. Therefore, concentration and temperature were kept constant 
allowing any differences observed to be linked to the nature of the molecule i.e. degree 
of ionisation. The Henderson – Hasselbalch equation (Equation 3.2 and Equation 3.3) 
describes the link between pH, pKa and the degree of ionisation for a weak acid or 
weak base (Martin Alfred et al. 1973). It also shows that a drug is completely ionised or 
non- ionised (as appropriate) when two pH units away from its pKa. 
𝑝𝐻 = 𝑝𝐾𝑎 − 𝑙𝑜𝑔10[𝐴
−]/[𝐻𝐴] 
EQUATION 3.10 





If the pKa  or pKb value of the drugs and the pH of the solutions are known then the 
degree of ionisation of the drugs can be calculated from the re-arranged Henderson- 










] = 𝑝𝐾𝑏 − 𝑝𝑂𝐻 
EQUATION 3.13 
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As an example, the pKa for paracetamol is 9.38, the measures pH of the solution was 




] = 9.38 − 5.54 
[𝐻𝐴]: [𝐴−] =  103.18 = 1513.56: 1 
Therefore, at the measuring conditions in this study, paracetamol is largely non-ionised 
hence it is not easily detected by the electronic tongue. The ionised: non-ionised ratios 
of all the other APIs used in this study are calculated in a similar manner to 
paracetamol and presented in Table 3.8 
 
Application of the Henderson-Hasselbalch equation in this study has revealed that 
where the drug is un-ionised, the molecule is not detected by the taste sensor. This is a 
significant finding as the degree of ionisation can be used as a predictor of detection 
capability by taste sensor. As shown in Table 3.8, quinine and quinine hydrochloride 
are ionised hence detectable. When considering metformin hydrochloride, it is ionised 
in both basic and acidic pH due to the presence of primary, secondary and tertiary 
amines on its structure which can either accept or donate a proton depending on pH. 
Therefore it is always detectable on the taste sensor. It is noteworthy that the biplot in 
Figure 3.21 illustrates that although metformin is detected, once compared to other 
APIs i.e. quinine and its salts, its detection is insignificant. No reports have been found 
in literature regarding the pKa values of caffeine citrate and quinine sulphate. However, 
both are ionic molecules therefore are both dissociated in solution and as such are 
detectable. 
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< 1 2.54 ----- ionised 
Sulphuric acid < 1 2.54 ----- ionised 
Caffeine 10.4 7.01 2454.71 : 1 un-ionised 
Theobromine 9.9 5.37 33884.4 : 1 un-ionised 
Theophylline 8.62 5.41 1621.81 : 1 un-ionised 
Caffeine citrate* ---- 3.04 -----  
Citric acid 3.08 4.40 0.05 : 1 ionised 
Quinine 4.21 8.34 7.41 x 10-5 : 1 ionised 
Quinine 
hydrochloride 
4.33 5.74 0.04 :1 ionised 
Quinine 
sulphate* 
----- 5.05 ---- ------ 
Paracetamol 9.38 5.54 6918.31 : 1 un-ionised 
Ibuprofen 4.61 3.94 4.68 : 1 un-ionised 
Metformin 
hydrochloride 
12.4 5.92 3019951: 1 ------ 
* no values quoted in literature. 
 
3.5.3 CONCENTRATION 
Investigating concentration dependence is vital for establishing sensor response. It 
begs to reason that different concentrations of the same drug should elicit different 
levels of sensor response. For quinine, quinine hydrochloride, quinine sulphate, HCl, 
H2SO4 and metformin hydrochloride all exhibited concentration dependence. With the 
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exception of metformin hydrochloride, the concentration dependence levelled off after 
50mM. At this point we do not have enough evidence to generalise this observation to 
all API. However, it is important to note that concentration does affect sensor response 
and thus a concentration response curve should always be used to establish saturation 
concentration i.e. concentrations above which any further increases in concentration 
does not result in increases in sensor response.  Sensor concentration curves are also 
important for establishing sensor response against a known standard. Based on the 
Gouy-Chapman-stern layer theory, a finite amount of cations/ anions can adhere to the 
membrane thus affecting a sensor response. This therefore implies that once the finite 
point has been reached, no further sensor response can be observed. The biplot 
displayed in Figure 3.21 suggests hydrochloric and sulphuric acid as having significant 
contribution from both basic bitterness1 and 2 and acidic bitterness sensors. This is in 
line with the magnitude values observed for the two acids in comparison with the other 
drugs. Quite rightly, PCA has identified the two acids as contributing to the most 
variation for the data observed. Variation of data in this case relates to magnitude of 
deviation from standard i.e. de-ionised water. However,  reports in literature identify the 
detection of protons as the mechanism of detection for the sour taste attribute in 
humans (Breslin et al. 2006, Breslin et al. 2008). Therefore, it has been established in 
the literature that the presence of acids gives rise to sour taste, yet the taste sensor 
predicts highest magnitude of response from basic and acidic bitterness. The 
manufactures also have on sale a sour sensor which could have been used in this 
study. However, it is interesting that the sensors that are designed to detect basic 
bitterness and acidic bitterness respond more to HCl and H2SO4, molecules that are 
known to be sour, over quinine hydrochloride the molecule which the manufactures 
used as a bitterness standard. This discovery leads us to conclude that the mechanism 
of sensor response is highly dependent on dissociation / ionisation profile of the drug in 
question. Furthermore, it leads to the question- if detection and response are 
dependent on ionisation/ dissociation profile is the taste sensor measuring true taste 
attributes or the extent of dissociation/ ionisation in solution of the drug. 
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3.5.4 A NOTE OF SENSOR LONGEVITY 
An issue that has not been discussed thus far is the lifespan of the sensors of the 
electronic tongue. This requires discussion because there is a significant financial 
implication in terms of overheads. More importantly, the longevity of the sensors 
impacts directly on the reliability of the measurement obtained. Table 6.1 gives a 
summary of the average number of cycles and days that each sensor had to be 
replaced throughout this study period. It is noteworthy that the acidic bitterness sensor 
was replaced almost twice as much as the basic bitterness sensors and three times as 
much as the astringency sensor. All sensors were stored and maintain as per 
manufactures’ guidance with the exception of they were thoroughly rinsed with distilled 
water at the end of each experimental cycle. Only a single operator used the sensors in 
question therefore any operator error would have applied to all sensors. Therefore, the 
reasons for this difference in longevity remains unknown, however the manufacturers 
have been notified of this finding and are considering this data. 
TABLE 3. 9 SUMMARY OF SENSOR USAGE THROUGHOUT THE STUDY 
Sensor Number of cycles 
before replacement  
(?̅?± SD) 












312 94 5 
Acidic 
bitterness (C00) 
156 51 9 
Astringency 
(AE1) 
399 123 3 
 




This study has shown that caffeine, theophylline, theobromine, paracetamol and 
ibuprofen are not detected by the taste sensor as no difference is observed between 
de-ionised water and increasing concentrations of these drugs. Quinine and its salts, 
hydrochloric acid, sulphuric acid, caffeine citrate, citric acid and metformin 
hydrochloride all show concentration dependant sensor response. The latter molecules 
are detected by the taste sensor due to the fact that they are either ionised or 
dissociated in solution. Hydrochloric and sulphuric acid which are strong acids are fully 
dissociated in solution and therefore give the highest magnitude of sensor response.  
The suggested  mechanism of sensor response is based on the Gouy – Chapman – 
Stern theory, i.e. when a lipid membrane is placed in aqueous solution an electrical 
double layer is formed. It is the change in this electrical double layer, caused by the 
presence of drug that is being measured and amplified by taste sensor. However, the 
extent to which the drug affects the change in membrane potential is mostly due to 
dissociation or ionisation extent of the molecule at the given concentration. This study 
has shown that those molecules that dissociate to a greater extent i.e. hydrochloric and 
sulphuric acid give highest magnitude of response. It has also shown that use of the 
Henderson – Hasselbalch equations can be used to predict the extent of ionisation 
hence predict if the drug can be detected or not. Drugs that are either ionised or 
dissociated salt forms in solutions can be detected unlike those that are non-ionised.  
The extent of ionisation is dependent on the pH of the system, therefore in order to 
validate that proposed mechanism it is necessary to explore the effect of pH on the 
detection of ibuprofen. Literature reports ibuprofen pKa at 4.61, therefore at pH 5-7, 
ibuprofen will be ionised and should be detectable.  
 
PCA reports hydrochloric and sulphuric acid having the most deviation from de-ionised 
water, when using a bitter drug sensor set i.e. sensors designed to detect bitterness 
and astringency. However, literature reports both acids to be sour and moreover it is 
well understood that sour taste perception in humans is innervated by hydrogen ions. 
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Quinine hydrochloride was used as a bitterness standard by the manufactures and it is 
reported to be bitter in literature yet its magnitude of response is lower than that of the 
two acids. This observation raises questions regarding the accuracy of each sensor 
response. Arguably, a bitterness sensor should respond more to a bitter drug than a 
sour drug. This study has shown that the sensor response is largely dependent on 
extent of ionisation / dissociation. Therefore, regardless of the “label” applied to the 
sensor i.e. bitter, astringent – sensors respond to highly ionised / dissociated 
molecules but this is not a true indicator of the taste of the molecule in question. We 
propose a further study to expose the sour sensor to hydrochloric acid, sulphuric acid 
and quinine hydrochloride, with the aim of comparing the magnitude of sensor 
response of the bitter sensors to the sour sensor. If our theory on sensor response is 
correct, then the order of magnitude of sensor response will be identical across the 
sensors.  
It has also demonstrated in this study that for any taste assessment using taste sensor, 
it is necessary to initially conduct a concentration response curve and more importantly, 
to compare the sensor response of the unknown tastant molecule to a known reference 
i.e. de-ionised. It should be noted that the taste sensor will respond to the blank i.e. de-
ionised water and therefore a comparison against the blank will allow the user to 
differentiate between the blank’s response and a true response. The concentration 
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CHAPTER 4- TASTE ASSESSMENT OF AMLODIPINE 
 
In the biography on the life of his children, Charles Darwin astutely noted that children 
live in different sensory worlds compared to adults. They exhibit heightened 
preferences for sweet tasting substances and a greater rejection of bitter tasting 
substances. These preferences differ between the different paediatric age groups i.e. 
neonates (≤ 28 days), infant (1 month – 2 years), young children (2-6 years), children 
(6-12 years) and adolescence (12-18 years); with the adolescent taste preferences 
mirroring those of an adult. As the child grows the positive hedonistic responses to 
strong sweets seem to decline in late childhood and adolescence (Cowart 1981). 
Moreover taste perception also changes between health and disease (Schiffman 2007). 
This variation in taste preference in children of different ages presents a challenge in 
terms of taste masking strategies. 
 
In recognising that “children are not small adults”, the European Medicines Agency 
(EMEA) published the paediatric regulation (EC No. 1901/2006), which came into 
effect in January 2007. This regulation requires the early submission of a 
pharmaceutical development plan for medicines: a paediatric investigation plan (PIP). 
The applicant is required to provide an overview of planned measures / performed 
studies of which taste masking and assessment are of particular relevance.  The 
applicant is expected to demonstrate paediatric acceptability of the product. However, 
debates are still ongoing as to the definition of acceptability. Questions are still being 
raised that, if the product is presented to children, what percentage of these children 
giving positive affirmation is deemed acceptable. Furthermore,  other questions revolve 
around whether acceptability referring to the type of formulation, ease of dose 
adjustment for the different paediatric populations, mouth feel, taste or all of the above. 
Nonetheless, it is clear that taste masking and taste assessment during development 
of paediatric oral formulations is undisputed. In addition, it is expected that human taste 
panels for paediatric formulations should as far as ethically possible be made up of 
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children and not adults. To this end, more and more taste testing studies of medicines 
for children is expected even for medicines already on the adult market. 
 
Over the past decade, the prevalence of childhood arterial hypertension in the 
paediatric population has increased due to increases in children’s excess body weight. 
Unfortunately from 1970 to 1990, the prevalence of overweight children and 
adolescents in the UK has increased from 5-11% (Hughes et al. 1997, Stamatakis et al. 
2005). The European Society of Hypertension (ESH) and European Society of 
Cardiology (ESC) recommend the use of calcium channel blockers in the treatment of 
hypertension, in particular amlodipine (Lurbe et al. 2009). However, only 5mg and 
10mg tablets are available on the UK market. These are available generically as 
amlodipine besilate, amlodipine maleate and amlodipine mesilate. In younger children 
that are unable to swallow tablets, parents and / or clinicians are encouraged to crush 
tablets and disperse them in water. In this form the taste of the amlodipine salt 
becomes apparent. In a  recent study comparing the palatability of calcium channel 
blockers, it was reported that from the perspective of the child, the taste of pulverised 
amlodipine besilate was less preferred to that of lernacadipine (Milani et al. 2010). 
There are no reports in the literature describing the taste of amlodipine maleate and 
amlodipine mesilate. 
  
In Japan, amlodipine orally disintegrating tablets (ODT) are popular and have been 
recently evaluated using a taste sensor SA501C equipped with a bitterness sensor 
AN0. However, it is important to point out that the main focus of this study was 
developing the method to evaluate the disintegration of ten ODTs thus identifying the 
main factors influencing the palatability of ODTs (Uchida et al. 2013). In the UK, in 
order to make amlodipine acceptable to children, generic tablets are extemporaneously 
prepared into two formulations. These two formulations have been shown to be stable 
for over 90 days when stored in the fridge and 56 days at room temperature  
(Nahata et al. 1999). The assessment of these two formulations in terms of palatability 
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has not been reported in the literature. The structure of the amlodipine has already 
been shown in Figure 2.9. The corresponding salts namely besilate, mesilate and 
maleate are shown in Figures 4.1, 4.2 and 4.3 respectively. 
 
 
FIGURE 4. 1  STRUCTURE OF BESILATE 
 
 
FIGURE 4. 2  STRUCTURE OF MESILATE 
 
 
FIGURE 4. 3  STRUCTURE OF MALEATE 
4.1 STUDY OBJECTIVES 
The overarching question addressed in this chapter was whether the taste sensor 
could be used to predict which salt of amlodipine was superior in terms of taste. In 
addition, the taste masking efficiency of two commonly used extemporaneous vehicles 
is investigated using the electronic tongue. Finally, the results from the electronic 
tongue are compared to an untrained human taste panel study with a view to draw 
correlations between the two methods of taste assessment. The responsiveness of the 
sensors (detailed in Section 4.2) to amlodipine (base) is compared to its salts with a 
view of establishing which salt demonstrates best palatability. Furthermore, in keeping 
with methodology established in chapter 3, amlodipine besilate, maleate are compared 
to  benzene sulphonic acid, sodium maleate  respectively in order to establish the 
sensitivity of the sensors to different salts of the same molecule. 




The bitter drug sensor set i.e. AC0 (basic bitterness1), AN0 (basic bitterness2), C00 
(acidic bitterness) and AE1 (astringency) were used to evaluate increasing 
concentrations of amlodipine and its salts. Solutions of amlodipine (0.25mg/ml, 
0.5mg/ml, 0.75mg/ml and 1mg/ml) were prepared by the addition of the required 
quantity of amlodipine, amlodipine besilate, and amlodipine maleate into the vortex 
created by the action of a magnetic stirrer. A 30% v/v aqueous ethanol was used as 
solvent. The stirring was continued for 30 minutes. All solutions were prepared at room 
temperature on the day of testing. 
 
Suspensions of amlodipine with similar concentrations to solutions were prepared 
using the schematic illustrated in Figure 4.6. Essentially, amlodipine tablets were 
pulverised using a pestle and mortar before being suspended in the different vehicles 
i.e. water (F1), 50:50 1% methylcellulose and simple syrup (F2) and 50:50 Ora sweet® 
and Ora plus® (F3). The suspension was stirred in the respective vehicle using a 
magnetic stirrer for 30 minutes. Schematics for the preparation of F1 and F2 are given 
in Appendix A2. All suspensions were prepared on the day of testing. Each of the 
different salts was prepared into three different formulations. The suspensions were 
tested on the taste sensor with no further agitation as the testing cycle was running. 




FIGURE 4. 4  SCHEMATIC OF PREPARATION OF AMLODIPINE SUSPENSIONS FOR F3 FORMULATIONS. 
4.2.1 DATA ANALYSIS 
Each solution / suspension was tested 4 times in order to ensure reliability. The 
average sensor response reading (µ) was calculated from the last three readings for 
every sensor response recorded for each sample tested. In order to analyse the 
reading directly from the API under investigation, the placebo value was subtracted 
from each sensor response reading. Sensor response curves and principal component 
analysis was performed as described in chapter 2 and Chapter 3, section 3.4.3. In 
addition, hierarchical cluster analysis was performed using the method described in 
Section 4.3.2. Data management and analysis was performed using Originpro® 9.0 
(OriginLab, Northampton, USA). 
 
4.2.2 HUMAN TASTE PANEL STUDY 
A single, blinded, cross over human taste assessment study was conducted in 
collaboration with J. Marbay, M.Orlu Gul, F. Olanipekun, S. Ranmal, J.Soto and C. 
Tuleu at the University College London (UCL), School of Pharmacy Policy and Practice 
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Unit. Ethical approval was sought from and granted by the UCL Research Ethics 
Committee (Project ID number 4612/001, Appendix A3). Twenty four healthy 
untrained participants (13 female, 11 male) were recruited.  Their mean age was 
23years and all participants completed the study. Each panellist attended four sessions, 
with each session lasting no more than two hours to prevent taste fatigue. The 
sessions were timetabled one week apart to allow for a washout period. The terminal 
elimination half-life of amlodipine is approximately 35- 50 hours (Faulkner et al. 1986) 
therefore, it was necessary to have a 7 day washout period gives sufficient time for the 
elimination of amlodipine from systemic circulation should any of the participants 
accidentally swallow instead of spitting amlodipine samples. To control for bias, the 
formulations were coded with random three digit codes and presented to the 
participants in random order.  
 
Participants were asked to swirl 5ml of each sample in their mouth for 20s. The swirling 
time was minimised to 20s in order to reduce the risk of oromucosal absorption. 
Following the swirling the participants had to spit the sample in the container provided. 
The participants were asked to pay particular attention to the whether the formulation 
was pleasant or unpleasant and annotate this on a 10cm visual analogue scale (VAS), 





FIGURE 4. 5  VISUAL ANALOGUE SCALE (NOT TO SCALE), USED BY PARTICIPANTS TO ASSESS 
PALATABILITY OF F1, F2 AND F3 FORMULATIONS 
 
Before and after each sample, the participants were given an unsalted cracker and 
bottled water to cleanse the palate and rinse their mouth. A ten minute washout period 
was observed between each sample to allow panellists sensor recovery and also to 
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including two controls namely; bottled water (positive control) and 1mg/ml amlodipine 
salt (negative control). The samples to be tasted were presented to each panellist in 
the order described in Table 4.1. 
TABLE 4. 1 ORDER OF PRESENTATION OF SAMPLES TO PANELLISTS ON EACH VISIT 
Visit 
number 
Formulation Presentation order of concentrations 
(mg/ml) 
1st visit amlodipine besilate 
API 
1 0.5 0 0.25 0.75 
amlodipine besilate F1 0.25 0.5 0 0.75 1 
2nd visit amlodipine mesilate 
F1 
0.75 0.5 0 0.25 1 
amlodipine maleate 
F1 
0.75 0.25 0 1 0.5 
3rd visit amlodipine besilate F2 1 0.25 0 0.75 0.5 
amlodipine besilate F3 1 0.25 0 0.5 0.75 
4th visit amlodipine maleate 
F2 
0.5 0.75 0 1 0.25 
amlodipine maleate 
F3 
0.5 0.25 0 1 0.75 
 
Data management and analysis was performed using Microsoft Excel® 2010.  
 
4.3 RESULTS 
4.3.1 AMLODIPINE AND ITS SALTS CONCENTRATION CURVES 
 
In keeping with methodology established in chapter 3, the responsiveness of the taste 
sensor to increasing concentrations of amlodipine and its salts i.e. mesilate, besilate 
and maleate was investigated.  In light of issues identified in chapter 3, de-ionised 
water was used as a negative control. Figure 4.8 illustrates the sensor responses to 
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increasing concentrations of amlodipine. The reading (mV) at concentration 0mg/ml is 
that for de-ionised water. The basic bitterness2 and acidic bitterness sensors both 
show variation to increasing concentrations of amlodipine. However, basic bitterness 1 
and astringency sensors do not illustrate responsiveness to increases in concentration 
of amlodipine. It is therefore important to note this response differs from water. Overall 
a one-way ANOVA showed no statistical difference between the sensor response and 
increasing concentrations of amlodipine (p= 1.97 x 10−6) 
 
FIGURE 4. 6  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE, SHOWING THE RESPONSES OF FOUR 
SENSORS WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A FUNCTION OF CONCENTRATION  
(N=3, ?̅?±SD) 
 
The responsiveness of the sensors to amlodipine besilate is illustrated in Figure 4.9. 
Both the acidic bitterness and astringency sensors show an increase in 
responsiveness with increase in concentration. It is also noteworthy, that the standard 
deviation error bars for these two sensors overlap therefore there is no statistical 
difference in response between the two sensors. The basic bitterness sensors show a 
































Amlodipine Sensor Response Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency
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dependence across the four concentrations explored in this study. A one-way ANOVA 
shows no statistical difference (p= 1.49 x10−5). 
 
FIGURE 4. 7  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE FOR AMLODIPINE BESILATE, 
SHOWING THE RESPONSES OF FOUR SENSORS AS A FUNCTION OF CONCENTRATION (N=3, ?̅?±SD) 
 
Amlodipine besilate (Figure 4.1) is composed of amlodipine and benzene sulphonic 
acid therefore in order to appreciate which species in solution was responsible for the 
sensor response observed; the sensors response to benzene sulphonic acid is 
illustrated in Figure 4.10. The acidic bitterness and astringency sensors show a change 
in response with increasing concentrations of benzene sulphonic acid. Both basic 
bitterness sensors show no difference with solvent and no difference in response 
between them. It is noteworthy that the pattern of response observed for benzene 
sulphonic acid is similar to that observed for amlodipine besilate. Once again, a one-
































Amlodipine besilate Sensor Response Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 8  RELATIVE SENSOR RESPONSE CURVE FOR BENZENE SULPHONIC ACID, SHOWING BITTER 
DRUG SENSOR SET RESPONSES AS A FUNCTION OF CONCENTRATION (N=3, ?̅?±SD) 
 
The responsiveness of the sensors to amlodipine maleate is given in Figure 4.11. 
Consistent with results observed for amlodipine besilate, the acidic bitterness and 
astringency sensors both show a clear concentration dependant response. The 
standard deviation error bars for both sensors overlap suggesting that there is no 
statistical difference in sensor response between the two sensors. The basic bitterness 
sensors illustrate a difference between solvent and solutions containing amlodipine 
maleate, however, no change in response is observed with increasing concentration of 
amlodipine maleate. This is confirmed using a one-way ANOVA which showed no 






























Benzene sulphonic acid Sensor Response Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 9  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE MALEATE, SHOWING THE 
RESPONSIVENESS OF FOUR SENSORS CODING FOR A TASTE ATTRIBUTES, AS A FUNCTION OF CONCENTRATION 
(N=3, ?̅?±SD) 
 
Similar to the strategy applied for amlodipine besilate and benzene sulphonic acid, 
sodium maleate, structure of which is given in Figure 4.5 was compared to amlodipine 
maleate. The responsiveness of sensors to sodium maleate is shown in Figure 4.12. In 
this case, a clear response is observed between solvent and solutions of sodium 
maleate were observed for the acidic bitterness and astringency sensors. Interestingly, 
there is no concentration dependence observed with increasing concentrations of 
sodium maleate for all four sensors. A one-way ANOVA confirms that there is no 


































Amlodipine maleate Sensor Response Curve  
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 10  RELATIVE SENSOR RESPONSE CURVE FOR SODIUM MALEATE, SHOWING THE 
RESPONSIVENESS OF FOUR SENSORS CODING FOR A TASTE ATTRIBUTES, AS A FUNCTION OF CONCENTRATION 
(N=3, ?̅?±SD) 
 
4.3.1.1 SUMMARY OF RESULTS 
The present study set out to investigate the responsiveness of sensors to pure 
amlodipine, its salts besilate and maleate. De-ionised water was used as negative 
control. It is apparent that there is a difference in sensor response patterns between 
amlodipine and its salts i.e. besilate and maleate. With respect to amlodipine base, 
only the basic bitterness 2 and acidic bitterness sensors show a response, while the 
salts show astringency and acidic bitterness being the predominant responses. This is 
supported by the fact that benzene sulphonic acid and sodium maleate also have same 
sensor response as amlodipine besilate and amlodipine maleate respectively. 
Therefore, it appears that in salt form, the sensor response switches from basic and 



































Sodium maleate Sensor Response Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency
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4.3.2 AMLODIPINE F1 FORMULATIONS 
Sensor response curve for pulverised amlodipine besilate tablets suspended in water 
(F1) is illustrated in Figure 4.13. Concentration dependent sensor response is 
observed with the astringency sensor, while this is absent for the other three sensors. 
Interestingly, the acidic sensor shows a response when solutions were made with 
30%v/v aqueous ethanol but this response is absent when water alone is used. 
However, overall, a one-way ANOVA shows that there is no statistical difference in 
senor response with increasing concentrations of amlodipine besilate (p= 2.71 x10−6). 
 
FIGURE 4. 11  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE BESILATE F1 FORMULATIONS, 
SHOWING THE RESPONSIVENESS OF FOUR SENSORS CODING FOR DIFFERENT TASTE ATTRIBUTES, AS A 
FUNCTION OF CONCENTRATION (N=3, ?̅?±SD) 
The sensor responses to amlodipine maleate tablets crushed and dispersed in water 
(F1) is illustrated in Figure 4.14. A clear concentration dependent response is observed 
with the astringency and acidic bitterness sensors. Conversely, there is no difference in 
response between water and formulations containing crushed amlodipine maleate 
tablets when considering the basic bitterness sensors. Interestingly, the sensor 
responses for the basic bitterness sensors are diminished in F1 compared to 30% 
aqueous ethanol. However, overall, a one-way ANOVA show that there is no statistical 































Amlodipine besilate F1 Sensor Response 
Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 12  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE MALEATE F1 FORMULATIONS, 
SHOWING THE RESPONSIVENESS OF FOUR SENSORS CODING FOR A TASTE ATTRIBUTES, AS A FUNCTION OF 
CONCENTRATION (N=3, ?̅?±SD) 
 
F1 formulations of amlodipine mesilate were investigated using the taste sensor. The 
responsiveness of the sensors is shown in Figure 4.15. The astringency sensor shows 
significant changes in sensor response with increasing concentration, which is not 
apparent for the other three sensors. Interestingly, the acidic sensor response is 
showing positive values (mV) as opposed to negative values which have been 
observed thus far on amlodipine and its salts besilate and maleate. However, overall, a 
one-way ANOVA show that there is no statistical difference in sensor response with 




























Amlodipine maleate F1 Sensor Response 
Curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency





FIGURE 4. 13  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE MALEATE F1 FORMULATIONS, 
SHOWING THE RESPONSIVENESS OF FOUR SENSORS CODING FOR A TASTE ATTRIBUTES, AS A FUNCTION OF 
CONCENTRATION (N=3, ?̅?±SD) 
 
Principle component analysis was performed in order to establish taste differentiation 
between F1 formulations of the amlodipine salts. The eigenvalues of the covariance 
matrix shown in Table 4.2, show the percentage of variance (spread of data) 
apportioned to each principal component. It is apparent that the first and second 
principle components (PC1 and PC2), have the highest eigenvalues and proportionally 
account for 98% of variance observed. Therefore a two axis plot would represent a 
statistically significant amount of data. It should be noted that low p values for PC1 and 
PC2 indicate a greater confidence that there is statistical difference between the 
observations for both principal components. A similar argument applies to the third 


































Amlodipine mesilate F1 sensor response 
curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency
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TABLE 4. 2 EIGENVALUES OF THE COVARIANCE MATRIX SHOWING CONTRIBUTION AND SIGNIFICANCE OF 
EACH PRINCIPLE COMPONENT 










1 4918.35 88.63 88.63 102.7
9 
9 4.28 x 10−18 
2 556.23 10.02 98.65 59.59 5 1.47 x 10−11 
3 74.38 1.34 99.99 35.20 2 2.26 x 10−8 
4 0.52 0.01 100.00 0 0 0 
 
The extracted eigenvectors give the contribution of each of the sensors to the first and 
second principal components. These are given in Table 4.3. Essentially, the 
astringency sensor has highest contribution to PC1, while the basic bitterness2 sensor 
is the predominant signal for PC2. Therefore, the separation of the amlodipine F1 
formulations is influenced by astringency on the x-axis and basic bitterness2 on the y-
axis. 
 
TABLE 4. 3 EXTRACTED EIGENVECTORS FOR PC1 AND PC2  AND CORRESPONDING SENSOR 
ALLOCATION 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 -0.01 0.12 
Basic bitterness2 -0.11 0.76 
Acidic bitterness 0.41 0.61 
Astringency 0.90 -0.18 
 
The biplot shown in Figure 4.16 displays both the loadings and the scores for principal 
components 1 and 2. The raw data under investigation are plotted as a scatter plot (in 
red dots). All four concentrations of each of the amlodipine salts are shown on the 
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biplot. There is a significant difference between the amlodipine salts and placebo  
(de-ionised water). As already illustrated with the extracted eigenvectors the 
astringency sensor is closely linked with the x-axis while the basic bitterness2 sensor is 
aligned to the y-axis. The acidic bitterness is located between the x and y axes. The 
loading for basic bitterness1 is insignificant. The amlodipine mesilate formulations 
(designated AMme) on the biplot are all aligned with the x-axis signifying astringency. 
As the concentration of amlodipine mesilate increases an element of acidic bitterness 
increases. The amlodipine besilate formulations (designated AMbe) are clustered 
together and closely associated with basic bitterness2. Interestingly, at low 
concentration i.e. 0.25mg/ml, amlodipine besilate is clustered with amlodipine mesilate.  
 
 
FIGURE 4. 14  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS AND LOADING PLOTS OF AMLODIPINE 
BESILATE, MALEATE AND MESILATE F1 FORMULATIONS IN TERMS OF THEIR PREDICTED TASTE ATTRIBUTES.  
 
Hierarchical clustering is one of the most straight forward methods of grouping 
heterogeneous data into homogenous data sets. It can either be agglomerative or 














































PC1 - astringency (88.63%)
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itself. At successive steps, similar clusters are merged (Kaufman et al. 2009). In this 
case, the average relative sensor response readings (mV) for each sensor per 
concentration of each amlodipine salt were a cluster. At the next step, the two sensor 
readings which have largest similarity are joined into a single cluster. For example, 
amlodipine ma (0.25) and amlodipine ma 0.5 have a small difference between them 
and as such are merged into one cluster. At every step, individual data are added to 
existing clusters, two individual clusters are combined or two existing clusters are 
combined. The algorithm ends with the whole data set merged into one cluster. In other 
words agglomerative hierarchical clustering is a bottom up approach to grouping data. 
In this type of clustering once the cluster is formed it cannot be split. In this study, 
agglomerative cluster analysis was used to determine the distances between each of 
the clusters observed in the principal component analysis. A visual representation of 
the distance at which the clusters are combined is shown in a dendrogram illustrated in 
Figure 4.17.  The dendrogram illustrates that the higher concentrations of amlodipine 
formulations are very similar. This is exemplified by the fact the first observations to be 
merged are 7:10, 9:12 and 8:11. As shown in Table 4.2, these observations represent 
the higher concentration of the amlodipine mesilate, amlodipine maleate and 
amlodipine besilate F1 formulations respectively. 




FIGURE 4. 15  A DENDROGRAM SHOWING CLUSTER ANALYSIS OF AMLODIPINE BESILATE, MALEATE AND 
MESILATE F1 FORMULATIONS, SHOWING FOUR CLUSTERS OF THE OBSERVED VARIABLES. 
 
The composition of each of the clusters is given in Table 4.4, to support the results 
shown by the principal analysis biplot, each of the amlodipine salts are clustered 
closely together. 
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TABLE 4. 4 CLUSTER MEMBERSHIP TABLE SHOWING THE OBSERVATION NUMBER AND SAMPLE NAME OF 
EACH SAMPLE IN THE FOUR DIFFERENT CLUSTERS IDENTIFIED 
Cluster Membership 
(observation number  and sample name) 
1 1 - placebo  
2 2- amlodipine besilate 0.25 
4- amlodipine mesilate 0.25 
7- amlodipine mesilate 0.5 
 
10- amlodipine mesilate 0.75 
13 – amlodipine mesilate 1 
3 3- amlodipine maleate 0.25 
6- amlodipine maleate 0.5 
 
9 - amlodipine maleate 0.75 
12- amlodipine maleate 1 
4 5- amlodipine besilate 0.5 
8- amlodipine besilate 0.75 
 
11- amlodipine besilate 1 
 
The distances between the clusters were calculated using the Euclidean equation 
below.  




EQUATION 4.14  
The distances between the clusters is given in Table 4.5, which shows that cluster 4 i.e. 
amlodipine besilate is furthest deviation from placebo therefore indicating that it has 
poor palatability in comparison to placebo. The distances were calculated using 
coordinates (x:y) at an imaginary centre point of the cluster, which is also known as 
cluster centre. 
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TABLE 4. 5 EUCLIDEAN DISTANCES BETWEEN CLUSTER CENTRES 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 48.56 154.43 168.21 
Cluster 2 48.56 0 126.81 138.21 
Cluster 3 154.43 126.81 0 59.12 
Cluster 4 168.21 138.21 59.12 0 
 
 
4.3.2.1  SUMMARY OF RESULTS 
The findings from this section suggest that in general, all the F1 formulations are 
detectable on the taste sensor with the astringency sensor exhibiting the most 
response (89%). The basic bitterness2 demonstrates the next prominent response, 
accounting for 10% of data variation observed. Cluster analysis revealed four distinct 
clusters. Cluster 2 was associated with astringency, while cluster 4 was linked to basic 
bitterness2. The results suggest that amlodipine besilate of concentrations 0.5, 0.75 
and 1mg/ml show the largest deviation from placebo (cluster 1), whilst cluster 2 
(consisting predominantly of amlodipine mesilate) shows closest distance to placebo. 
Therefore when considering F1 formulations, amlodipine besilate is least palatable 
while amlodipine mesilate has the best palatability. In the next section a similar 
comparison is reported for F2 formulations of amlodipine salts. 
 
4.3.3 AMLODIPINE F2 FORMULATIONS 
To recap, F2 formulations were prepared using 1:1 mixture of 1% methylcellulose and 
simple syrup before suspending pulverised amlodipine besilate, maleate and mesilate 
tablets. The responsiveness of the sensors AN0 (basic bitterness1), AC0 (basic 
bitterness2), C00 (acidic bitterness) and AE1 (astringency) was investigated using 
increasing concentrations of each amlodipine salt. Figure 4.18 reveals that there is 
change in sensor response (mV) with increasing concentrations of amlodipine besilate 
when considering the astringency sensor.  With respect to the bitterness sensors, 
although a significant change is observed between placebo (0mg/ml) and 0.25mg/ml 
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no further changes in response are observed with increases in concentration of 
amlodipine besilate. A one-way ANOVA shows that there is no statistical difference in 
the sensor responses (p= 1.15 x10−5) 
 
FIGURE 4. 16  RELATIVE SENSOR RESPONSE OF AMLODIPINE BESILATE F2, SHOWING SENSOR RESPONSES 
AS A FUNCTION OF CONCENTRATION ((N=3, ?̅?±SD) 
 
The graph shown in Figure 4.19 reveals similar trends to those observed in Figure 4.18. 
The astringency sensor shows a concentration dependant change in sensor response. 
The other bitterness sensors however, demonstrate a change in response to placebo 
but no change with increasing concentrations of amlodipine maleate. A one-way 
ANOVA shows that there is no statistical difference between sensor response and 

































Amlodipine besilate F2 sensor response 
curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 17  RELATIVE SENSOR RESPONSE CURVE OF AMLODIPINE MALEATE F2, SHOWING SENSOR 
RESPONSES AS A FUNCTION OF CONCENTRATION (N=3, ?̅?±SD) 
 
In contrast to sensor responses observed in Figures 4.18 and 4.19, Figure 4.20 reveals 
that the basic bitterness 2 sensor shows a definite change in sensor response with 
increases in concentrations of amlodipine mesilate. The other three sensors i.e. basic 
bitterness 1, acidic bitterness and astringency do not show any significant deviation 
from placebo. A statistical analysis using one-way ANOVA showed that there was no 
difference between sensor response and increases in concentration of amlodipine 





























Amlodipine maleate F2 sensor response 
curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency




FIGURE 4. 18  RELATIVE SENSOR RESPONSE CURVE OF AMLODIPINE MESILATE F2, SHOWING SENSOR 
RESPONSES AS A FUNCTION OF CONCENTRATION (N=3, ?̅?±SD) 
 
The eigenvalues of the covariance matrix shown in Table 4.6 show the percentage of 
variance apportioned to each principal component. It is apparent that PC1 and PC2 
have the highest eigenvalues and proportionally account for 99% of variance observed. 
Therefore a two axis plot would represent a statistically significant amount of data. It 
should be noted that low p values (i.e. > 0.05) for PC1 and PC2 indicate a greater 
confidence that there is statistical difference between the observations for both 
principal components. A similar argument applies to PC3 even though it has not been 

































Amlodipine mesilate F2 sensor response 
curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency
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TABLE 4. 6 EIGENVALUES OF THE COVARIANCE MATRIX SHOWING CONTRIBUTION AND SIGNIFICANCE OF 
EACH PRINCIPLE COMPONENT 










1 2419.48 89.99 89.99 118.6
9 
9 2.48 x 10−21 
2 264.96 99.84 99.84 71.88 5 4.17 x 10−14 
3 3.68 99.98 99.98 8.57 2 0.01 
4 0.50 0.02 100 0 0 0 
 
After looking at the value of the spread as given by the eigenvalues, the extracted 
eigenvectors show the direction of the spread. In other words the eigenvectors 
quantitatively demonstrate which sensor(s) are responsible for the variation observed. 
In this case, it is clear that the astringency sensor contributes heavily on the variation 
observed for the first principal component while basic bitterness 2 dominates response 
in PC2.  It is worth pointing out that where the coefficient eigenvector takes a negative 
value, this suggests that that particular vector has no significance. 
 
TABLE 4. 7 EXTRACTED EIGENVECTORS FOR PC1 AND PC2, SHOWING THE CONTRIBUTION OF EACH 
SENSOR TO THE FIRST AND SECOND PRINCIPAL COMPONENTS 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 0.01 0.08 
Basic bitterness2 -0.08 0.99 
Acidic bitterness 0.49 0.12 
Astringency 0.86 0.02 
 
The results of the principal component analysis biplot are presented in Figure 4.21.The 
loading plot (illustrated in blue) shows the magnitude (in length) and the direction of the 
contribution of each sensor to each principal component. In this case, astringency has 
the highest magnitude in the direction of the first principal component PC1 while basic 
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bitterness2 has close association with the second principal component. The amlodipine 
mesilate formulations show close association with astringency. So much so, that at 
0.25mg/ml amlodipine mesilate (shown on plot as AMMe 0.25) is in line with x-axis and 
astringency loading. Surprisingly, increasing the concentration of amlodipine mesilate 
appears to reduce the association with astringency. Amlodipine maleate suspensions 
(shown as AMMa0.25, AMMa0.5, AMMa0.75 and AMMa1) show some association with 
basic bitterness2 while amlodipine besilate suspensions (shown as AMBe0.25, 
AMBe0.5, AMBe0.75 and AMBe1) have no clear association with any of the sensors. 
Equally so the placebo does not show association with any of the sensors.  
 
 
FIGURE 4. 19  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS TOGETHER WITH LOADING PLOT OF 
EACH OF THE FOUR SENSORS SHOWING THE PREDICTED TASTE SPECIFICATION OF F2 AMLODIPINE BESILATE 
(AMBE), AMLODIPINE MALEATE (AMMA) AND AMLODIPINE MESILATE (AMME). 
 
Figure 4.21 presents a dendrogram (produced using agglomerative hierarchical 
clustering), shows the breakdown of the amlodipine formulations in groups based on 
their taste attributes. 4 groups have been identified. These are distinguished by their 
colour. The observations on the x-axis refer to the sample under investigation while the 










































PC1 - Astringency (89.99%)




FIGURE 4. 20  A DENDROGRAM USING THE CLUSTERING OF THE AMLODIPINE F2 SUSPENSIONS.  
 
Table 4.8 shows the breakdown of the clusters and their membership. What is 
interesting but expected in this data is the fact that all the samples are grouped 
according to their salt forms, i.e. all the amlodipine mesilate samples are in the same 
group. The exception to this observation is amlodipine maleate 0.25, which is grouped 
together with the amlodipine besilate suspensions. 
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TABLE 4. 8 CLUSTER MEMBERSHIP, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER 
Cluster Membership 
(observation number  and sample name) 
1 1 - placebo 
2 4- amlodipine mesilate(0.25) 
7- amlodipine mesilate (0.50 
10- amlodipine mesilate (0.75) 
13 – amlodipine mesilate (1) 
3 2- amlodipine besilate (0.25) 
3- amlodipine maleate (0.25) 
5 – amlodipine besilate (0.5) 
 
8 – amlodipine besilate (0.75) 
11 – amlodipine besilate )1) 
4 6- amlodipine maleate (0.5) 
9- amlodipine maleate (0.75) 
12- amlodipine maleate (1) 
 
The Euclidean distances between the imaginary centre of the clusters is given in Table 
4.8. Interestingly the largest difference is observed between placebo (cluster 1) and 
amlodipine maleate (cluster 4). Another interesting observation is that amlodipine 
mesilate (cluster 2) has the smallest separation from placebo.  
 
TABLE 4. 9 EUCLIDEAN DISTANCES BETWEEN THE CLUSTER CENTRES OF THE FOUR CLUSTERS 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 47.22 91.99 123.61 
Cluster 2 47.22 0 85.04 107.40 
Cluster 3 91.99 85.04 0 34.43 
Cluster 4 123.61 107.40 34.43 0 
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4.3.3.1 SUMMARY OF RESULTS 
The results in this section indicate that, all the F2 formulations are detectable on the 
taste sensor with the astringency sensor exhibiting the most response (89%). The 
basic bitterness2 demonstrates the next prominent response, accounting for 10% of 
data variation observed. Cluster analysis revealed four distinct clusters. The 
association between the clustering and the PCA loading is unclear for the F2 
formulations. Amlodipine maleate of concentrations 0.5, 0.75 and 1mg/ml show the 
largest deviation from placebo (cluster 1), whilst cluster 2 (consisting predominantly of 
amlodipine mesilate) shows closest distance to placebo. Therefore when considering 
F2 formulations, amlodipine maleate is least palatable while amlodipine mesilate has 
the best palatability. It is noteworthy that amlodipine mesilate F1 and F2 formulations 
have been identified to have the least separation from water thus far. The next section, 
therefore, will move on to explore F3 formulations of the three different salts. 
 
4.3.4 AMLODIPINE F3 FORMULATIONS 
The sensor response patterns of amlodipine besilate F3 formulation is shown in Figure 
4.23. This figure reveals a gradual change in sensor response with increases in 
concentration for acidic bitterness and astringency. The changes for the basic 
bitterness sensors are not readily obvious. There is no change observed at lower 
concentrations i.e. 0.25 and 0.5mg/ml, however for the basic bitterness1 sensor, a step 
change is observed between 0.5mg/ml and 0.75mg/ml. In general, a statistical anaylsis 
using a one-way ANOVA showed that there was no significant difference  
(p= 4.94x10−5). 





FIGURE 4. 21  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE BESILATE F3 FORMULATION, 
SHOWING THE RESPONSES OF FOUR SENSORS WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A 
FUNCTION OF CONCENTRATION (N-3, ?̅?±SD) 
 
The responsiveness of the sensors to amlodipine maleate F3 formulations is shown in 
Figure 4.24. The most striking result to emerge from this data is that the response 
pattern for amlodipine F3 is similar to that observed in amlodipine F2 formulations. 
Both the astringency and acidic bitterness sensors show a concentration dependant 
response. The basic bitterness 1 sensors shows no difference in response to placebo, 
while basic bitterness 2 sensors shows a difference between placebo and 0.25mg/ml 
concentration, however no further changes in response are observed as 
concentrations continued to increase. This was confirmed by a one-way ANOVA which 


































Amlodipine besilate F3 sensor response 
curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency





FIGURE 4. 22  RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE MALEATE F3 FORMULATION, 
SHOWING THE RESPONSES OF FOUR SENSORS WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A 
FUNCTION OF CONCENTRATION (N-3, ?̅?±SD) 
 
Contrary to the results reported for amlodipine maleate, amlodipine mesilate shows a 
different pattern of response between the F2 and F3 formulations. With the exception 
of the basic bitterness1 sensor which shows no concentration dependent response, all 
the other sensors exhibit that trait. Interestingly the acidic bitterness sensor shows no 
concentration dependence when comparing the higher concentrations. A one-way 
ANOVA showed that there was no statistically significant difference in the sensor 
































Amlodipine maleate F3 sensor response curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency





FIGURE 4. 23 RELATIVE SENSOR RESPONSE CURVE FOR AMLODIPINE MESILATE F3 FORMULATION, 
SHOWING THE RESPONSES OF FOUR SENSORS WHICH CORRESPOND TO DIFFERENT TASTE SPECIFICATIONS, AS A 
FUNCTION OF CONCENTRATION (N-3, ?̅?±SD) 
 
The eigenvalues and corresponding variance for each of the principal components are 
shown in Table 4.10. The cumulative percentage shows that the first and second 
principal components (PC1) and (PC2) respectively, account for approximately 99% of 
the variance. To this end, only PC1 and PC2 are used in further analysis of the data. It 
is noteworthy that the significance levels of PC1 and PC2 are both low (p<0.05), 

































Amlodipine mesilate F3 sensor response curve 
basic bitterness1 basic bitterness2 acidic bitterness astringency
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TABLE 4. 10 EIGENVALUES OF THE COVARIANCE MATRIX ILLUSTRATING THE CONTRIBUTION AND 
SIGNIFICANCE OF EACH PRINCIPLE COMPONENT 










1 2432.34 96.84 96.84 110.4 9 1.22 x 10−19 
2 66.48 2.65 99.48 22.19 5 4.81 x 10−4 
3 8.98 0.36 99.84 1.71 2 0.42 
4 4.01 0.16 100 0 0 0 
 
Similar to the results reported in Section 4.3.3, the extracted eigenvalues are shown in  
Table 4.11. It is clear that the highest contribution to PC1 is predominantly astringency, 
while PC2 has major influence from acidic bitterness. 
TABLE 4. 11 EXTRACTED EIGENVECTORS FOR PC1 AND PC2, SHOWING THE CONTRIBUTION OF EACH 
SENSOR TO THE FIRST AND SECOND PRINCIPAL COMPONENTS. 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 0.02 0.12 
Basic bitterness2 -0.14 -0.15 
Acidic bitterness 0.27 0.93 
Astringency 0.95 -0.29 
 
The results of the principal component analysis scores and loadings are set out in 
Figure 4.26. The biplot is revealing in several ways. In the first instance, the amlodipine 
mesilate (AMMe) samples are clustered together with the placebo (1:1 mixture of ora-
sweet® and ora- plus®). Secondly, none of the samples under investigation are 
aligned with astringency. Thirdly, the amlodipine mesilate samples are associated with 
acidic bitterness; however caution is needed when interpreting this observation as 
acidic bitterness only accounts for approximately 3% of the variance.  Lastly, significant 
and expected differentiation is observed between F3 formulations and water.  




FIGURE 4. 24  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS TOGETHER WITH LOADING PLOT OF 
EACH OF THE FOUR SENSORS SHOWING THE PREDICTED TASTE SPECIFICATION OF AMLODIPINE BESILATE 





FIGURE 4. 25  DENDROGRAM FOR AMLODIPINE F3 FORMUALTIONS, SHOWING FOUR CLUSTERS 
 








































PC1 - astringency (96.84%)
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The clusters identified from the sensor responses are presented in Table 4.11 and the 
Euclidean distances between the clusters is given in Table 4.12. As can been seen 
from the biplot (Figure 4.26) and dendrogram (Figure 4.27), the amlodipine mesilate F3 
formulations are similar to placebo hence in the same cluster. It is somewhat surprising 
that the separation between amlodipine besilate and maleate is unclear. It appears the 
lower concentrations of both salts are clustered together and the same is true for the 
higher concentrations. 
TABLE 4. 12 CLUSTER MEMBERSHIPS, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER 
Cluster Membership 
(observation number  and sample name ( concentration)) 
1 1- placebo 
5- amlodipine mesilate (0.25) 
8 – amlodipine mesilate (0.5) 
11- amlodipine mesilate (0.75) 
14 – amlodipine mesilate (1) 
2 3- amlodipine besilate (0.25) 
4- amlodipine maleate (0.25) 
6 – amlodipine besilate (0.5) 
3 7- amlodipine maleate (0.5) 
9 – amlodipine besilate (0.75) 
10 – amlodipine maleate 
(0.75) 
12- amlodipine besilate (1) 
13 amlodipine maleate (1) 
4 2 - water  
 
 
The Euclidean distances between the imaginary centres of the four clusters are given 
in Table 4.12. Unsurprisingly, clusters 3 and 4 show the largest separation  




TABLE 4. 13 EUCLIDEAN DISTANCES BETWEEN THE CLUSTER CENTRES OF THE FOUR CLUSTERS 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 38.11 67.54 115.90 
Cluster 2 38.11 0 29.56 151.20 
Cluster 3 67.55 29.56 0 179.39 
Cluster 4 115.90 151.20 179.39 0 
 
4.3.4.1 SUMMARY OF RESULTS 
The findings from this section suggest that all the F3 formulations are detectable on the 
taste sensor with the astringency sensor exhibiting the most response (97%). The 
acidic bitterness demonstrates the next prominent response, accounting for 3% of data 
variation observed. Cluster analysis revealed four distinct clusters. Unlike the previous 
reported results in Section 4.32 and 4.3.3, in these results the cluster and sensors 
association is not evidently obvious. Furthermore, there is no significant separation 
between the clustering of amlodipine maleate and amlodipine besilate. However, it is 
clear that these two amlodipine salts exhibit the largest Euclidean distance from water. 
Again, amlodipine mesilate has the smallest separation from water in terms of the 
Euclidean distance. Therefore when considering F3 formulations amlodipine mesilate 
has the best palatability, a result which has been consistent in observations thus far. 
The next section reports a comparison of amlodipine besilate salt in the three different 
formulations. 
 
4.3.5 AMLODIPINE BESILATE F1, F2, F3 
It can be seen from the data presented in Table 4.14 that the cumulative percentage of 
variance for PC1 and PC2 is approximately 99%, therefore this suggests that only the 
first two principal components were necessary to display data on a biplot. The 
significance level of both principal components 1 and 2 are less than 0.05 therefore 
these principal components are statistically significant. 




TABLE 4. 14 EIGENVALUES OF THE COVARIANCE MATRIX FOR AMLODIPINE BESILATE F1, F2 AND F3 
FORMULATIONS 










1 5729.12 95.89 95.89 98.75 9 2.82 x 10−17 
2 212.63 3.56 99.45 26.29 5 7.83 x 10−5 
3 26.10 0.44 99.89 4.13 2 0.13 
4 6.82 0.11 100.00 0 0 0 
 
The data presented in Table 4.15 shows that the astringency sensor has the highest 
contribution to PC1. The major contributor for PC2 is acidic bitterness. 
 
TABLE 4. 15 EXTRACTED EIGENVECTORS FOR PC1 AND PC2, SHOWING THE CONTRIBUTION OF EACH 
SENSOR TO THE FIRST AND SECOND PRINCIPAL COMPONENTS 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 -0.04 0.21 
Basic bitterness2 -0.23 0.21 
Acidic bitterness 0.06 0.95 
Astringency 0.97 -0.01 
 
The biplot shown in Figure 4.27 unsurprisingly shows the separation between F1 
formulations and the rest of the samples. From the biplot, the separation between F2 
and F3 formulations is not as clear. As previously highlighted the F1 formulations are 
closely associated with acidic bitterness while F2 and F3 formulations as clustered 
around astringency. However, it is also clear than none of the formulations are 
associated with water which is removed from the loadings of the sensors. 




FIGURE 4. 26  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS TOGETHER WITH LOADING PLOT OF 
EACH OF THE FOUR SENSORS SHOWING THE PREDICTED TASTE SPECIFICATION OF AMLODIPINE BESILATE F1, F2 
AND F3 FORMULATIONS. 
 
 
FIGURE 4. 27  DENDROGRAM FOR AMLODIPINE BESILATE F1, F2 AND F3 FORMULATIONS, SHOWING FOUR 
CLUSTERS DIFFERENTIATED BY COLOURS. 
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The data presented in Table 4.16 supports the observations reported on the biplot. 
From this data, it is apparent that cluster analysis has shown separation between F2 
and F3 formulations. It appears that only F2 0.25mg/ml is clustered with the F3 
formulations. The significance of the separation is given in Table 4.16 in the form of 
Euclidean distances. 
 
TABLE 4. 16 CLUSTER MEMBERSHIP, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER  
Cluster Membership 
(observation number  and sample name ( concentration)) 
1 1-water  
2 2- F1(0.25) 
3- F1 (0.5) 
4- F1 (0.75 
5- F1 (1) 
3 6- F2 (0.25) 
10- F3 (0.25) 
11-F3 (0.5) 
12- F3 (0.75) 
13- F3 (1) 
4 7- F2 (0.5) 
8- F2 (0.75) 
9- F2 (1) 
 
Clusters 1 and 2 (water and F1 formulations) exhibit the biggest separation 
represented by the Euclidean distance between them, as illustrated in Table 4.17. The 
smallest separation is observed between clusters 1 and 3 (F3 formulations), 
suggesting that the F3 formulations have better palatability when compared to the 
other formulations. It can therefore be concluded that the ordering of separation of the 
samples from water is as follows: F1>F2>F3. 
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TABLE 4. 17 EUCLIDEAN DISTANCES BETWEEN THE CLUSTER CENTRES OF THE FOUR CLUSTERS OF 
AMLODIPINE BESILATE F1, F2 AND F3 FORMULATIONS 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 271.58 163.86 207.43 
Cluster 2 271.58 0 111.35 75.32 
Cluster 3 163.86 111.35 0 45.31 
Cluster 4 207.43 75.32 45.32 0 
 
4.3.5.1 SUMMARY OF RESULTS 
The findings in this section show that the astringency (96%) and acidic bitterness (4%) 
sensors are the major contributors to responses observed. Unsurprisingly, the largest 
separation in terms of Euclidean distances is observed between water and the F1 
formulations.  However, cluster analysis does not show a significant difference 
between the F2 and F3 formulations.   
 
4.3.6 AMLODIPINE MALEATE F1, F2 AND F3 
The data presented in Table 4.18 shows that the first and second principal components 
account for over 99% of the variation observed, therefore only these principal 
components are considered when plotting the biplot shown in Figure 4:30. 
 
TABLE 4. 18 EIGENVALUES OF THE COVARIANCE MATRIX FOR AMLODIPINE MALEATE F1, F2 AND F3 
FORMULATIONS 










1 4853.35 89.19 89.19 131.8
8 
9 4.88 x 10−24 
2 577.33 10.61 99.80 87.24 5 2.55 x 10−17 
3 10.73 0.20 100 27.40 2 1.12 x 10−6 
4 0.17 0 100 0 0 0 




The extracted eigenvectors of PC1 and PC2 are given in Table 4.19. They show that 
the astringency sensor has the highest coefficient of PC1 (0.98).  The basic bitterness2 
sensor has the highest coefficient of PC2 (0.95). 
 
TABLE 4. 19 EXTRACTED EIGENVECTORS FOR PC1 AND PC2, SHOWING THE CONTRIBUTION OF EACH 
SENSOR TO THE FIRST AND SECOND PRINCIPAL COMPONENTS 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 -0.00 0.06 
Basic bitterness2 -0.06 0.95 
Acidic bitterness 0.02 -0.29 
Astringency 0.98 0.12 
 
The biplot given in Figure 4:30, shows the principal components 1 and 2 together with 
the loadings of the sensors.  The F2 formulations are closely associated with the basic 
bitterness 2 while the F3 formulations are associated with astringency and acidic 
bitterness. It is also apparent that there is clear separation between all three 
formulations. 
 




FIGURE 4. 28  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS TOGETHER WITH LOADING PLOT OF 
EACH OF THE FOUR SENSORS SHOWING THE PREDICTED TASTE SPECIFICATION OF AMLODIPINE MALEATE F1, F2 
AND F3 FORMULATIONS 
 
The dendrogram illustrated in Figure 4.31 produced following agglomerative 
hierarchical cluster analysis shows the grouping of formulations (x-axis) which are 
similar in terms of principal component analysis. The y axis shows the Euclidean 
distances separating the imaginary centres of each cluster. Table 4.20 details which 
formulations make up each cluster.  Interestingly, the lowest concentration of F2 i.e. F2 
(0.25), is grouped together with the F3 formulations. Although the biplot appears to 
demonstrate separation between all the formulation groups cluster analysis has 
revealed that there no clear separation between F2 and F3 formulations of amlodipine 
maleate.  
 







































PC1 - astringency (89.19%)




FIGURE 4. 29  DENDROGRAM FOR AMLODIPINE MALEATE F1, F2 AND F3 FORMULATIONS, SHOWING FOUR 
CLUSTERS DIFFERENTIATED BY FOUR COLOURS. 
 
TABLE 4. 20 CLUSTER MEMBERSHIP, SHOWING THE GROUPING OF FORMULATIONS BY SIMILARITY 
Cluster Membership 
(observation number  and sample name ( concentration)) 
1 Water 
2 1- F1 (0.25) 
2- F1(0.5) 
3- F1 (0.75) 
4- F1 (1) 
3 5- F2 (0.25) 
10 – F3 (0.25) 
11- F3 (0.5) 
12- F3 (0.75) 
13 – F3 (1) 
4 6- F2 (0.5) 
7- F2 (0.75) 
F2 (1) 
 
The Euclidean distances between the imaginary centres of the four clusters are given 
in Table 4.21. Unsurprisingly, the largest separation distance is observed between 
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water (cluster 1) and the F1 formulations in cluster 2. Assuming that water has good 
palatability, this implies that F1 formulations are furthest away from the same 
palatability as water. Equally of note, is that fact that the shortest Euclidean distance is 
observed between clusters 1 and 3. This suggests that F3 formulations are closest to 
water in terms of taste therefore suggesting better palatability than the other 
formulation clusters. The ordering of the formulations with respect to their separation 
from water is as follows: F1>F2>F3. This observation is similar to that already shown 
for amlodipine besilate reported in Section 4.3.5. 
 
TABLE 4. 21 CLUSTER MEMBERSHIPS, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 256.16 179.40 226.41 
Cluster 2 256.16 0 80.87 60.70 
Cluster 3 179.40 80.87 0 55.22 
Cluster 4 226.41 69.70 55.22 0 
 
4.3.7 AMLODIPINE MESILATE F1, F2 AND F3 
The eigenvalues and corresponding variance for each of the principal components are 
shown in Table 4.22. The cumulative percentage shows that the first and second 
principal components (PC1) and (PC2) respectively, account for approximately 95% of 
the variance. To this end, only PC1 and PC2 are used in further analysis of the data. It 
is noteworthy that the significance levels of PC1 and PC2 are both low (<0.05), 
therefore suggesting that there a statistically significant difference between them. 
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1 1678.68 77.16 77.16 84.51 9 2.04 x 10−24 
2 400.95 18.43 95.59 60.52 5 9.48 x 10−12 
3 95.70 4.40 99.99 44.85 2 1.83 x 10−10 
4 0.25 0.01 0.01 0 0 0 
 
The extracted eigenvectors for the first and second principal components are given in 
Table 4.23. It is clear that the astringency sensor with a coefficient of 0.98 is the only 
contributor to PC1 and the basic bitterness2 sensor which has a coefficient of 0.98 is 
the major contributor for PC2. With this in mind it can be inferred that the x-axis on the 
biplot illustrates astringency while the y- axis illustrates basic bitterness. 
 
TABLE 4. 23 EXTRACTED EIGENVECTORS FOR PC1 AND PC2, SHOWING THE CONTRIBUTION OF EACH 
SENSOR TO THE FIRST AND SECOND PRINCIPAL COMPONENTS 
 Coefficient of PC1 Coefficient of PC2 
Basic bitterness1 -0.02 0.04 
Basic bitterness2 -0.14 0.98 
Acidic bitterness -0.16 -0.29 
Astringency 0.98 0.09 
 
The biplot shown in Figure 4.32 gives the first and second principal components plotted 
on the x and y- axes respectively, with the sample plotted as a scatter plot. The 
sensors loadings (shown in blue) are also plotted. As already illustrated via the 
extracted eigenvalues, the astringency sensor is closely associated with the x- axis, 
while the basic bitterness 2 sensor is associated with the y- axis. It is clear from this 
biplot that there is separation between F1, F2, F3 formulations and water. 




FIGURE 4. 30  A BIPLOT SHOWING PRINCIPAL COMPONENT ANALYSIS TOGETHER WITH LOADING PLOT OF 
EACH OF THE FOUR SENSORS SHOWING THE PREDICTED TASTE SPECIFICATION OF AMLODIPINE MESILATE F1, F2 
AND F3 FORMULATIONS 
The dendrogram shown in Figure 4.33 illustrates hierarchical agglomerative cluster 
analysis which groups the samples according to their similarities. Four clusters are 
identified as predicted by the biplot shown the in Figure 4.32.  
 
FIGURE 4. 31  DENDROGRAM FOR AMLODIPINE MESILATE F1, F2 AND F3 FORMULATIONS, SHOWING FOUR 








































PC1 - astringency (77.16%)
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The membership of each cluster is given in Table 4.24. It is noteworthy that unlike in 
the case of the previous salts i.e. besilate and maleate, the mesilate formulations are 
homogenous in each cluster.  
TABLE 4. 24 CLUSTER MEMBERSHIP, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER 
Cluster Membership 
(observation number  and sample name ( concentration)) 
1 1 - water 
2 2- F1 (0.25) 
3- F1 (0.5) 
4- F1 (0.75) 
5 – F1 (1) 
3 6 – F2 (0.25) 
7 – F2(0.5) 
8 – F2 (0.75) 
9 – F2 (1) 
4 10 – F3 (0.25) 
11 – F3(0.5) 
12 – F3 (0.75) 
13- F3 (1) 
 
The extent of separation of the four clusters is shown in Table 4.25, which gives the 
Euclidean distances between each cluster. It is evident that the largest separation is 
observed between water and the F1 formulations. The F3 formulations are closest to 
water. Therefore, the separation of the formulations from water is as follows: 
F1>F2>F3. 
TABLE 4. 25 CLUSTER MEMBERSHIP, SHOWING WHICH OBSERVATIONS ARE SIMILAR HENCE GROUPED 
TOGETHER  
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Cluster 1 0 155.88 129.10 116.72 
Cluster 2 155.88 0 55.50 47.33 
Cluster 3 129.10 55.50 0 40.97 
Cluster 4 116.72 47.33 40.97 0 
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4.3.8 HUMAN TASTE PANEL  
4.3.8.1 AMLODIPINE F1 FORMULATIONS 
The taste scores from the participants for the amlodipine are given in Table 4.24. In 
general, for all three salts, there is an increase in taste scores with increasing 
concentrations. The highest taste scores were recorded for amlodipine besilate 
suggesting that this salt was associated with highest unpleasantness.  
 
TABLE 4. 26 AVERAGE TASTE SCORES FOR AMLODIPINE F1 FORMULATIONS 
Concentrations (mg/ml) 0 0.25 0.5 0.75 1.0 






7.7±2.0 8.4±1.9 8.9±1.8 
Amlodipine maleate average 
score ± SD 
2.6± 2.3 5.8±2.4 7.3± 
1.8 
8.2±1.6 8.6±1.4 
Amlodipine mesilate average 
score ± SD 
2.9±2.4 5.6±2.2 5.9±2.4 5.8±2.4 8.2±1.5 
 
A graphical representation of the taste scores of the F1 formulations of the amlodipine 
salts is shown in Figure 4.34. It is apparent that there is taste scores of amlodipine 
besilate and maleate increase with increasing concentration. This is not the case with 
amlodipine mesilate where no significant difference is observed between 0.25mg/ml – 
0.75mg/ml. In all three cases, there is statistically significant difference between 
placebo and the tastant concentrations. 
 




FIGURE 4. 32  AVERAGE TASTE SCORES OF AMLODIPINE F1 FORMULATIONS SHOWING AN INCREASE IN 
UNPLEASANTNESS WITH INCREASING CONCENTRATION OF EACH SALT (N= 24, ?̅?±SD). 
 
4.3.8.2 AMLODIPINE F2 FORMULATIONS 
In view of results obtained in section 4.3.8.1, which showed that amlodipine mesilate 
had the least taste score, it was therefore prudent to only investigate amlodipine 
besilate and maleate in relation to the taste masking efficiency of F2 formulation. This 
was necessary to limit the number of samples presented to the participants in order to 
minimise the risk of taste fatigue. Figure 4.35 illustrates a comparison of taste scores 
between amlodipine besilate F1 and F2 formulations in conjunction with amlodipine 
maleate F1 and F2 formulations. It is clear that the addition of simple syrup and 1% 
methylcellulose reduces the unpleasantness of amlodipine salts. Of interest is the 
observation that the highest concentration (1mg/ml) appears to have lower taste scores 
than the proceeding concentration. However, this is not statistically significant in view 
of the overlapping standard deviation. Also of note is the fact that for the F2 
formulations the difference in taste scores between placebo and 0.25mg/ml 
concentration is negligible. While in contrast, for the F1 concentrations the difference in 
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FIGURE 4. 33  AVERAGE TASTE SCORES COMPARING THE DIFFERENCES IN TASTE PERCEPTIONS BETWEEN 
F1 AND F2 FORMULATIONS FOR AMLODIPINE MALEATE AND BESILATE SALTS (N= 24 ?̅?±SD). 
 
4.3.8.3 AMLODIPINE F3 FORMULATIONS 
Similar to the comparison already made in section 4.3.8.2, amlodipine F3 formulations 
were compared to amlodipine F1 formulations. Similar to the previous comparison to 
F2 formulations, there is a clear difference in taste scores between the F1 and F3 
formulations. Unsurprisingly, the F3 formulations appear to be more pleasant than the 
F1 formulations. Interestingly, the separation between the amlodipine besilate and 
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FIGURE 4. 34  AVERAGE TASTE SCORES COMPARING THE DIFFERENCES IN TASTE PERCEPTIONS BETWEEN 
F1 AND F2 FORMULATIONS FOR AMLODIPINE MALEATE AND BESILATE SALTS (N= 24 ?̅?±SD). 
 
A comparison of the taste scores for F2 and F3 formulations is shown in Figure 4.37. 
Although, a general increase in unpleasantness is reported with increase 
concentrations of amlodipine, the separation between the F2 and F3 formulations for 
each salt is not as clear. This therefore points to the conclusion that it is not possible to 
separate F2 and F3 formulations in terms of taste, an observation already suggested 
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FIGURE 4. 35  HUMAN TASTE PANEL SCORES COMPARING AMLODIPINE BESILATE AND AMLODIPINE MALEATE 
F2 AND F3 FORMULATIONS (N= 24 ?̅?±SD).. 
 
4.3.9  HUMAN, ELECTRONIC TONGUE CORRELATION 
Thus far results have been reported separately; in the section the correlation between 
the electronic tongue results and the scores from the human panel is highlighted. The 
findings highlighted in sections 4.3.2, 4.3.3 and 4.3.4, show that astringency sensor 
accounts for 89- 92% of sensor responses observed. Therefore astringency sensor 
responses from the electronic tongue were compared to taste scores from the human 
taste panel Figure 4.38 shows positive correlation between the electronic tongue and 
human panel for all three salts in F1 formulations.  Amlodipine besilate and maleate 
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FIGURE 4. 36  CORRELATION BETWEEN HUMAN TASTE SCORES AND ELECTRONIC TONGUE FOR AMLODIPINE 
SALTS DISSOLVED IN WATER (F1) 
 
Figure 4.39 shows the correlation between human taste scores and electronic tongue 
in relation to F2 formulations. Similar to results reported for F1 formulations, positive 
correlation is realised for the F2 samples. 
 
y = -27.718x - 4.1012 
R² = 0.9882 
y = -10.214x - 2.5792 
R² = 0.8902 
y = -25.295x - 10.014 
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FIGURE 4. 37  CORRELATION BETWEEN HUMAN TASTE SCORES AND ELECTRONIC TONGUE PREDICTIONS 
FOR AMLODIPINE MALEATE AND BESILATE SUSPENDED IN F2 FORMULATIONS. 
 
Correlation analysis of F3 formulations are illustrated in Figure 4.40. Positive 
correlation was found between the human panel taste scores and those recorded on 
the electronic tongue. The correlation coefficients reported are similar to those for F2 
formulations. The significance of these findings will become apparent in the  
section 4.4.3. 
y = -37.952x - 20.427 
R² = 0.6954 
y = -31.552x - 12.61 
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FIGURE 4. 38 CORRELATION BETWEEN HUMAN TASTE SCORES AND ELECTRONIC TONGUE FOR AMLODIPINE 
MALEATE AND BESISLATE SUSPENDED IN F3 FORMULATIONS. 
 
4.4 DISCUSSION 
4.4.1 ELECTRONIC TONGUE 
The first question in this study sought to establish the responsiveness of the sensors: 
basic bitterness1 (AC0), basic bitterness2 (AN0), acidic bitter (C00) and astringency 
(AE1) to different salts of amlodipine. Amlodipine base (AM), amlodipine besilate 
(AMB) and amlodipine maleate (AMM) were investigated. A summary of the 
responding sensor is given in Table 4.26. In brief, the basic bitterness2 and acidic 
bitterness sensors show concentration response to amlodipine base when compared to 
negative control (de-ionised water). It is somewhat surprising that there is a difference 
in response between the basic bitterness1 and basic bitterness2 sensors. This result 
has not been previously reported. In all other experimental work carried out thus far in 
chapters 3 and 4, both the negatively charged sensors have responded in an identical 
fashion. Woertz et al (2010) showed similar response patterns between the two 
negatively charged sensors when looking at different salts of ibuprofen. Equally, 
Guhman et al 2012 also reported identical response patterns for the both negatively 
y = -25.599x - 16.917 
R² = 0.6164 
y = -27.848x - 11.644 
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charged sensors when comparing diclofenac sodium and potassium salts. It is 
therefore surprising that only one of the sensors would respond. In chapter 3, it was 
postulated that the mechanism of sensor response was dependent on both nature and 
extent of dissociation. Based on this hypothesis, it was therefore expected that 
amlodipine which is positively charged, would produce an identical reaction to both 
bitterness sensors that are negatively charged.  It is important to note that this 
behaviour is only reported with amlodipine (free base). At present it is difficult to 
explain this result but it may be related to the fact that when in physiological 
membranes, it is suggested that the nonpolar ring system of amlodipine adopts the 
same orientation as the hydrophobic part of the membrane. The long molecular axis 
extends parallel to the hydrocarbon chains. The dihydropyridine ring of the drug is 
positioned with the –NH end pointing towards the aqueous phase, while the aromatic 
system is buried in the hydrocarbon core (Baeuerle et al. 1991). The difficulty lies in the 
fact that the orientation of the lipids on the artificial membrane of the sensor is 
unknown as it is commercially protected, therefore this orientation could affect the 
response of the sensors in question. 
 
In salt form i.e. amlodipine besilate and maleate, concentration dependant response is 
observed from the astringency and acidic bitterness sensors. This response pattern is 
also observed for benzene sulphonic acid and sodium maleate. These findings 
therefore suggest that in their salt forms, the sensor response switches from basic and 
acidic bitterness to astringency and acidic bitterness. In essence this translates to a 
reversal of the predominant species being detected. In the former case, the positively 
charged amlodipine is being detected by negatively charges sensors whereas in the 
latter the besilate and maleate anion are being detected by the positively charged 
sensors.  It could be suggested that due to the steric size of the amlodipine cation, 
proportionally fewer of these cations interact with the sensor membrane in comparison 
with the relatively smaller besilate and maleate anions. As such based on a 
concentration dependant effect a larger response is observed for the positively charged 
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response. This suggestion is quashed by the fact that in benzene sulphonic acid and 
sodium maleate the predominant response is also from the astringency and basic 
bitterness sensors. In these two molecules, the besilate and maleate anions are larger 
molecules than the H+ and Na+ cations, which would imply that the negatively charged 
membranes would have larger response. But this is not the case. However, it should 
be noted that since benzene sulphonic acid and sodium maleate were dissolved in 
30% aqueous ethanol, the cations H+ and Na+ both react with OH- groups from the 
ethanol hence are “taken out” and do not interact with the sensors, which leaves the 
cationic amlodipine (which will effectively be at a higher concentration as a result), to 
interact with the sensors hence giving the results observed. Of course, the implications 
of this result should be taken with caution because most biological membranes are 
negatively charged which therefore begs the question whether the mechanism 
suggested could be translated to human beings. 
TABLE 4. 27 SUMMARY TABLE, SHOWING PRE-DOMINANT SENSOR RESPONSE FOR EACH MOLECULE 
Drug / molecule Sensors showing concentration dependant response 
Amlodipine Basic bitterness2 and acidic bitterness 
Amlodipine besilate Acidic bitterness and astringency 
Amlodipine maleate Acidic bitterness and astringency 
Benzene sulphonic acid Acidic bitterness and astringency 
Sodium maleate Acidic bitterness and astringency 
 
A NOTE ON EXCIPIENTS 
A question that remains to be addressed pertains to the contribution of the excipients 
to the overall taste quality described by the electronic tongue. The excipients used for 
the amlodipine salts are given in Table 4.26. Amlodipine besilate and mesilate both 
have identical excipients albeit concentrations of these excipients remain a commercial 
secret for each tablet. This therefore implies that the taste differentiation observed 
between these two tablets is either due to intrinsic bitterness or a function of 
concentrations of the excipients. 
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TABLE 4. 28 LIST OF EXCIPIENTS IN EACH AMLODIPINE TABLET 
Drug Manufacturer Excipients 
amlodipine 
besilate 
Teva®, UK Microcrystalline cellulose, calcium hydrogen 




Dr Reddy’s ® 
Laboratories, UK 
Microcrystalline cellulose, sodium starch 




Actavis®, UK Microcrystalline cellulose, anhydrous calcium 
hydrogen phosphate, sodium starch gylcollate 
type A, magnesium stearate 
 
Microcrystalline cellulose is used primarily used as a binder / diluent in tablets. It is 
purified, partially depolymerised cellulose that occurs as a white, odourless, tasteless 
powder. It is practically insoluble in water, dilute acids and most organic solvents but 
slightly soluble in 5% w/v sodium hydroxide. In light of this information, it can be 
assumed that microcrystalline cellulose does not contribute to the overall taste 
perception on the electronic tongue. 
 
Magnesium stearate is a very fine, light white, precipitate or milled, impalpable powder 
of low bulk density having a faint odour of stearic acid and a characteristic taste. It is 
practically insoluble in ethanol, ethanol (95%), ether and water whilst slightly soluble in 
warm benzene and warm ethanol (95%). Although magnesium stearate is described as 
having a characteristic taste, its insolubility in water or ethanol implies that in this study 
it was suspended rather than solubilised. Since the electronic tongue requires 
substances to be in solution in order to be detected it therefore be concluded that 
magnesium stearate is not detected and therefore can be discounted as contributing to 
taste specification recorded on the electronic tongue. 
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Calcium hydrogen phosphate is a white odourless, tasteless powder used both as an 
excipient and a source of calcium in nutritional supplements. During the tableting 
process, it is used for its compaction and good flow properties of course grade material. 
Similar to the other excipients discussed thus far, it is also practically insoluble in ether, 
ethanol and water but soluble in dilute acids. To this end, it can also be concluded that 
calcium hydrogen phosphate provides no bearing on the taste attributes recorded on 
the electronic tongue.  
 
Sodium starch glycolate is used as a disintegrant in tablet formulations prepared either 
via direct compression or wet granulation processes. The usual concentration 
employed in such formulations is between 2% and 8%. It occurs as a white or almost 
white free flowing very hygroscopic powder. It is practically insoluble in methylene 
chloride and gives a translucent suspension in water. Although, the taste of sodium 
starch glycolate is not readily described in the literature, since it forms a suspension in 
water and it can be concluded that it has no significant addition to taste attributes 
described by the electronic tongue.  
 
Colloidal anhydrous silica has nano-sized primary particles and a large specific surface 
area which provided desirable flow characteristics in dry powders used for tableting. 
Hence, it is used as an anticaking, emulsion stabilising, suspending, viscosity 
increasing agent and glidant. It is soluble in 1 in 6.7 parts of water, practically insoluble 
in organic solvents and acids except hydrofluoric acid. It is soluble in hot solutions of 
alkali hydroxide. The taste of silica is not directly documented in the literature, however, 
a formulation containing silica was used to sufficiently taste mask roxithromycin (Gao 
et al. 2006). Based on these facts, it is unlikely that colloidal silica could contribute to 
taste information obtained from the electronic tongue.  
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Therefore with respect to the excipients that are present in the amlodipine tablets used 
in this study, due to their poor water solubility none of the excipients can be regarded 
to contribute to the taste information described by the electronic tongue.  
 
4.4.2 HUMAN TASTE PANEL 
The initial objective of this study was to ascertain taste differences between the 
amlodipine besilate, maleate and mesilate tablets when they were crushed and 
dispersed in water (F1). The results of the study point towards amlodipine besilate 
being identified as being unpleasant by the panel of untrained participants. This was 
particularly obvious at the lower concentrations where amlodipine besilate averages 
scores were higher than those of the other two salts. More importantly, with the 
increase in concentration of amlodipine besilate the taste scores also increased. 
Amlodipine maleate follows the same trend as amlodipine besilate. Surprisingly, there 
is no increase in taste scores with increasing concentration of amlodipine mesilate. 
This therefore suggested that the unpleasantness of amlodipine mesilate was related 
to intrinsic unpleasantness rather than concentration dependant, while the other two 
salts exhibit both intrinsic and concentration dependant unpleasantness. It is worth 
noting that a limitation of the study design was the use of the terms “pleasant” and 
“unpleasant” as descriptors. With respect to palatability, the term unpleasant could 
describe bitterness and / or grittiness i.e. bad taste or bad mouthfeel.  In this study, all 
three amlodipine salts tablets were pulverised using the same method i.e. pestle and 
mortar therefore an assumption was made that the participants were scoring samples 
in terms of their taste. Therefore, based on the participants’ scores, it can be concluded 
that amlodipine mesilate had the least bitterness. This result in itself is significant as 
there are no studies in the literature comparing the taste of different salts on the same 
API. However, these findings do not explain why amlodipine mesilate is described as 
more pleasant in comparison to the other two salts. Therefore, caution must be applied, 
as these results might not be transferrable to all APIs in their different salt forms.  
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Following the establishment of amlodipine mesilate having the least bitterness, it was 
necessary to continue the study using only amlodipine besilate and maleate. This is 
because, the second question of this study sought to assess the taste masking effect 
of using a 1:1 mixture of 1% methylcellulose and simple syrup (F2) and 1:1 mixture of 
Ora-sweet® and Ora-plus® (F3) on the bitter amlodipine salts. The results of this study 
showed a clear difference in scores between the F1 and F2 formulation containing 
amlodipine besilate or amlodipine maleate: with the F2 formulations scoring lower i.e. 
more palatable. In fact, all the taste scores recorded for both F2 formulations were no 
greater than 4, a score which has no statistical difference with scores recorded for the 
F1 placebo. This is to say that the F2 formulations scores were similar to water. Also to 
note, was that there was no difference in scores for the F2 formulations between 
amlodipine besilate and maleate. At 1mg/ml concentration, there is a 60% reduction 
taste scores between the F1 and F2 formulations. The results from this study 
unsurprisingly illustrate that the use of a 1:1 mixture of simple syrup and 1% 
methylcellulose was sufficient as a taste masking medium. The mechanism of the 
bitter-masking strategy remains unknown. Historically it was thought that the high 
concentrations of sucrose in simple syrup saturates the taste receptor cells thereby 
reducing the contact of API with taste receptor cells which in turn translates to reduced 
taste detection therefore taste masking. However, the elucidations of the mechanisms 
of taste transduction of bitter and sweet molecules which both utilise G-protein coupled 
receptors (GPRC) have disproved this line of thinking. It has currently been suggested 
that the taste masking activities are mostly caused by the psychophysical effects of 
using a strong flavour to overcome another i.e. off-taste by camouflage. Unfortunately, 
the use of strong flavours or tastant is not acceptable in a lot of applications. If anything, 
this is growing unpopular particular in the paediatric population where dental 
practitioners are raising concerns with increasing dental carries amongst children with 
chronic illnesses who need long term treatment.  
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The taste scores recorded for the comparison of F1 and F3 formulations present a 
similar pattern to those described between F1 and F2. Essentially, at 1mg/ml 
concentration, there is a 70% reduction in bitterness between F1 and F3 formulations. 
Interestingly, a one way ANOVA showed that there was no statistical difference 
between placebo and F3 formulations containing amlodipine salts (p > 0.05). Another 
interesting observation is that no difference was observed between amlodipine besilate 
and amlodipine maleate in relation to their taste scores. In similar fashion to analysis of 
the F2 formulations, the mechanism behind the bitter-taste masking remains unknown 
but can be postulated as psychophysical. 
 
Another noteworthy observation was that this study did not find a significant difference 
between F2 and F3 formulations. A possible explanation for this result is that in both F2 
and F3 formulations, the sweetening agent; sucrose was sufficient to achieve taste 
masking. It should be noted that sweet and bitter taste transduction in humans occurs 
via T1R and T2R G-protein coupled receptors respectively (chapter one). In both cases, 
the taste receptor cells secrete the same neurotransmitter substance i.e. ATP onto 
afferent fibres (Breslin et al. 2006). Discrete synapses are lacking that might couple 
receptor cells with sensory afferent fibres to transmit a single taste quality. Although 
some taste cells and sensory afferent neurons are tightly tuned, while others are 
responsive to multiple taste qualities (Chaudhari et al. 2010). Therefore, the question 
remains as to exactly how information gathered by taste receptor cells in taste buds is 
“coded” for the eventual perception of distinct taste qualities. This question remains to 
be addressed in the literature and has fundamental importance in understanding the 
reduction in bitterness perception in the presence of heightened sweetness perception. 
In addition, other questions remain i.e. is the ATP production from T1R and T2R cells 
dependant on cell activation which may be dependent on concentration of ligands or is 
ATP production dependent on T1R and T2R cell density. Also to note, is that 
comparison of F1 formulations in water did not reveal a distinct difference between the 
two salts. Therefore, it can be suggested that seeing as the two salts have similar 
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score before taste masking, they exhibit similar scores with suspended in F2 and F3 
vehicles.  
4.4.3 HUMAN PANEL – E-TONGUE CORRELATION 
Despite various reports in the literature illustrating the utility of electronic tongues as a 
method of taste assessment, questions still remain as to whether this technology can 
be used in place of human panels. Recently, Eckert el al (2013) compared the 
detection of herbal products in lozenges using HPLC, an electronic tongue and a 
human panel. The study concluded that electronic tongues although useful they cannot 
replace human panels (Eckert et al. 2013).  Therefore, the most significant question in 
this study relates to whether the electronic tongue could be used as a predictor of taste 
in human beings.  
 
The findings from electronic tongue reported in sections 4.3.1 – 7, showed that the 
astringency sensor response was the predominant sensor response, therefore in this 
section; correlation between the predominant sensors responses were compared to 
human panel scores. In all cases investigated, there is a strong positive correlation 
between the astringency sensor responses and the human panel taste scores.  
Although, these findings are significant, they should be treated with caution. In the first 
instance only one group of molecules was investigated therefore these results may not 
be transferrable to other APIs. In the second incidence, a small sample size was used 
therefore in order to allow for broad strokes to be used, the studies will need to be 
modified with power calculations and multicentre in order to ensure that results are 
transferrable to different populations. 
 
4.5 CONCLUSION  
This chapter has investigated the taste assessment of amlodipine (base), amlodipine 
besilate, maleate and mesilate using the electronic tongue. One of the more significant 
findings to emerge from this study is that the electronic tongue predominantly and 
consistently identifies astringency as the major descriptor of all the amlodipine salts. It 
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would appear that amlodipine free base can be described in terms of basic and acidic 
bitterness while its salts are all described in terms of astringency. These findings are 
unique for several reasons. Firstly, this study has shown a difference in response 
patterns between amlodipine free base and its salts. It is clear the presence of cationic 
amlodipine and anionic besilate and maleate ions affects the detection profile, which 
further cements mechanism described in chapter 3. Secondly, this study has also 
shown that in addition to considering the dissociation profile of the salt forms, it is also 
important to consider the size of the resulting moieties. In the case where the cation is 
considerably larger than the corresponding anion, then more anions interact with the 
sensors therefore showing large response. Of course, this observation should be 
treated with caution because the interaction between the positively charged sensor and 
anions is an unusual occurrence in nature. Thirdly, this study has also shown a 
difference in response patterns between the two negatively charged sensors, 
particularly when considering amlodipine free base. A clear reason could not be 
identified for this phenomenon which has not been reported this far. However, it is 
possible that the possibly different orientation of the lipids on the two sensors could be 
attributed to the difference in sensor response. With respect to the electronic tongue, 
the amlodipine besilate salt was identified as having the least palatability in comparison 
to the other amlodipine salts. Results from the electronic tongue showed that F1 
formulations were the least palatable formulations, however, it was not possible to 
statistically distinguish between F2 and F3 formulations. Finally, a strong positive 
correlation was observed between the electronic tongue scores and those from the 
human taste panel. However, these results need to be treated with caution as only 
amlodipine salts were investigated and furthermore a small sample size was used. 
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CHAPTER 5 – TASTE ASSESSMENT OF QUININE HYDROCHLORIDE 
 
In Chapter 4, the taste masking efficiency of sweeteners and flavours was investigated 
using the TS500Z electronic tongue and a human taste panel. Broadly speaking, this 
approach to taste masking uses strong flavours to overpower the bitter API or to 
reduce contact between API and taste buds or to reduce the release of API in the oral 
cavity (Sohi et al. 2004). Whilst flavours and sweeteners provide a straight forward 
taste masking strategy, they are not without limitations. Many excipients are subject to 
regulatory restrictions which limit their use particularly in paediatric setting. For 
example, it is well understood that sucrose, a common sweetener can contribute to 
dental disease (Roberts et al. 1979), whilst flavours have been associated with 
hypersensitivity, toxicity or allergy reactions and as such their use has been kept to a 
minimum (Kanny et al. 1994). In addition, they may not sufficiently mask the taste of 
extremely bitter APIs.  
 
There are numerous taste masking strategies and these have already been highlighted 
in chapter 1, section 1.5. Reports in the literature have indicated that the formation of 
solid dispersions provide a framework for taste masking. As highlighted in chapter 1, 
section 1.5, there are a limited number of studies that use recognised taste 
assessment methods to validate taste masking using solid dispersions. Therefore, this 
chapter describes the production of hot melt extruded quinine hydrochloride dihydrate 
with Eudragit® EPO, with a view of assessing the taste masking efficacy of this 
formulation using the Insent® TS5000Z electronic tongue. 
 
5.1 STUDY OBJECTIVES 
The work detailed in this chapter takes on a two pronged approach. The first arm 
focuses on the characterisation of quinine and its salts i.e. quinine hydrochloride 
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dihydrate and quinine hemisulphate dihydrate with a view to highlight the similarities 
and differences between the salts. This characterisation aided the choice of which 
quinine salt was used for the Eudragit® EPO melt extrudates. In addition, the analysis 
also provided baseline characteristics which formed the basis of comparison with hot 
melt extrudates. Quinine hydrochloride dihydrate was selected following this analysis; 
therefore an attempt was made to describe the form of quinine hydrochloride dihydrate 
salt that was present following hot melt extrusion. The reasoning behind the selection 
of quinine hydrochloride dihydrate will become apparent in section 5.4.1. An 
investigation into the stability of the melt extrudates form is also reported. The second 
half describes the taste masking capability of hot melt extruded quinine hydrochloride 
dihydrate with Eudragit®EPO. This analysis was carried out using a modified 
dissolution apparatus in combination with spectrophotochemical analysis together with 
a comparison on the electronic tongue.  Modification to the dissolution apparatus have 
been discussed in chapter 2 while the rationale for the modification is detailed in 
chapter 1. 
5.2 METHODOLOGY 
5.2.1 HOT MELT EXTRUSION 
Quinine hydrochloride dihydrate (QHD) formulations with Eudragit® EPO (EPO) were 
mixed using a pestle and mortar in 30g batches for five minutes. The extrusion of all 
quinine hydrochloride blends were performed using Thermo Scientific Process 11 twin 
screw extruder (Thermo Scientific UK) with co-rotating screws. The drug/polymer 
composition consisted of QHD/ EPO at a ratio of 1) 10/90, 2) 30/70, 3) 50/50 and 4) 
70/30 (%w/w). The process parameters of the HME barrel are shown in Table 5.1 
These parameters were used for formulations 1-3.  
TABLE 5 1 PROCESS PARAMETERS FOR HOT MELT EXTRUSION FOR FORMULATIONS 1, 2 AND 3 
Zone 1 (feed) 2(mixing) 3 4 5 6 7 8 (die) 
Temp oC 120 120 140 140 140 140 140 140 
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The temperature profile for formulation 4 is given in Table 5.2. The screw speed was 
set to 50rpm. An explanation of the difference in the process parameters will be given 
in section 5.4.1. 
TABLE 5 2 PROCESS PARAMETERS FOR HOT MELT EXTRUSION FOR FORMULATION 4 
Zone 1 (feed) 2(mixing) 3 4 5 6 7 8 (die) 
 120 120 140 140 140 140 160 160 
 
The produced extrudates (strands) were approximately 1.5mm in diameter allowed to 
cool at room temperature before being milled using the methods described in chapter 
2, section 2.4.3. The powders obtained were sieved manually using an 180µm sieve 
and stored in the following conditions: a) 25oC, 0% relative humidity b) 4oC, and 50% 
relative humidity and c) 40oC, 75% relative humidity. The extrudates were 
characterised using a number of thermal and analytical techniques namely, DSC 
(chapter 2.4.4), PXRD (chapter 2.4.5), SEM (chapter 2.4.6), HSM (chapter 2.4.7), 
TGA (chapter 2.4.8). 
5.2.3 DISSOLUTION TESTING  
The solubility of the QHD-EPO extrudates powder was assessed after adding required 
amount of melt extrudate powder (milled as described in chapter 2, section 2.4.9) to 
90ml of de-ionised water in a beaker. This was then shaken using the Incu shaker, the 
resulting solution was filtered using a 0.22µm filter and assessed 
spectrophotochemically. In order to avoid duplication, the reader is referred back to 
chapter 2, section 2.4.11 for full descriptions of methods.  
5.3 RESULTS 
The objective of the work detailed in this section focuses on the characterisation of the 
raw materials i.e. unprocessed quinine, quinine hydrochloride dihydrate, quinine 
hemisulphate and Eudragit® EPO. This was necessary in order to recognise the 
differences between the salts and more importantly to establish baseline characteristics 
from which comparisons will be made against the hot melt extrudates. 
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5.3.1 POWDER X-RAY DIFFRACTION (PXRD) ANALYSIS OF RAW MATERIALS 
PXRD diffractograms of quinine hydrochloride dihydrate, quinine and quinine 
hemisulphate are shown in Figures 5.1, 5.2 and 5.3 respectively. All three 
diffractograms display spectra characteristic of crystalline materials with numerous 
diffraction peaks. The three peaks of highest intensity for quinine hydrochloride 
dihydrate are observed at 8.8o, 17.2o and 12.2o.Quinine’s three highest peaks are 
recorded at 15.8o, 16.5o and 5.1o. The diffraction peaks for quinine hydrochloride 
dihydrate and quinine recorded in this study correspond to those reported in the 
literature (Jones et al. 2014). The diffractogram for quinine hemisulphate dihydrate also 
has numerous peaks with the two highest observed at 18.8o and 8.2o. This is consistent 
with predominant form reported in the literature (Karan et al. 2012). 
 
As expected the diffractograms have distinct difference. These are mainly related to the 
intensity of peaks approximately 8o and 18o. Quinine hydrochloride dihydrate exhibits 
peak intensity at 8o and closely followed by peak at 18o. In contrast, quinine only has 
one major peak at 18o, while the one at 8o is significantly diminished. Similar to quinine 
hydrochloride dihydrate, quinine hemisulphate dihydrate shows two distinct peaks at 8o 
and 18o. However the intensities for these peaks are reversed with respect to quinine 
hemisulphate dihydrate. This is to say that the highest peak is observed 18o then 
closely followed by the peak at 8o. 
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FIGURE 5. 1 PXRD DIFFRACTOGRAM OF QUININE HYDROCHLORIDE DIHYDRATE 



















FIGURE 5. 2 PXRD DIFFRACTOGRAM OF QUININE (QN) 
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FIGURE 5. 3 PXRD DIFFRACTOGRAM OF QUININE HEMISULPHATE (QHS) 
 
The PXRD diffractogram of Eudragit® EPO is shown in Figure 5.4. Eudragit®EPO 
showed an “amorphous halo” pattern showing no sign of peaks, indicating the absence 
of crystallinity (within the instrument detection limits). The observed “amorphous halo” 
pattern occurs as a result of relative random arrangements of molecules within the 
amorphous material. PXRD results for both amorphous and crystalline materials 
highlight the distinct differences in molecular arrangements between the two states. 
The “amorphous halo” exhibited by Eudragit® EPO is expected as it is described as an 
amorphous polymer in the literature (Kojima et al. 2012). 
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FIGURE 5. 4 PXRD DIFFRACTOGRAM OF EUDRAGIT® EPO 
 
5.3.2 THERMAL ANALYSIS OF RAW MATERIALS 
In this section the characterisation of the thermal properties of quinine hydrochloride 
dihydrate (QHD), quinine (Qn), quinine hemisulphate dihydrate (QhS) and Eudragit® 
EPO using conventional differential scanning calorimetry (DSC), thermogravimmetric 
analysis (TGA) and hot stage microscopy (HSM) was reported. DSC experiments were 
performed using open pans at 10oC/min from 25oC to 250oC to study the sample 
thermal transitions. HSM and TGA experiments were used in conjunction with DSC 
(using the same heating parameters) to capture visual images of the samples to aid 
interpretation of the observed thermal events. Details of these techniques are fully 
discussed in Chapter 2. 
 
Figures 5.5, 5.10 and 5.11 show the DSC (in green) and corresponding TGA (in blue) 
traces for quinine hydrochloride dihydrochloride (QHD), quinine (Qn) and quinine 
hemisulphate dihydrate (QhS) respectively. The DSC heat flow for QHD (Figure 5.5) 
shows a broad temperature endotherm (a) at onset 48oC with no presence of noise in 
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the baseline. Another smaller endotherm (b) is observed at onset 135oC. This is 
followed by a temperature exotherm (c) at onset 171oC. The final transition observed is 
a sharp low endotherm at onset 221oC (d). This is interesting because it implies that 
quinine hydrochloride dihydrate initially get dehydrated into an unstable form (a) which 
melts (b) and crystallises (c) into a stable form which eventually melts (d)  
(Margetson et al. 2008). The corresponding measured water content (TGA) was 
9.01%. This was within the expected water content values of QHD of 9.07%.  
 
FIGURE 5. 5 TYPICAL TGA AND DSC HEAT FLOW SIGNAL FOR QUININE HYDROCHLORIDE DIHYDRATE 
(QHD) AT 10OC/MIN USING AN OPEN PAN. 
 
The objective of the thermal analysis was to elucidate what form of quinine 
hydrochloride would be present in the final quinine hydrochloride dihydrate – Eudragit® 
EPO; therefore since three endotherms were observed (Figure 5.5), further analysis 
was necessary. Initially, quinine hydrochloride dihydrate was heated to 100oC, cooled 
to 25oC then reheated to 250oC. The DSC heating and cooling rates were 10oC/min. 
Open pans were used and the DSC thermograph is shown in Figure 5.6. The transition 
initially observed between 53oC and 95oC during the first heating cycle is not observed 
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cycle therefore once it is lost the transition is not observed during the 2nd heating cycle. 
However, the melt, re-crystallisation and melt are observed consistent with initial 
standard heating of quinine hydrochloride dihydrate. Curiously, there appears to be a 
second exotherm starting after 240oC, therefore further investigation is required to 
ascertain is this is indeed another thermal event, however it is almost certainly the 
degradation of the material. 
 
 
FIGURE 5. 6 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE FOLLOWING 
HEATING TO 100
O
C, THEN COOLING TO 25
O
C AND REHEATING TO 250
O





DSC thermograph for quinine hydrochloride dihydrate following heating to 156oC at 
10oC/min, cooling to 25oC then reheating to 250oC at the same rate is shown in  
Figure 5.7. Similar to the thermograph shown in Figure 5.6, the initial transition which 
could possibly be ascribed as water loss is also not observed when sample is heated to 
156oC. Interestingly, the second heat shows a Tg at 127
oC followed by a 
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FIGURE 5. 7 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE FOLLOWING 
HEATING TO 156
O
C, THEN COOLING TO 25
O
C AND REHEATING TO 250
O
C. HEATING AND COOLING RATE WAS 
10
O
C/MIN USING OPEN PAN. 
DSC thermograph for quinine hydrochloride dihydrate following heating to 180oC at 
10oC/min, cooling to 25oC then reheating to 250oC at the same rate is shown in Figure 
5.8. Unsurprisingly, the initial endotherms reported for quinine hydrochloride dihydrate 
(Figure 5.5) are not observed on the second heating. Furthermore, the melt observed 
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FIGURE 5. 8 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE FOLLOWING 
HEATING TO 180
O
C, THEN COOLING TO 25
O
C AND REHEATING TO 250
O





Figure 5.9 gives a summary of the three heat– cool- heat cycles described individually 
in Figures 5.6, 5.7 and 5.8. All three traces are of the second heating. To recap, the 
first DSC trace (when describing top to bottom), shows the second heating cycle 
following heating of quinine hydrochloride dihydrate to 100oC, then cooling to 25oC 
before reheating to 250oC. The second (shown in red) and third (shown in blue) traces 
were heated to 156oC and 180oC respectively before being cooled to 25oC and then 
reheated to 250oC. It is noteworthy that a downward shift in endotherms and reduced 
peaks between heating to 100oC and heating to 156oC. However the final melt was 





















0 50 100 150 200 250
Temperature (°C)
Sample: QnHCl - day0
Size:  4.0300 mg




Run Date: 14-Dec-2013 19:20
Instrument: DSC Q2000 V24.10 Build 122
Exo Up Universal V4.5A TA Instruments




FIGURE 5. 9 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE FOLLOWING 
HEATING TO 100
O
C (GREEN), HEATING TO 156
O
C (RED) OR HEATING TO 180
O
C (BLUE), THEN COOLING TO 
25
O
C AND REHEATING TO 250
O
C. HEATING RATE WAS 10
O
C/MIN USING OPEN PAN. 
 
The DSC heat flow of quinine (Figure 5.10) shows a temperature endotherm at 177oC. 
Notably unlike quinine hydrochloride dihydrate, there are no other transitions observed 
for quinine. 
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The DSC heat flow of quinine hemisulphate dihydrate illustrated in Figure 5.11 shows a 
broad temperature endotherm at onset 42oC. The shape and size of this endotherm is 
similar to the one observed for quinine hydrochloride dihydrate. A sharp endotherm 
with onset temperature 221oC was observed. Interestingly, this endotherm is also 
similar to the one observed for QHD. The measured water content (TGA) for quinine 
hemisulphate dihydrochloride was 9.30% which is within the expected water content 
value of 9.20%. The DSC trace recorded for QhS has also been described in the 
literature (Karan et al. 2012).  
 
FIGURE 5. 11 TYPICAL TGA AND DSC HEAT FLOW SIGNAL OF QUININE HEMISULPHATE DIHYDRATE (QHS) 
RECORDED AT HEATING RATE 10
O
C/MIN USING ON OPEN PAN. 
 
Figure 5.12 shows comparative DSC traces of the quinine salts i.e. quinine 
hydrochloride dihydrate (red), quinine hemisulphate dihydrate (black) and quinine 
(blue). It is clear that both the dihydrates exhibit endotherms which correspond to water 
loss and feature not displayed by quinine. Recrystallisation is shown for quinine 
hydrochloride dihydrate while the other two salts only show a final melt. The melting 
temperatures of the three salts are 177oC, 228oC and 232oC for quinine, quinine 
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FIGURE 5. 12 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE (QHD), QUININE 
HEMISULPHATE DIHYDRATE (QHS) AND QUININE RECORDED AT HEATING RATE 10
O
C/MIN USING AN OPEN PAN 
 
The DSC heat flow of Eudragit® EPO illustrated in Figure 5.11 shows a broad 
temperature endotherm at onset 45oC. Since, Eudragit®EPO is an amorphous 
copolymer, this endotherm is consistent with a glass transition (Tg). Reports in the 
literature suggest that the Tg value observed at 48
oC is accompanied by an 
endothermic relaxation over the Tg region when analysed using modulated temperature 
DSC (MTDSC) (Qi et al. 2008c, Moffat et al. 2014). 
 
FIGURE 5. 13 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT® EPO RECORDED AT HEATING RATE 
10
O
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Slow heating rates result in good resolution of thermal events, but unfortunately this is 
coupled with poor sensitivity, whilst fast heating rates result in poor resolution but good 
sensitivity of thermal events. Various reports in the literature have identified that the 
dehydration process is dependent on the heating rate. Increasing heating rates from 
0.5oC – 50oC/min were used. Higher heating rates were used to eliminate kinetic 
events on the observed thermal transitions. Figure 5.14 shows a typical DSC heat flow 
signal for quinine hydrochloride dihydrate at 0.5, 1, 2, 5, 10, 20 and 50oC/min using an 
open pan. There is an upward shift for the onset of the endotherms with increasing 
heating rates for all endothermic and exothermic peaks. For example the 
recrystallisation peaks occurs at 152.1oC at 0.5oC/min heating rate while the same 
exotherm occurs at 203.9oC when 50oC/min heating rate is used. Transitions such as 
crystallisation are kinetic events and therefore are a function of both time and 
temperature. This means that the transition will shift to a higher temperature when 
heated at a higher rate because it has less time at any specific temperature. Although, 
these endothermic- and exothermic peaks are not pronounced for the lower heating 
rates there is still a visible shift from baseline which suggests that these are indeed 
kinetic events. 
 
It was evident from Figure 5.14 that the recrystallisation of the melt was dependant on 
the heating rates. As the heating rate increased the peak recrystallisation temperature 
increased. At the fast heating rates the total thermal energy that the sample was 
exposed to at any particular time was smaller, thus a higher temperature was required 
before the thermal energy quota to activate the recrystallisation process is obtained. 
The same is true for the subsequent final melt. 




FIGURE 5. 14 TYPICAL DSC HEAT FLOW SIGNAL FOR QUININE HYDROCHLORIDE DIHYDRATE AT 0.5, 1, 2, 5, 
10, 20, AND 50
O
C/MIN USING AN OPEN PAN. 
 
HSM was conducted on all three quinine molecules; all were cohesive, agglomerated, 
coloured. Quinine hydrochloride dihydrate and quinine sulphate both showed 
birefringence at 30oC (Figure 5.15 and Figure 5.16) while quinine did not. Although not 
conclusive, some studies have suggested that birefringence is observed for the hydrate 
forms of local anaesthetics while their anhydrous forms did not (Schmidt et al. 2005).  
Birefringence results from the refractive index of a sample, which is derived from the 
ratio between the speed of light within a vacuum and the speed of light within the 
sample. It refers to colour produced when polarised light passes through a crystal.  
A sample is deemed to be birefringent when a light ray splits into two beams when 
passing through it having the effect of birefringence (or double refraction). Figure 5.15 
shows HSM images captured at specific temperatures for quinine hydrochloride 
dihydrate on heating samples at 10oC/min.  On heating, no change in birefringence is 
observed until 141.5oC where birefringence is lost as the crystals melt. It is noteworthy 
that there is no complete melting of the crystals. Crystallisation started at 149.8oC 
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Figure 5.16 shows HSM images of quinine captured at 30.2oC and 176.9oC. Essentially 
on heating, the quinine crystals do not show any changes until the complete melting of 
the crystals at 176.9oC. Figure 5.17 shows HSM images of quinine hemisulphate 
dihydrate. In contrast to quinine hydrochloride dihydrate, heating of quinine sulphate 
did not change birefringence; in fact the only change observed was the dissolution of 
the crystals which started at 167.0oC with complete melt at 225.3oC. 
 
 
FIGURE 5. 15 HOT STAGE MICROSCOPE IMAGES CAPTURING THE RECRYSTALLISATION OF QUININE 
HYDROCHLORIDE FROM THE DEHYDRATE FORM. SAMPLES WERE HEATED AT 10
O
C/MIN 




FIGURE 5. 16 HOT STAGE MICROSCOPY IMAGES CAPTURING THE MELTING OF QUININE CRYSTALS. SAMPLES 




FIGURE 5. 17 HOT STAGE MICROSCOPY IMAGES CAPTURED AT SPECIFIC TEMPERATURES FOR QUININE 




5.3.3 PARTICLE MORPHOLOGY OF RAW MATERIALS 
SEM images of quinine hydrochloride dihydrate (Figure 5.18), quinine hemisulphate 
dihydrate (Figure 5.19) and Eudragit® EPO (Figure 5.20). The quinine particles appear 
to be crystalline in nature.  




FIGURE 5. 18 SEM IMAGE OF CRYSTALLINE QUININE HYDROCHLORIDE DIHYDRATE. SCALE BAR 
CORRESPONDS TO 30µM 
 
 
FIGURE 5. 19 SEM IMAGE OF CRYSTALLINE QUININE HEMISULPHATE DIHYDRATE. SCALE BAR 
CORRESPONDS TO 30µM 
 
FIGURE 5. 20 SEM IMAGE OF EUDRAGIT® EPO. SCALE BAR CORRESPONDS TO 50µM 
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5.3.4 CHARACTERISATION OF HOT MELT EXTRUDED SAMPLES OF QUININE 
HYDROCHLORIDE DIHYDRATE AND EUDRAGIT® EPO 
In section 5.3.2., the thermal characteristics of quinine hydrochloride dihydrate and  
Eudragit® EPO were reported. To recap, quinine hydrochloride dihydrate shows four 
transitions from baseline. The first endotherm is broad and has onset at 48oC. The TGA 
trace suggests that this endotherm corresponds to water loss. Therefore, this implies 
that at the point of the next transition whose onset was 135oC, quinine hydrochloride 
exists in the anhydrous form. This form undergoes a melt followed by a re-
crystallisation which is shown in Figure 5.11. In the next section, the Eudragit® EPO – 
quinine hydrochloride (EPO-QHD) extrudates are characterised. As previously 
described in chapter 2, the extrudates are milled before being analysed. 
 
5.3.4.1 POWDER X-RAY DIFFRACTION OF EUDRGIT® EPO – QUININE HYDROCHLORIDE 
MELT EXTRUDATES 
In section 5.3.1 the crystallinity of quinine hydrochloride is described using PXRD. In 
addition, the “amorphous halo” of Eudragit®EPO (EPO) is also described. This section 
was concerned with reporting the effect of hot melt extrusion on the materials in 
question with a view of understanding whether the drug remained crystalline following 
hot melt extrusion with the amorphous polymer. In addition, an investigation into the 
miscibility of the two materials is described. The thermal stability of the  
Eudragit®EPO-QHD extrudates was also investigated and finally the release profile of 
quinine hydrochloride dihydrate from the Eudragit® EPO–QHD extrudate was 
compared to the corresponding physical mixtures with a view to describe the taste 
masking efficacy of the extrudates. To this end, increasing concentrations of quinine 
hydrochloride dihydrate i.e. 30%, 50% and 70% w/w Eudragit® EPO extrudates and 
their corresponding physical mixtures were investigated.   
 
Figure 5.21 shows a comparative PXRD diffractograms of untreated quinine 
hydrochloride dihydrate and Eudragit® EPO together with  Eudragit®EPO 30% quinine 
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hydrochloride dihydrate (EPO30% QHD), Eudragit®EPO 50% quinine hydrochloride 
dihydrate (EPO50% QHD), Eudragit®EPO 70% quinine hydrochloride dihydrate  
(EPO70% QHD). It is clear from the diffractograms that at all three drug loading, 
quinine remains crystalline. Interestingly, at 70% drug loading, two peaks are recorded 
at 38o and 45o. These peaks are both not observed for pure quinine hydrochloride 
dihydrate. This suggests that the crystal habit of the quinine in EPO70%QHD is 
different from that of QHD. The significance of this observation will become apparent in 
section 5.4.3. The simplest explanation could be that the dehydration process which 
the drug undergoes during the HME process produces the anhydrous form of QHD 
which has different crystal habit when compared to the hydrate form. It can be 
postulated that the presence of this crystallinity could indicate that the saturation 
solubility has been exceeded such that crystalline material does not undergo a melt 
(Qi et al. 2008c). In addition, noticeable changes were observed on viscosity/torque 
during processing of EPO 70% QHD extrudates, indicating that at this concentration of 
QHD, there was a lack of intermolecular interaction between drug and polymer  
(Wu et al. 1999). To this end processing parameters were altered as described in  
Table 5.2. 
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FIGURE 5. 21 PXRD DIFFRACTOGRAM OF QUININE HYDROCHLORIDE DIHYDRATE, EUDRAGIT® EPO AND 
QUININE HYDROCHLORIDE DIHYDRATE – EUDRAGIT® EPO MELT EXTRUDATES AT 30%, 50% AND 70% W/W 
RECORDED ON DAY ZERO 
 
Although the crystallinity of the EPO-QHD melt extrudates had been compared to 
untreated quinine hydrochloride dihydrate and Eudragit®EPO, it was also necessary to 
compare these diffractograms to physical mixtures of quinine hydrochloride dihydrate 
and Eudragit®EPO at similar drug loading concentration. This was done to ascertain 
whether the diffractograms observed differed from those of the physical mixtures. 
Figure 5.22 shows the PXRD diffractograms of the EPO-QHD physical mixtures. This 
figure illustrates that the physical mixtures retain crystallinity and lack the “amorphous 
halo” of Eudragit® EPO. A distinctive peak is observed at 8o, although the intensity of 
the peak is reduced with decreasing concentrations of quinine hydrochloride dihydrate. 
Also to note, is the absence of two peaks at 38o and 45o, for the EPO 70%QHD 
physical mixture, whereas they were observed for the same concentrate of extrudate. 
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FIGURE 5. 22 PXRD DIFFRACTOGRAM OF QUININE HYDROCHLORIDE DIHYDRATE, EUDRAGIT® EPO AND 
QUININE HYDROCHLORIDE DIHYDRATE – EUDRAGIT® EPO PHYSICAL MIXTURES AT 30%, 50% AND 70% W/W 
RECORDED ON DAY ZERO 
 
EFFECT OF TEMPERATURE, HUMIDITY AND TIME. 
In the previous section, the crystallinity of 30, 50% and 70% w/w EPO-QHD melt 
extrudates when the samples were fresh is reported. However, in order to understand 
the stability of the EPO-QHD melt extrudates, the samples were exposed to stresses of 
temperature and humidity over twenty eight days with the view to describe changes to 
the crystal character of the melt extrudates. The samples were exposed to 0% relative 
humidity, 25oC and 50% relative humidity, 4oC.  
Tables 5.3 and 5.4 gives a summary of the PXRD diffractograms of EPO 30% QHD, 
EPO 50% QHD and EPO 70% QHD melt extrudates after ageing for seven, fourteen 
and twenty eight days in two different conditions i.e. 0% relative humidity, 25oC and 
50% relative humidity, 4oC. It is clear that after seven days, there is a peak of highest 
intensity at 12.2o. This signifies that the drug is crystalline. In addition, the crystal habit 
remains the same across the different storage conditions. After fourteen days, the 
samples retain crystallinity and the diffractograms are similar to those of the fresh 
sample, hence suggesting that the drug is crystalline. The different stress conditions do 
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not affect the results observed It is clear from the diffractograms that there is no 
change in the crystallinity of the melt extrudates after twenty eight days  
Similar analysis was conducted for EPO50%QHD melt extrudates. Tables 5.3 and 5.4 
shows PXRD diffractograms of EPO 50%QHD melt extrudates after storing for seven 
days at same condition as those described for EPO 30% QHD. The aged samples 
show crystallinity which is similar to fresh samples and different to the amorphous halo 
of Eudragit®EPO (Figure 5.4). After fourteen and twenty eight day ageing of 
Eudragit®EPO 50%QHD samples, It is apparent from this diffractogram that the melt 
extrudate stored at 50% relative humidity and 4oC remains crystalline. A noticeable 
observation is that the sample stored at 50%RH and 4oC shows an amorphous halo 
suggesting that this sample is amorphous. An explanation for this observation is that 
this sample congealed into a solid mass and despite efforts to load onto sampling pan, 
it is conceivable that the detection of this sample was impaired and as such is appears 
to be amorphous. Further discussions on this issue will be made in section 5.4.2. 
 
Following on from investigating the 30% and 50% EPO-QHD melt extrudates, the  
EPO 70% QHD melt extrudates were also investigated. The PXRD diffractograms are 
shown also shown in Tables 5.3 and 5.4 ageing for seven, fourteen and twenty eight 
days respectively. On all three occasions, there is no difference in the patterns 
between the fresh and aged samples. What is also noteworthy is the presence of two 
peaks at 38o and 45o, which are characteristic peaks only observed for EPO 70% QHD, 
again suggesting a different crystal habit in these samples. It would appear that at 
these conditions did not affect the crystallinity of the EPO70% QHD melt extrudates 
when stored at 0% relative humidity and 25oC. It would appear that at 50% relative 
humidity and 4oC the PXRD trace is parallel to the x-axis. This could be ascribed to that 
fact that after storage for twenty eight days the powder extrudate congealed into a solid 
mass. Even though an attempt was made to mount this sample on the PXRD sample 
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holders the resultant diffractogram suggests that the sample was not detected. Further 
discussions on this issue will be made in section 5.4.2. 
 
The corresponding diffractograms of Eudragit® EPO 30% QHD and EPO 50% QHD for 
the physical mixtures have been summarised in Table 5.3 after seven days of stress 
conditions. Unremarkably, there are no changes in the diffractograms with time or 
stress conditions. This trend also continues after fourteen and twenty eight days of 
storage. What is apparent is that the three peaks of highest intensity at 8.8o, 12.2o and 
17.2o reported in Figure 5.1 are also shown in the diffractograms of the physical 
mixtures shown in Table 5.3 which is expected because the quinine hydrochloride in 
the physical mixtures is unprocessed 
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TABLE 5 3 SUMMARY OF PXRD DIFFRACTOGRAMS OF EPOQHD MELT EXTRUDATES AFTER EXPOSURE TO STRESS CONDITION OF 0% RELATIVE HUMIDITY, 25
O




Day EPO30% QHD EPO50% QHD EPO70% QHD 
Seven 
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 EPO 50%- QHD (fresh)
 EPO 50%- QHD (0RH25)
 EPO 50%-QHD (50RH4)
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 EPO 70% -QHD (fresh)
 EPO 70%-QHD (0RH25)
 EPO 70%-QHD (50RH4)
 EPO
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TABLE 5 4 SUMMARY OF PXRD DIFFRACTOGRAMS OF EPOQHD MELT EXTRUDATES AFTER EXPOSURE TO STRESS CONDITION OF 0% RELATIVE HUMIDITY, 25
O
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TABLE 5 5 SUMMARY OF PXRD DIFFRACTOGRAMS OF EPOQHD PHYSICAL MIXTURES AFTER EXPOSURE TO STRESS CONDITION OF 0% RELATIVE HUMIDITY, 25
O
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SUMMARY OF RESULTS 
Before proceeding to the next section where thermal analysis of the melt extrudate is 
described, it is worth pointing out that so far PXRD has shown that EPO30%QHD and 
EPO50%QHD both crystalline when fresh. This is also true for EPO70%QHD which 
shows sharp peaks at 38o and 45o indicative of crystallinity. These two peaks are 
absent on the diffractogram for untreated quinine hydrochloride dihydrate. At the 
temperatures at which melt extrusion was carried out. After storing EPO 50%QHD and 
EPO70%QHD for twenty eight days at 50% relative humidity and 4oC PXRD 
diffractograms show an amorphous halo. In both cases, due to the samples being a 
solid mass, hence it was not in powder form when mounted onto the sample holders. 
Therefore, it is possible that the detection was impaired hence an erroneous result. 
This significance of these findings will be discussed in section 5.4.2 in conjunction with 
findings from the next section which look at thermal analysis of the samples. 
Unsurprisingly there is no change in crystallinity observed for the physical mixtures of 
Eudragit® EPO QHD. 
 
5.3.4.2 THERMAL ANALYSIS OF EUDRAGIT® EPO –QUININE HYDROCHLORIDE 
SAMPLES 
In section 5.3.2, the DSC thermographs of quinine hydrochloride dihydrate and 
Eudragit® EPO are shown in Figures 5.5 and Figure 5.10 respectively. In this section, 
these thermographs will be compared with those obtained from Eudragit® EPO-quinine 
hydrochloride (EPO QHD). The EPOQHD extrudates analysed were in increasing 
concentrations of quinine hydrochloride dihydrate i.e. 10%, 30%, 50% and 70% w/w. In 
addition, the EPOQHD extrudates were compared with physical mixtures of the same 
concentrations. 
 
Figure 5.23 shows the DSC thermographs of the EPOQHD extrudates. Unsurprisingly, 
the increasing concentrations of quinine hydrochloride dihydrate (top to bottom) 
translated to the DSC thermograph matching that of quinine hydrochloride dihydrate. 
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Interestingly, QHD has a melt at 232oC however EPO 70%QHD shows a downward 
shift in this melt to 222oC. The significance of this finding will be discussed in  
section 5.4. In addition the other transitions reported for QHD are not pronounced for 
the other EPO-QHD melt extrudates. This can be possibly explained by the fact that in 
order for crystal growth to occur after melting, secondary nucleation (crystal growth 
generated in the vicinity of other crystalline matter present in the melt) needs to occur. 
Strickland-Constable (1968) described several possible mechanisms of secondary 
nucleation of which “collision” breeding (a complex process resulting from interaction of 
crystals with one another) seems particularly significant in this instance. HSM studies 
showed that secondary crystal growth was more prolific with increasing concentrations 
of quinine hydrochloride in the melt extrudates. As such the DSC traces also show that 
increasing concentrations of quinine in the melt extrudates results in the DSC trace 
resembling that of pure quinine hydrochloride dihydrate. Another point to note is that 
EPO 50%QHD shows a broad endotherm with onset at 205oC. At this stage it is 
unclear as to what this endotherm represents, however it could be suggested that 
crystal growth is ongoing though this was not visible under HSM.  




FIGURE 5. 23 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE (QHD), 
EUDRAGIT® EPO 70% QUININE HYDROCHLORIDE DIHYDRATE EXTRUDATE (EPO70%QHD),  
EUDRAGIT® EPO 50% QUININE HYDROCHLORIDE DIHYDRATE EXTRUDATE (EPO 50% QHD),  
EUDRAGIT® EPO 30% QUININE HYDROCHLORIDE DIHYDRATE EXTRUDATE (EPO 30% QHD) AND EUDRAGIT® 
EPO 10% QUININE HYDROCHLORIDE DIHYDRATE EXTRUDATE (EPO10% QHD) RECORDED AT HEATING RATE 
10
O
C/MIN USING AN OPEN PAN 
 
In order to understand the effect of the hot melt extrusion process on the thermal 
characteristic of the EPOQHD extrudates, it was necessary to compare the extrudates 
with their physical mixture counterparts. Figure 5.24 shows the DSC thermographs of 
10, 30, 50, 70% w/w Eudragit®EPO – quinine hydrochloride dihydrate (EPOQHD) 
physical mixtures. It is safe to say that the inclusion of the polymer to quinine causes a 
downward shift in the water loss endotherm reported in Figure 5.5. Furthermore, the 
subsequent transitions also show a downward shift albeit they are not pronounced for 
30, 50 and 70% w/w EPOQHD physical mixtures. The significance of this downward 
shift will become apparent in section 5.4. The same transition are relatively  
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FIGURE 5. 24 TYPICAL DSC HEAT FLOW SIGNAL OF QUININE HYDROCHLORIDE DIHYDRATE (QHD), 
EUDRAGIT® EPO 70% QUININE HYDROCHLORIDE DIHYDRATE PHYSICAL MIXTURE (EPO 70% QHD),  
EUDRAGIT® EPO 50% QUININE HYDROCHLORIDE DIHYDRATE PHYSICAL MIXTURE (EPO 50% QHD),  
EUDRAGIT® EPO 30% QUININE HYDROCHLORIDE DIHYDRATE PHYSICAL MIXTURE (EPO 30% QHD) AND 
EUDRAGIT® EPO 10% QUININE HYDROCHLORIDE DIHYDRATE PHYSICAL MIXTURE (EPO10% QHD) RECORDED 
AT HEATING RATE 10
O
C/MIN USING OPEN PANS 
 
EFFECT OF TEMPERATURE, HUMIDITY AND TIME 
The characterisation of EPOQHD extrudates has been described in section 5.3.4. This 
analysis focussed on freshly prepared samples. However, as already eluded to, 
anhydrous quinine hydrochloride is formed during the extrusion process therefore it 
was necessary to investigate the stability of this form by exposing it to extreme 
stresses of temperature and humidity. In addition, the samples stability was 
investigated as a function of time. EPO 10%QHD did not exhibit any interesting 
behaviour therefore has not been reported here. Further analysis in terms of 
temperature, humidity and time was conducted on the EPO 30%, 50% and 70% QHD 
samples.  
 
Table 5.5 shows the DSC (green) and the overlaid TGA (blue) for Eudragit®EPO 30% 
quinine hydrochloride dihydrate (EPO 30% QHD) after storing for seven, fourteen and 
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The DSC heat flow shows a small endotherm between 48oC and 55oC with no 
presence of noise in the baseline. In comparison to untreated QHD shown in Figure 
5.3 this endotherm can be ascribed to Tg of Eudragit® EPO. In addition, it is clear that 
the overarching water loss endotherm observed for untreated quinine hydrochloride 
dihydrate (Figure 5.5) is clearly absent in this DSC trace. This is expected as water 
loss occurs during the HME process. An exotherm is also observed between 122oC 
and 138oC (re-crystallisation) which is followed by a broad endotherm with onset at 
202oC (melt). Of note, is there are a downward shift both the  
re-crystallisation and melt temperatures. The corresponding measured weight change 
was 12.08%. Initially it appears that this weight change is attributed to water loss. 
However, on closer inspection, this weight loss could also include the degradation of 
Eudragit®EPO. A typical TGA trace for Eudragit® EPO is given in Figure 5.25 as a 
basis for comparison. 
 
The EPO30% QHD extrudates which were stored for seven, fourteen and twenty eight 
days at 50% relative humidity and 4oC and the DSC (green) and corresponding TGA 
(blue) also shown in the summary Table 5.5. It is apparent that the DSC trace is similar 
to that described for EPO 30%QHD which had been stored at 0% relative humidity and 
25oC. It would appear that after seven days of different storage conditions the thermal 
behaviour of Eudragit®EPO remains unchanged and is in still the anhydrous form of 
quinine hydrochloride. No further changes are observed in the DSC traces with 
increasing storage time. 
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TABLE 5 6 SUMMARY TABLE OF DSC AND TGA TRACES OF EPO 30% QHD EXTRUDATES AFTER 
STORAGE AT 0RH, 25
O
C, 50RH AND 4
O
C FOR SEVEN, FOURTEEN AND TWENTY EIGHT DAYS 
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FIGURE 5. 25 TYPICAL TGA TRACE FOR EUDRAGIT®EPO, HEATING RATE 10
O
C/MIN USING AN OPEN PAN 
 
Table 5.6 focuses on the physical mixture of EPO 30% QHD after storing for seven 
days at 0% relative humidity and 25oC. The DSC (green) heat flow shows a broad 
endotherm with onset at 46oC. Another smaller endotherm is observed with onset 
temperature 148oC. This is quickly followed by an exotherm with onset temperature 
162oC then a broad endotherm with onset temperature 208oC. What is interesting 
about the physical mixture is the absence of an obvious melt endotherm which was 
prominent in all previous DSC traces of QHD. A possible explanation for this lies in the 
fact that like many solid state reaction, recrystallisation occurs through the processes 
of nucleation and growth. The lack of other crystals to aid the nucleation and growth 
process results in diminished recrystallisation hence the absence of the melt 
endothermic peak. The corresponding measured weight change (TGA) shown in blue, 
was 9.02%. This weight change can be attributed to both water loss from the 30% 
quinine hydrochloride and 70%Eudragit®EPO.  
Table 5.6 also shows DSC and TGA traces of the physical mixture of Eudragit ®EPO 
30% QHD stored at 50% relative humidity and 4oC for seven days. Unsurprisingly, the 
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physical mixture stored at 0% relative humidity and 25oC shown in the same table. 
Unsurprisingly, the DSC and TGA traces remain unchanged over the twenty eight day 
storage time. 
TABLE 5 7 SUMMARY TABLE OF DSC AND TGA TRACES OF EPO 30% QHD PHYSICAL MIXTURES 
AFTER STORAGE AT 0RH, 25
O
C, 50RH AND 4
O
C FOR SEVEN DAYS 




EPO 50% QHD extrudates were stored at 0% relative humidity, and temperature of 
25oC for seven days and the corresponding DSC (green) and TGA (blue) traces are 
shown in Table 5.7. In contrast to EPO 30% QHD extrudates, the DSC trace shows a 
broad endotherm with onset 48oC. This endotherm is similar to the endotherm 
observed for quinine hydrochloride dihydrate and is attributed to water loss. In addition, 
the other two transitions at 142oC and 162oC are more pronounced when compared to 
EPO30% QHD. A possible explanation for this observation is that at 50% drug loading 
there are more “seeds” allowing nucleation and crystal growth. This DSC trace 
resembles that of pure quinine hydrochloride dihydrate which could also suggest that 
under these conditions EPO50%QHD, the anhydrous form reverts back to resemble 
pure quinine hydrochloride. The weight change measured was 10.02%, which can be 
ascribed to both water losses from quinine hydrochloride dihydrate and degradation of 
EPO.  
Table 5.7 also shows the DSC (green) and overlaid TGA (blue) traces of EPO 50% 
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Interestingly, this DSC and corresponding TGA traces are similar to those for EPO 
50%QHD stored at 0% relative humidity and 25oC. Therefore this implies that after 
seven days, the stress conditions applied do not seem to affect the thermal behaviour 
of EPO 50%QHD. This suggests that this extrudate is thermally stable under these 
stress conditions. 
TABLE 5 8 SUMMARY TABLE OF DSC AND TGA TRACES OF EPO 50% QHD EXTRUDATES AFTER 
STORAGE AT 0RH, 25
O
C, 50RH AND 4
O
C FOR SEVEN DAYS 




The DSC (green) and TGA (blue) traces of the physical mixture of EPO 50% QHD after 
storing for seven days at 0% relative humidity and 25oC are shown in Table 5.8. What 
is apparent from the DSC trace is that it exhibits similar endotherms and exotherm to 
those observed for quinine hydrochloride dihydrate (Figure 5.5). Also to note, albeit 
unremarkable is the fact that the physical mixture remains unchanged in terms of 
thermal properties. The measured weight changed was 10.4% which can be ascribed 
to water loss. The physical mixture of EPO50% QHD were also stored at 50% relative 
humidity and 4oC and the overlaid DSC and TGA traces are reported in Table 5.8. 
Unsurprisingly, the traces reported do not deviate from those previously reported for 
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TABLE 5 9 SUMMARY TABLE OF DSC AND TGA TRACES OF EPO 50% QHD PHYSICAL MIXTURES 
AFTER STORAGE AT 0RH, 25
O
C, 50RH AND 4
O
C FOR SEVEN DAYS 




Figure 5.26 gives a comparative summary of the DSC traces of EPO30%QHD stored 
at the different stress conditions for seven days. This suggests that the thermal 
behaviour of this extrudate is not affected by the storage conditions to which it is 
exposed. Quinine hydrochloride remains in its dehydrated form. In all cases, an 
endothermic step change from baseline is observed with onset 48oC. This step change 
denotes the Tg of Eudragit® EPO. The next transition is an exothermic peak with onset 
128oC which is the recrystallisation of quinine hydrochloride. The final endotherm with 
onset at 218oC represents the melt of the recrystallized quinine hydrochloride. What is 
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FIGURE 5. 26 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO30% QUININE HYDROCHLORIDE 













C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
O
C/MIN USING OPEN PANS 
 
On examination of the same samples i.e. EPO 30% QHD after they had been stored 
for fourteen days (Figure 5.27), it is apparent that similar to results reported after seven 
days, there are no differences between the fresh sample and the other three which had 
been exposed to temperature and humidity stresses. In addition, the different stress 
conditions appear to have not altered the thermal properties of the EPO30% QHD 
samples. What is also apparent is the exothermic and endothermic peaks reported for 
after seven days (Figure 5.47) are less pronounced after fourteen days. This suggests 
that quinine hydrochloride is still in the anhydrous form and in addition the nucleation 
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FIGURE 5. 27 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 30% QUININE HYDROCHLORIDE 













C) FOR FOURTEEN 
DAYS. HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN 
 
Finally, the EPO30%extrudates are analysed again after twenty days and a 
comparative summary is given in Figure 5.28 It is also apparent from this figure that 
there is no difference in the thermal behaviour of the fresh samples and those that 
have been stored for twenty eight days. This is to say that quinine hydrochloride 
remains in its dehydrated form hence the endothermic peak at 48oC denoted the Tg of 
Eudragit®EPO while to exothermic peak at 128oC shows recrystallisation followed by 
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FIGURE 5. 28 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 30% QUININE HYDROCHLORIDE 













C) FOR TWENTY EIGHT 
DAYS. HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN. 
 
In similar fashion to EPO30%QHD extrudate thermographs shown in Figure 5.29, the 
DSC traces of the EPO 30%QHD physical mixtures are shown in Table 5.9. A marked 
difference is observed in terms of the transitions. Unsurprisingly the physical mixtures 
exhibit the broad endotherm with onset 45oC, which can be ascribed to both water 
losses from the quinine hydrochloride dihydrate and the Tg of Eudragit® EPO. It  is also 
essential to point out is that after the broad endotherm attributed to water loss, the next 
transition observed is similar to that observed for QHD (Figure 5.5), however the 
recrystallisation and subsequent melt are not as pronounced for the physical mixtures. 
A possible explanation for this is that the presence of the polymer means that quinine 
hydrochloride crystals are separated therefore nucleation and subsequent crystal 
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FIGURE 5. 29 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 30% QUININE HYDROCHLORIDE 













C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN 
 
The differences between the fresh Eudragit® EPO 50% quinine hydrochloride 
dihydrate (EPO 50% QHD) and the same sample having been exposed to stresses of 
temperature and humidity is highlighted in Figure 5.30. It is clear that when fresh, there 
is only one transition, however after seven days each of the samples of EPO 50% QHD 
DSC thermographs begins to resemble the original QHD thermograph shown in Figure 
5.5. This therefore suggests that after storing the anhydrous form of quinine gets 
hydrated and as such the DSC trace resembles that of quinine hydrochloride dihydrate. 
Interestingly, EPO 50%QHD milled melt extrudate stored at 75% relative humidity and 
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FIGURE 5. 30 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO  50% QUININE HYDROCHLORIDE 
DIHYDRATE  EXTRUDATES FOLLOWING STORAGE AT  0% RELATIVE HUMIDITY, 25
O
C ( 0RH, 25
O
C),  50% 
RELATIVE HUMIDITY, 4OC (50RH,4
O




C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN. 
 
The DSC analysis of the EPO 50% QHD physical mixtures are illustrated in  
Figure 5.31. It is apparent that the physical mixtures thermographs resemble those of 
the fresh samples. In essence, the stresses of humidity and temperature do not appear 
to change the thermal properties of the physical mixtures. This is not surprising 
because there is no chemical interaction between the polymer and quinine 
hydrochloride dihydrate and as such each individual component remains in the same 
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FIGURE 5. 31 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 50% QUININE HYDROCHLORIDE 













C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN. 
 
The DSC trace which examines the thermal behaviour of EPO50% melt extrudates 
after fourteen days of stress conditions of 0% relative humidity, 25oC is presented in 
Figure 5.32. The thermal behaviour of the melt extrudates does not deviate from that 
observed after seven days. It would appear that this anhydrous form of QHD is stable 
under these stress conditions at fourteen days. 
 
FIGURE 5. 32 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 50% QUININE HYDROCHLORIDE 
DIHYDRATE  EXTRUDATES FOLLOWING STORAGE AT  0% RELATIVE HUMIDITY, 25
O
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A further thermal analysis using DSC was conducted on EPO50%QHD after twenty 
eight days of storage. The resultant DSC thermograph is shown in Figure 5.33. What is 
evident from these traces is that the EPO50%QHD exposed to stress conditions of 
75% relative humidity and 40oC shows a DSC trace similar to that of unprocessed 
quinine hydrochloride dihydrate with a distinguished melt endotherm with onset 208oC. 
 
FIGURE 5. 33 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 50% QUININE HYDROCHLORIDE 
DIHYDRATE  EXTRUDATES FOLLOWING STORAGE AT  0% RELATIVE HUMIDITY, 25
O
C ( 0RH, 25
O









C) FOR TWENTY DAYS. 
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The DSC thermographs of EPO 70%QHD melt extrudates after seven days of stresses 
of humidity and temperature are shown in Figure 5.34. It is clear that the exception of 
the sample exposed to 50% relative humidity, 4oC, all the other retain an endotherm 
with onset 222oC. However, sample that is exposed to 75% relative humidity and 40oC 
temperature, shows an endotherm with onset temperature 102oC, which has not been 
observed in any of the samples so far. In addition, the same sample shows an 
exothermic peak with onset temperature 158oC. This endothermic peak corresponds to 
the exothermic peak observed for raw quinine hydrochloride dihydrate (Figure 5.5). 
Therefore, the sample exposed to 75% relative humidity, 40oC reverts back to 
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FIGURE 5. 34 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 70% QUININE HYDROCHLORIDE 
DIHYDRATE  EXTRUDATES FOLLOWING STORAGE AT  0% RELATIVE HUMIDITY, 25
O
C ( 0RH, 25
O









C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN 
 
The corresponding DSC traces for EPO70%QHD physical mixtures after storage for 
seven days are shown in Figure 5.35. In short, the different stress conditions do not 
affect the thermal behaviour of QHD. 
 
FIGURE 5. 35 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 70% QUININE HYDROCHLORIDE 













C) FOR SEVEN DAYS. 
HEATING RATE WAS 10
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After fourteen and twenty eight days of storage, the EPO70% QHD melt extrudates 
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to illustrate that there is no change in thermal behaviour of QHD between fourteen and 
twenty eight days storage. 
 
FIGURE 5. 36 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 70% QUININE HYDROCHLORIDE 
DIHYDRATE  EXTRUDATES FOLLOWING STORAGE AT 0% RELATIVE HUMIDITY, 25
O
C ( 0RH, 25
O









C) FOR FOURTEEN 
DAYS. HEATING RATE WAS 10
O
C/MIN USING AN OPEN PAN. 
 
FIGURE 5. 37 TYPICAL DSC HEAT FLOW SIGNAL OF EUDRAGIT®EPO 70% QUININE HYDROCHLORIDE 
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SUMMARY OF RESULTS 
This section began by describing the DSC thermographs of Eudragit® EPO-QHD melt 
extrudates. Unsurprisingly, as the content of quinine hydrochloride increased in the 
melt extrudates the DSC traces begin to resemble that of pure quinine hydrochloride 
dihydrate. Just highlighting EPO70%QHD melt extrudates which shows a downward 
shift in the melt endotherm from 232oC (pure quinine hydrochloride) to 222oC. 
EPO30%QHD and EPO50%QHD also have a similar phenomenon both with melt 
endotherms at 205oC. It is worth noting that the DSC traces of the melt extrudates 
differ remarkably from their corresponding physical mixtures. This is evidenced by the 
absence of the broad endotherm with onset 48oC which signifies water loss. This 
analysis has shown that quinine hydrochloride exists as the anhydrous form after HME.  
This section also investigated the effect of temperature, humidity and time on the melt 
extrudate powders with a view of assessing the stability of quinine hydrochloride in this 
formulation. The thermal analysis has revealed that at 30% drug loading there is no 
change in the thermal behaviour of quinine hydrochloride over twenty eight days 
despite exposure to different stress conditions. EPO50%QHD has a somewhat 
different behaviour in that when fresh, there is a marked absence of broad endotherm 
(onset 45oC), which is ascribed to water loss. This is to say when fresh the anhydrous 
form of quinine hydrochloride is predominant in the melt extrudates. However, after 
seven days of exposure to stress conditions the quinine hydrochloride rehydrates and 
as such the broad endotherm (onset 45oC) can be observed. In addition, after seven 
days the melt extrudate stored at 75% relative humidity and 40oC shows a melt with 
onset 220oC, which is not as apparent for the other stress conditions. This suggests 
that this stress condition seems to hasten the rehydration of quinine hydrochloride in 
the melt extrudate powders. Interestingly EPO70%QHD melt extrudate powders which 
were stored at 50% relative humidity and 4oC, show a broad exotherm (onset 205oC) 
and no subsequent melt endotherm. This would suggest that this sample is undergoing 
recrystallisation. When this sample was analysed after fourteen days, the absence of 
this broad endotherm is noted. It is instead replaced with an endotherm (onset 130oC) 
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and a subsequent melt endotherm at 222oC which is in keeping with transitions that are 
observed for the samples stored at the other stress conditions. The analysis of the 
corresponding physical mixtures showed no changes with time, temperature or 
humidity 
5.3.4.3 TASTE ASSESSMENT OF EUDRAGIT®EPO – QUININE 
HYDROCHLORIDE DIHYDRATE EXTRUDATES. 
The third objective in this chapter was to assess the taste masking ability of the newly 
formulated EPO-QHD melt extrudates; this was assessed following method described 
in chapter 2. The release of quinine hydrochloride from the EPO-QHD melt extrudates 
in illustrated in Figure 5.38. There are a number of observations to note. Firstly, across 
of three drug-loading concentrations of EPO-QHD melt extrudates, there is less than 
10% drug released in the first three minutes. In contrast, almost 90% of drug is 
detected in the absence of polymer. Secondly, there is no difference in the release 
profiles of the three drug loading EPO-QHD extrudates. Lastly, after two hours, only 
60% of the drug is released. The significance of these findings will become apparent in 
section 5.4.3. 
 
FIGURE 5. 38 HINDERED RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO®-QHD MELT 
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The detection of the quinine hydrochloride released from the melt extrudate was 
analysed using the Insent® TS5000Z electronic tongue. It is worth making it clear that 
the maximum concentration of quinine hydrochloride that could be released from the 
extrudates was set at 0.5mM (a concentration that has been shown is detectable on 
the electronic tongue and also measureable on the UV spectrometer). Sensor 
response curves for the increasing concentrations of QHD are shown in Figure 5.39. 
These reading were recorded after three minutes of shaking. The mark 0 in the x-axis 
represents de-ionised water. The concentration increase on the x-axis is that of quinine 
hydrochloride in the melt extrudates. Surprisingly, there is no statistical difference in 
sensor response curves with increasing concentrations of QHD i.e. 10, 30, 50 and 70% 
(one-way ANOVA, p=0.05). This suggests that the released quinine hydrochloride is 
not detectable on the electronic tongue. Since in chapter 3, it has already been shown 
that this molecule is detectable on the electronic tongue, the drug released is in 
concentration that are below the detection concentration of the electronic tongue. 
 
FIGURE 5. 39 RELATIVE SENSOR RESPONSE CURVE OF EPO50%QHD EXTRUDATES DISSOLVED IN DE-
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In order to ascertain the taste masking effect of the extrusion process, it was necessary 
to investigate the release of quinine hydrochloride dihydrate from physical mixtures of  
Eudragit® EPO and quinine hydrochloride dihydrate. The drug release profiles are 
illustrated in Figure 5.40. Notably, the cumulative percentage release of drug in the first 
two minutes ranged from 10% to 20%. This was not statistically significant as illustrated 
by a one-way ANOVA (p= 0.97). However, after sixty minutes 90% of the QHD is 
released and detectable. This observation is statistically different, shown by a one-way 
ANOVA (p = 4.96x 10-3) when compared to the melt extrudates. 
 
FIGURE 5. 40 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO®-QHD PHYSICAL 
MIXTURES WITH DIFFERENT CONCENTRATION OF DRUG LOADING, 30, 50 AND 70% W/W (N=3, ?̅?±SD). 
 
The EPO30%QHD extrudates were exposed to 0% relative humidity and 25oC for 
seven, fourteen and twenty eight days and the release profiles of the QHD from the 
extrudate powders is shown in Figure 5.41. The graph shows that there is no difference 
in the release profile of quinine hydrochloride from the melt extrudates. The stress 
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FIGURE 5. 41 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 30%QHD MELT 
EXTRUDATES AFTER STORAGE AT 0% RELATIVE HUMIDITY AND 25
O
C FOR SEVEN, FOURTEEN AND TWENTY 
EIGHT DAYS (N=3, ?̅?±SD). 
 
Eudragit®EPO 30%QHD melt extrudate were also stored at 50% relative humidity and 
4oC and the release profile after seven, fourteen and twenty eight days is shown in 
Figure 5.42. What is clear from this graph is that under these stress conditions, the 
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FIGURE 5. 42 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 30%QHD MELT 
EXTRUDATES AFTER STORAGE AT 50% RELATIVE HUMIDITY AND 4
O
C FOR SEVEN, FOURTEEN AND TWENTY 
EIGHT DAYS (N=3, ?̅?±SD) 
 
A similar analysis was conducted for EPO50%QHD melt extrudate powders after 
storing them under two stress conditions i.e. 0% relative humidity,25oC and 50% 
relative humidity,4oC for seven, fourteen and twenty eight days. Figure 5.43 shows the 
release profile of quinine hydrochloride when EPO50%QHD melt extrudate powders 
were exposed to 0% relative humidity, 25oC, while Figure 5.44 shows release after 
storage at 50% relative humidity, 4oC. In both cases the release profile of quinine 
hydrochloride remains unchanged across both time and stress condition hence 
suggesting that the EPO50%QHD melt extrudate remain stable for up to twenty eight 
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FIGURE 5. 43 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 50%QHD MELT 
EXTRUDATES AFTER STORAGE AT 0% RELATIVE HUMIDITY AND 25
O
C FOR SEVEN, FOURTEEN AND TWENTY 
EIGHT DAYS (N=3, ?̅?±SD). 
 
 
FIGURE 5. 44 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 50%QHD MELT 
EXTRUDATES AFTER STORAGE AT 50% RELATIVE HUMIDITY AND 4
O
C FOR SEVEN, FOURTEEN AND TWENTY 
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Figure 5.45 shows the release profile of quinine hydrochloride from EPO70%QHD melt 
extrudate powders after exposure to ageing conditions of time, temperature and 
humidity i.e. 0% relative humidity and 25oC. Notably, there is a 50% increase in the 
release of QHD after seven days, and expectedly this release rate continues through to 
twenty eight days. This is consistent with thermal analysis which showed that after 
seven days the thermal behaviour of EPO70%QHD largely mirrors that of unprocessed 
QHD. This difference is confirmed by a one-way ANOVA (p= 8.28). 
 
FIGURE 5. 45 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 50%QHD MELT 
EXTRUDATES AFTER STORAGE AT 0% RELATIVE HUMIDITY AND 25
O
C FOR SEVEN, FOURTEEN AND TWENTY 
EIGHT DAYS (N=3, ?̅?±SD). 
 
Similarly, the release profiles of quinine hydrochloride dihydrate from EPO70%QHD 
melt extrudates were analysed after they were stored at 50% relative humidity and 4oC 
for seven, fourteen and twenty eight days. The results of these release profiles are 
given in Figure 5.46. Interestingly, there is an approximate 50% increase in the release 
of QHD at day fourteen and twenty days in comparison to the fresh samples. At seven 
days, the release rate is similar to that of the fresh samples. This difference is 
































QHD release profile from EPO70% QHD after 
storage at 0% relative humidity and 25oC 
Fresh day 7 day 14 day 28
CHAPTER 5 TASTE ASSESSMENT OF QUININE HYDROCHLORIDE 
268 
 
more interesting is that in Table 5.6 DSC thermograph of EPO70%QHD stored at 50% 
relative humidity and 4oC suggests that QHD in this form is undergoing 
recrystallisation. In addition, it would appear at these conditions the relaxation of 
quinine hydrochloride is somewhat retarded. This is not evident in the release profile. 
An explanation for this observation is suggested in section 5.4.3. 
 
FIGURE 5. 46 RELEASE OF QUININE HYDROCHLORIDE FROM TASTE MASKED EPO® 50%QHD MELT 
EXTRUDATES AFTER STORAGE AT 50% RELATIVE HUMIDITY AND 4
O
C FOR SEVEN, FOURTEEN AND TWENTY 
EIGHT DAYS (N=3, ?̅?±SD). 
 
After 120 minutes, the solutions from EPO30%QHD and EPO50%QHD were then 
tested on the Insent TS500Z electronic tongue and the results are shown the  
Figures 5.47 and Figure 5.48 respectively. These figures show sensor response for 
each of the melt extrudates under the different stress conditions. What is worth noting 
is that a one-way ANOVA showed there is no statistically significant difference in 
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FIGURE 5. 47 RELATIVE SENSOR RESPONSE CURVE OF EPO50%QHD EXTRUDATES DISSOLVED IN DE-




FIGURE 5. 48 RELATIVE SENSOR RESPONSE CURVE OF EPO50%QHD EXTRUDATES DISSOLVED IN DE-
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The sensor response curve of EPO70%QHD melt extrudates after testing on the 
electronic tongue is shown in Figure 5.49. What is evident from this graph is that there 
is a clear dose response observed with the ageing of the samples. This is confirmed 
via a one-way ANOVA (p= 0.73). Contrary to the trends observed for EPO30% and 




FIGURE 5. 49 RELATIVE SENSOR RESPONSE CURVE OF EPO70%QHD EXTRUDATES DISSOLVED IN DE-
IONISED WATER, SHOWING SENSOR RESPONSES AS A FUNCTION OF CONCENTRATION (N=3, ?̅?±SD). 
 
SUMMARY OF RESULTS 
This section sought to describe the taste masking efficacy of the Eudragit®EPO melt 
extrudates using a modified dissolution apparatus in conjunction with 
spectrophotochemical analysis. The Insent® electronic tongue was also used as basis 
of comparison. The first major observation was that less than 10% of QHD was 
released from EPO30%QHD, EPO50%QHD and EPO70%QHD after three minutes. In 
comparison, the corresponding physical mixtures all released 10 -20% in the first three 
minutes of sampling. The EPOQHD melt extrudates had more than50% reduction on 
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absence of polymer) was released within the first three minutes of sampling. What is 
also clear is that after two hours in the dissolution medium, up to 60% of QHD is 
released from the melt extrudates while 100% is released from the physical mixtures. 
Further analysis of the melt extrudates on the electronic tongue showed that there was 
no significant difference with increasing time. This suggests that even though QHD 
could be detected spectrophotochemically the amounts released were below the 
detection of the electronic tongue. This observation applied to EPO30%, 50% and 70% 
QHD. 
 
Analysis of the release profiles of QHD from the melt extrudate after stress condition of 
temperature and humidity was also examined.  The release profiles of QHD from 
EPO30%QHD  and EPO50%QHD melt extrudates did not change with increasing time 
despite exposure to both 0% relative humidity, 25oC and 50% relative, 4oC. However, 
EPO70%QHD showed interesting behaviour. In the first instance, EPO70%QHD stored 
at 0% relative humidity and 25oC showed a statistically significant release compared to 
fresh samples after seven days. This release was the same right through to twenty 
eight days. In contrast, EPO70%QHD stored at 50% relative humidity and 4oC, showed 
similar release rates between the fresh samples and those analysed after seven days. 
The picture after fourteen days was statistically different as the melt extrudates’ release 
rate mirrored that of the physical mixtures. In both cases, 100% of QHD was released 
at day twenty eight. 
 
5.4 DISCUSSION 
5.4.1 CHARACTERISATION OF QUININE HYDROCHLORIDE DIHYDRATE 
The initial objective of the work described in this chapter was to characterise quinine 
(Qn), quinine hydrochloride dihydrate (QHD) and quinine hemisulphate dihydrate 
(QhS) with a view to describe the similarities and / or differences between the salts. 
The initial characterisation focussed on the crystallinity of the quinine and its salts. The 
PRXD diffractograms of quinine, quinine hydrochloride dihydrate and quinine 
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hemisulphate are given in Figures 5.1, 5.2 and 5.3 respectively. The first observation to 
report is that all quinine molecules show distinct peaks which therefore can be 
interpreted as being crystalline. The most prominent peak positions observed are 8o for 
QHD and 18o for Qn and QhSD. Quinine hydrochloride dihydrate has four other peaks 
at 12o, 18o, 22o and 28o. Quinine also has four other peaks at 6o, 8o, 12o and 20o. 
Quinine hemisulphate dihydrate has three other peaks at 8o, 22 and 26o. Based on 
these observations it can be concluded that all three quinine molecules are crystalline 
in nature. 
 
Very little was found in the literature pertaining to the thermal characteristics of the 
quinine molecules. Hence in keeping with the objective to characterise quinine, quinine 
hydrochloride dihydrate and quinine hemisulphate dihydrate, their comparative DSC 
thermographs are shown in Figure 5.12. What is clear from this figure is that quinine 
only has one transition i.e. a melt with onset at 177oC. Quinine hydrochloride dihydrate 
and quinine hemisulphate dihydrate both exhibit a similar broad endotherm with onset 
at 45oC. The corresponding TGA analysis suggests that this endotherm corresponds to 
water loss. Quinine hemisulphate then shows one further transition corresponding to a 
melt with onset at 228oC. Quinine hydrochloride dihydrate show interesting thermal 
behaviour in that following on from the broad endotherm ascribed to water loss, it 
undergoes a melt (onset at 135oC), recrystallisation (onset at 171oC),melt (onset at  
221oC). These transitions are observed on the DSC traces as well at the hot stage 
images shown in Figure 5.14. This was an unanticipated finding. Reports in the 
literature have stated that the melting point of quinine hydrochloride dihydrate was 115-
116oC. It is possible that the melting point reported in the literature refers the loss of 
water which has been illustrated by DSC, TGA and HSM. What is clear, especially via 
HSM is formation of a different crystal after the loss of water. In addition, it is also clear 
that the second crystal melts at temperature over 200oC. The most important finding in 
this analysis aided to selection of quinine hydrochloride dihydrate as model drug for 
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formulation of Eudragit® QHD extrudates. Quinine and quinine hemisulphate dihydrate 
were not suitable for this formulation because their melt onset were at 177oC and 
221oC respectively, which would mean that processing temperatures would need to be 
excessively high i.e. approximately 190oC and 230oC. It is worth mentioning that at 
180oC Eudragit® EPO begins to burn, this is say it undergoes substantial discoloration. 
The TGA trace of Eudragit® EPO (Figure 5.31) shows a weight loss with onset 
approximately 178oC, which could be ascribed to degradation. This observation has not 
been previously reported in the literature. Conversely, quinine hydrochloride dihydrate 
(QHD) had a melt with onset 135oC therefore this provided the lowest possible 
processing temperature hence QHD was selected as model drug for extrusions. It also 
noteworthy to remind the reader that all three drug were detectable on the Insent® 
TS5000Z electronic tongue hence they were selected in the first instance. 
 
As already alluded to, anhydrous quinine hydrochloride dehydrate melts and then 
recrystallizes. With this in mind the processing temperature for the hot melt extrusion 
was set at 140oC. This was because at this temperature the anhydrous form of quinine 
hydrochloride is molten and this temperature is prior to the recrystallisation which has 
onset temperature at 171oC. For Eudragit® EPO 70%QHD a processing temperature 
of 160oC, this was because processing at 140oC resulted in high torque values 
therefore temperature was increased negated this issue and additionally this 
temperature was below the onset of the recrystallisation. 
With regards to the crystallinity of Qn, QhS and QHD, it is clear from the both the 
PXRD and SEM images that all the molecules are crystalline in nature. Interestingly, 
the positioning of the peaks on the PXRD diffractograms was similar across the three 
molecules, however the intensity differed. This significance of this is not apparent at 
this stage and is outside the scope of this study; however an investigation using 
crystallography techniques would offer substantial information particularly when 
comparing the native crystal with that formed following dehydration in the case of 
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quinine hydrochloride. Even more interesting would be to understand the crystal 
behaviour of the anhydrous form and how this influences its thermal properties 
particularly how easily it reverts back to the hydrated form. 
 
5.4.2 CHARACTERISATION OF EUDRAGIT®EPO – QHD 
The second objective of the work detailed in this chapter sought to characterise the 
form of quinine hydrochloride dihydrate present in the EPO-QHD melt extrudates. In 
addition to this an analysis of the miscibility between API and polymer is also 
described. An investigation into the thermal stability of this form was investigated. This 
was done by exposing each extrudate concentration to 0% relative humidity, 25oC, 
50% relative humidity, 4oC and 75% relative humidity, 40oC. 
 
What is abundantly clear from the thermal analysis is that the low drug loading 
concentration i.e. EPO10%QHD is not affected by these stress conditions. On the 
other end of the spectrum, the EPO 70%QHD is vastly affected by the stress 
conditions, hence reverting back to hydrated form of quinine hydrochloride when tested 
after seven days. In addition, these powders congealed into a compact mass to the 
point where any downward investigations where not possible without further processing 
of the sample i.e. further grinding. In this study, this was not attempted because as 
highlighted in chapter 2, section 2.4.3, milling generates heat therefore this heat could 
alter the thermal character of the stored sample and as such give significantly different 
results. This limitation was more apparent for PXRD, were the holding pans for the 
Rigaku miniflex 600 required at least 1g of sample for processing. Therefore, future 
considerations could side step this limitation by casting in situ. This is to say, the 
samples for Eudragit® EPO70%QHD can be stored in the sample holders while under 
the stress conditions. Of course, caution needs to be taken to ensure that the sample 
holders (which are usually made from aluminium) do not degrade and interact with the 
samples to be investigated. An attempt was made to mount the congealed mass onto 
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the PXRD sample holder; however the resulting diffractogram showed that this 
ordering of the molecules was not detectable. 
 
Another interesting observation is that fresh samples of EPO30%QHD, EPO50%QHD 
and EPO70%QHD have PXRD diffractograms that clearly show crystallinity. This 
observation has not been reported in the literature. In addition, exposure to stress 
conditions does not result in alteration in the crystallinity of all three EPO-QHD 
extrudates. DSC traces of these extrudates also confirm crystallinity. This is also 
supported by HSM. This result is encouraging in that it shows that at these 
concentrations the EPOQHD extrudates are stable for up to twenty eight days.  
ESTIMATION OF DRUG POLYMER MISCIBILITY 
The issue of thermodynamic miscibility between quinine hydrochloride dihydrate and 
Eudrgit® EPO can be predicted using the Hansen solubility parameters (δ) of drugs 
and polymer. This is calculated from their respective chemical structures using the van 
Krevelen and Hoftyzer methods described in Equations 5.1 and 5.2. The total solubility 
parameter (δt) is determined from the interactions between dispersive forces (δd), polar 
interaction (δp) and hydrogen bonding (δh) of the functional groups in the parent 



























where Fdi, Fpi, and Ehi are the group contribution of different components i.e. dispersive 
forces, polar interactions and hydrogen bonding respectively of the structural groups 
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reported in the literature. The Hansen solubility parameter (δ) for each component as 
reported in the literature is given in Table 5.10 
TABLE 5 10 GROUP CONTRIBUTIONS TO HASSEN SOLUBILITY PARAMETERS FOR QUININE 











CH3- 33.5 1.125 
-CH2< 16.1 1.18 
-CH- -1.0 820 
>C< -19.2 350 
-OH 10.0 7120 
-O- 3.8 800 
N= 4.5 2000 
Cl- 24.0 2760 
Eudragit® EPO CH3- 33.5 1.125 
-CH2< 16.1 1.180 
N- 6.7 5850 
COO-ester 18.0 4300 
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The drug-polymer parameter, χ, using the solubility parameters difference between the 
drug and the polymer, can be estimated as follows, 







where 𝑉𝑜 is the volume of the lattice site, R is the gas constant and T is the absolute 
temperature (oK). The Hansen solubility parameter (δ) for each component, the 
difference between drug and polymer (Δδ) and the interaction parameter are given in 
Table 5.10. If drug and polymer have similar values of solubility parameter, i.e. Δδ < 
7.0 MPa1/2 they are more likely to be miscible. However, if Δδ > 10.0 MPa1/2 this 
suggests that the compounds are more likely to be immiscible (Greenhalgh et al. 1999). 
Δδ = 3.7 therefore this implies that quinine hydrochloride dihydrate and Eudragit® EPO 
are miscible. If the drug-polymer parameter is closer to zero then this suggests greater 
interaction between drug and polymer (Van Krevelen et al. 2009b). In this case χ = 
0.396 which is closer to zero therefore suggesting that there is interaction between 
drug and polymer. Results of these calculations are shown in Table 5.11. 
TABLE 5 11 CALCULATED SOLUBILITY PARAMETERS AND INTERACTION PARAMETERS USING THE HANSEN 
GROUP CONTRIBUTION THEORY FOR QUININE HYDROCHLORIDE DIHYDRATE AND EUDRAGIT®EPO 
Compound δ (MPa1/2) Δδ (MPa1/2) χ 
Quinine hydrochloride dihydrate 13.85 3.7 0.396 
Eudragit®EPO 10.15 
 
5.4.3 TASTE ASSESSMENT OF EUDRAGIT®EPO – QHD 
The final objective of the work detailed in this chapter was to assess the taste masking 
effect of the EPO-QHD melt extrudates. A modified dissolution apparatus was used, 
the first modification was to reduce the volume of the dissolution medium. As 
previously illustrated the conventional 900ml volume is inappropriate for taste 
assessment as this volume mimics stomach contents rather that salivary volume in the 
oral cavity. 90ml was used in this study which was the minimum volume to allow for 
downward testing on both the electronic tongue and the UV spectrometer. Of course, 
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this volume is still not a true representative of volume present in the oral cavity, but is a 
step in the right direction towards making the volume used appropriate. De-ionised 
water was used as a solvent. Although, it could be argued that in order to mimic the 
oral cavity, then the solvent used should also mimic saliva. However, in chapter 1, it is 
highlighted that saliva is composite mixture of 99% water, salivary enzymes and 
buffering salts, which thus far has been difficult to formulate. In this study the use of de-
ionised water is justified by the fact that a) water is the major constituent of saliva and 
b) use of buffering salts would affect the detection capability of the electronic tongue. 
 
In this study in order to assess the taste masking efficiency of EPOQHD melt 
extrudates the concentration of drug release was measured initially at three minutes. 
This sampling time was chosen for practical operational reasons. Lee at al (2012) used 
a sampling time of two minutes while the FIP/AAPS guideline recommended five 
minutes. Since a single operator was operating the Incu® shaker, UV 
spectrophotometer and the Insent® electronic tongue, the sampling time was selected 
to allow a single operator to manage all three pieces of equipment simultaneously. 
According to FIP/AAPS taste masking guideline, a drug release of ≤ 10% within the first 
five minutes of dissolution indicates successful taste masking  
(Siewert et al. 2003a). The most clinically relevant finding from this study showed that 
the melt extrudates produced with drug loadings 30%, 50% and 70% all released 5.6%, 
5.7% and 5.4% quinine hydrochloride respectively within the first three minutes. It is 
worth pointing out that although this guideline primarily addresses orodispersible 
preparations, it is the only guideline currently available in the literature relating to taste 
masking assessment. Therefore, the melt extrudates have demonstrated successful 
taste masking. This is further supported using the electronic tongue where the sensor 
responses are no statistically different to water when samples are tested after three 
minutes. 
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Another finding from the taste assessment showed that the EPO-30%QHD and  
EPO-50%QHD release profiles did not change with time, humidity or temperature. This 
observation mirrored the results also shown via PXRD diffractograms and DSC 
thermographs. EPO-70%QHD however had two different release profiles depending on 
the storage conditions. In the first instance when these melt extrudate were stored at 
0% relative humidity and 25oC, the release rate matched that of the physical mixtures 
after seven days thus releasing 18% QHD after three minutes. In contrast the  
EPO-70% QHD melt extrudate powders which were stored at 50% relative humidity 
and 4oC released 5.6% after seven days, a percentage that similar to the fresh 
samples. However, after fourteen days, the amount of quinine hydrochloride released 
at the three minutes sampling time was similar to the physical mixture therefore 
releasing 41.4% quinine hydrochloride. It appears that when stored to 50% relative 
humidity and 4oC, the EPO70%QHD is stable for up to seven days. At this stage it is 
unclear as to when the form of quinine hydrochloride reverts back to resemble its 
untreated counterpart because analysis was only done to day seven and day fourteen. 
Therefore, further investigation is required between those days to establish this. 
 
A question that still remains to be discussed pertains to the relation between the 
crystalline nature of an API in a formulation and how that translates to taste masking 
ability of the same. The perception of the taste is dependent on the dissolution of the 
drug from the formulation. A literature review has looked at the issue of dissolution rate 
(Craig 2002). Essentially two mechanisms are identified. Carrier controlled and drug 
controlled systems. In the former, the dissolution rate of the drug is controlled by 
dissolution rate of the inert carrier which therefore implies the physical properties of the 
drug have no influence in the process. The other mechanism, drug –controlled 
dissolution so called because the dissolution rate is defined by the characteristics of 
the drug i.e size and physical form among others. In this study, the polymeric carrier 
used i.e. Eudragit®EPO is insoluble in water therefore it is highly unlikely that the 
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carrier controlled system is in play. Therefore, by default the dissolution mechanism is 
drug controlled. However, regardless of the dissolution mechanism, two factors are 
clearly important when discussing taste masking i.e. the proportion of API that is 
released within the residence time of the formulation within the oral cavity and the 
intrinsic taste of the API in question. At present, there is no consensus in the literature 
regarding both issues. A logical approach would suggest that the proportion of API 
released should vary in accordance with API. This is because each API has a 
difference detection threshold in humans. For example, human detection thresholds of 
quinine hydrochloride and caffeine are 0.0083±0.001mM and 1.2±0.12mM respectively 
(Keast et al. 2007).  Therefore, the proportion of drug released should mirror the 
detection profile of the API. Using the example of the quinine and caffeine, quinine is 
one thousand time more detectable than caffeine which therefore 10% of quinine 
released should not be equated to 10% caffeine. This may not always be possible 
because unlike the APIs used in this study, in most cases the detection threshold of the 
drug under investigation is unknown. Therefore, it is reasonable to use 10% when 
considering in-vitro methods of taste assessment; however formulators should be 
prepared to adjust taste masking strategies when translating to human taste panel. 
 
5.5 CONCLUSION 
The thermal characterisation of quinine, quinine hydrochloride dihydrate and quinine 
hemisulphate dihydrate has shown that all three molecules are crystalline in nature. 
The first major finding from this analysis has shown that quinine hydrochloride 
dihydrate undergoes dehydration (range 48 – 102oC). This is followed by melting of the 
anhydrous form which has onset at 135oC. Recrystallisation occurs at onset 
temperature 168oC, while the final melt has onset 232oC. The dehydration, melt, 
recrystallisation and melt of quinine hydrochloride have not been reported in the 
literature. In addition, this finding contradicts previous reports in the literature which 
suggested that the melting point of quinine hydrochloride dihydrate was 115-116oC. 
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The thermal behaviour of quinine and quinine hemisulphate dihydrate were both 
consistent with reports in the literature, although literature does not highlight the 
dehydration of quinine hemisulphate dihydrate. The implications of this finding indicate 
that were quinine hydrochloride dihydrate is being heat treated in order to form a solid 
dispersion, researchers need to be mindful of the resultant form of the quinine 
hydrochloride present in the solid dispersion as this study suggests that there are three 
different forms. A number of caveats are apparent from this study. The first one 
involves the issue examining the effect of different heating on formation of the 
anhydrous and subsequent forms of quinine hydrochloride. The other involves the 
characterisation of each of these forms using crystallography techniques with the aim 
of establishing the crystal habit similarities and differences if any between the forms of 
quinine hydrochloride dihydrate. 
 
In addition to the characterisation of quinine and its salts, this study also characterised 
melt extrudates of Eudragit® EPO and quinine hydrochloride dihydrate. The most 
obvious finding to emerge from this study was that melt extrudate were successfully 
produced for 10, 30, 50 and 70% drug loadings. The freshly prepared 30% and 50% 
EPOQHD melt extrudate were shown to be crystalline and that the extrudate quinine 
hydrochloride existed in the dehydrated form. EPO70%QHD however reverted back to 
the hydrate after seven days of storage while the EPO30% and 50% remained 
dehydrated for up to twenty eight days. The PXRD diffractogram of EPO70%QHD did 
not match that of unprocessed QHD. This suggests that at the processing parameters 
used in this study EPO70%QHD may have a form that is different from that of pure 
quinine hydrochloride dihydrate. It is also clear that melt extrudates have different 
thermal behaviour in comparison to their physical mixture counterparts. 
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Another major objective of the work presented in this study was to analyse the taste 
masking efficacy of Eudragit®EPO quinine hydrochloride dihydrate extrudates in 
comparison to the same physical mixtures. The melt extrudates produced in this study 
all released ≤10% of quinine hydrochloride in the first three minutes of sampling. In 
addition the EPO-30% and 50% QHD melt extrudates continued to release less than 
10% for up to and including twenty eight days. The EPO-70%QHD was only stable for 
fourteen days before the release profile began to match that of the physical mixtures. 
When analysing the fresh melt extrudates on the electronic tongue, there was no 
difference to the responses of water, therefore suggesting that the quinine 
hydrochloride was not detectable at these concentrations, therefore also suggesting 
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CHAPTER 6 – CONCLUSION AND FUTURE WORK 
The publication of the European Paediatric Regulation (EC No. 1901/2006) that 
came into effect in January 2007 brought the taste and taste assessment to the 
forefront once again. This regulation requires the early submission of a 
pharmaceutical development plan for medicines: a paediatric investigation plan 
(PIP). The applicant is required to provide an overview of planned measures / 
performed studies of which taste masking and assessment are of particular 
relevance. Therefore, there has been an increased interest in the development 
of objective taste assessment methods. An overview of these taste assessment 
methods has been described in chapter 1. The main research objective 
presented here was to further the understanding of the mechanism of detection 
of the Insent electronic tongue TS 5000Z (a commercially available electronic 
tongue manufactured by Insent Japan). In addition, this research also set out to 
understand the utility of this electronic tongue in formulation development. 
Finally the taste masking efficacy of hot melt extrudates was assessed using 
the electronic tongue as well as UV spectrophotochemical techniques both of 
which are described in chapter 2. 
 
Although the utility of electronic tongues in validating taste masking strategies is 
widely reported in the literature, very little is published concerning the 
mechanism of detection. The aim of the preliminary work detailed in chapter 3 
was to investigate the detection capability of the electronic tongue. The chapter 
detailed the investigation of the molecules with similar structures and 
demonstrated that caffeine, theobromine and theophylline were not detectable 
on this electronic tongue a finding which remains unpublished. In addition, the 
investigation of quinine, quinine hydrochloride dihydrate and quinine sulphate 
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revealed differences in sensor response for each molecule although they all 
possessed the same parent (quinine) molecule, another finding that is yet to be 
published. A comparison of the responses of quinine hydrochloride dihydrate 
and quinine sulphate to those of hydrochloric and sulphuric acid respectively, 
showed a similar pattern of response with a difference in magnitude. It was 
suggested that the difference observed can be attributed to the ionisation / 
dissociation profile of the API. Essentially, strong acids exhibit complete 
dissociation in solution therefore show a greater response on the electronic 
tongue and vice versa is true. The investigation of paracetamol and ibuprofen 
showed that these two APIs were not detected. In contrast, ibuprofen sodium 
and metformin hydrochloride were both detectable further supporting the 
ionisation/ dissociation profile theory. These findings have not been reported in 
the literature and furthermore, they contradict the adsorption theory suggested 
by Kobayashi et al 2010. However, they support the electro-chemical theory 
suggested by Woertz et al 2010 but further elucidates the understanding of the 
mechanism by also taking into consideration not only the molecule to be 
detected but also the solvent in which it is present.   
 
A key concern that emerged during the course of the work detailed in chapter 3 
was the issue that the sensors registered a response for placebo including de-
ionised water. The results from the work in chapter 3 suggest that it is 
necessary to conduct sensor response studies using increasing concentrations 
of API under investigation. This is because the sensors are calibrated to record 
0mV using a reference solution composed of 0.03mM tartaric acid and 3.0mM 
KCl (as per manufacturer’s recommendation and design), therefore any other 
solution / solvent used would register a reading (mV) that would deviate from 
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this reference. That being the case, it is therefore important that sensor 
response curves be constructed initially in order to establish the true sensor 
response of the solution under investigation. Furthermore, during analysis the 
sensor response for the placebo should be accounted for. In chapter 4 of this 
thesis, the placebo response has been subtracted from the overall response 
recorded therefore the responses reported only relate to API and excipients  
(if any). 
 
The generalizability of these results is subject to certain limitations. For instance, 
although the study has successfully demonstrated that the detection 
mechanism is reliant on the ionisation / dissociation of the API and the solvent 
in which the API is dissolved, the issue of pH has not been fully explored. The 
pH of the resultant solutions was measured in order to allow for the use of the 
Henderson-Hasselbalch equation in order to understand the proportion of API 
that is ionised to that is unionised. Further research needs to examine more 
closely the impact of detection capability when the pH of the solution is varied 
because varying the pH of the solution will obviously affect the proportion of API 
that is ionised and that which is unionised. It goes without saying that this 
further experimentation needs to take into account that the use of any buffering 
solution to maintain pH may not only affect the API under investigation but the 
salts used to make buffer (which are generally ionic) will also be detectable. In 
addition to use of strong acids or strong alkali to obtain extremes of pH will not 
only affect sensor detection but may more than likely also affect sensor integrity 
since these are lipid based sensors. Therefore, care will need to be taken 
during the analysis to ensure that the sensor response under investigation only 
represents the tastant molecule rather than the buffering solution used as a 
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solvent. Caution will also need to be taken in order to maximise sensor integrity 
and this will not only affect detection capability but will also result increased 
consumable overheads. 
 
In chapter 4, a “real life” application of the electronic tongue is presented in the 
form of an investigation of taste assessment of amlodipine (base), amlodipine 
besilate, maleate and mesilate using the electronic tongue. One of the more 
significant findings to emerge from this study is that the electronic tongue 
predominantly and consistently identifies astringency as the major descriptor of 
all the amlodipine salts. It would appear that amlodipine free base can be 
described in terms of basic and acidic bitterness while its salts are all described 
in terms of astringency. These findings are unique for several reasons. Firstly, 
this study has shown a difference in response patterns between amlodipine free 
base and its salts. It is clear the presence of cationic amlodipine and anionic 
besilate and maleate ions affects the detection profile, which further cements 
mechanism described in chapter 3. Secondly, the work reported in chapter 4 
has also shown that in addition to considering the dissociation profile of the salt 
forms, it is also important to consider the size of the resulting moieties. In the 
case where the cation is considerably larger than the corresponding anion, then 
more anions interact with the sensors therefore showing large response. Of 
course, this observation should be treated with caution because the interaction 
between the positively charged sensor and anions is an unusual occurrence in 
nature. This is to say that in nature most biological membranes are negatively 
charged therefore naturally expectation for positively charged ions would 
interact with them. 
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The third major observation from chapter 4 showed a difference in response 
patterns between the two negatively charged sensors, particularly when 
considering amlodipine free base. A clear reason could not be identified for this 
phenomenon which has not been reported this far. However, it is possible that 
the possibly different orientation of the lipids on the two sensors could be 
attributed to the difference in sensor response. With respect to the electronic 
tongue, the amlodipine besilate salt was identified as having the least 
palatability in comparison to the other amlodipine salts. Results from the 
electronic tongue showed that F1 formulations were the least palatable 
formulations, however, it was not possible to statistically distinguish between F2 
and F3 formulations.  
 
The final and most significant result reported in chapter 4 is that a strong 
positive correlation was observed between the electronic tongue scores and 
those from the human taste panel when considering F1, F2 and F3 formulations 
of amlodipine besilate and mesilate. This finding adds to the limited body of 
evidence showing correlation between human taste and electronic tongue. 
Although this is a significant finding, these results need to be treated with 
caution as only amlodipine besilate and mesilate were investigated and 
furthermore a small sample size (n= 24) was used. Therefore, further research 
is required on different APIs and larger sample sizes in the human panels 
before suggestions that electronic tongue can replace human taste panels can 
be scientifically proven. 
 
In chapter 5, the first objective was to characterise quinine, quinine 
hemisulphate dihydrate and quinine hydrochloride dihydrate using thermal 
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characterisation techniques with view of using this analysis to guide the 
selection of which quinine salt to use in the hot melt extrusion. The first major 
finding from this work showed that the quinine hydrochloride dihydrate had a 
number of transitions i.e. broad endotherm (onset 45oC, ascribed to water loss), 
melt exotherm (onset 135oC), recrystallisation exotherm (onset - 168oC) and 
melt exotherm (onset 232oC). This finding contradicts previous reports in the 
literature which suggested that the melting point of quinine hydrochloride 
dihydrate was 115-6oC. This study adds to our knowledge on the dehydration of 
quinine hydrochloride dihydrate which is crucial particularly from a stability point 
of view. In addition the existence of a dehydrate form and subsequent melt and 
recrystallisation play a vital role in decision making with regards to temperature 
selection for the hot melt extrusion process. Other findings confirmed the 
melting points of quinine and quinine hemisulphate dihydrate to mirror those 
reported in the literature. It is important to note that quinine hemisulphate 
dihydrate also undergoes dehydration. Further work needs to be conducted on 
two fronts. The first one would focus on looking at the stability of dehydrate 
forms of quinine hemisulphate and quinine hydrochloride using crystallography 
techniques with a view of adding to our understanding of behaviour of hydrates 
and their dehydrate forms. Included in this could be explanations focussing the 
binding of water i.e. free water or otherwise. The second would zone in on the 
secondary form of quinine hydrochloride which is formed post melt and 
recrystallisation. Again, crystallography techniques could shed light on the 
identity of this crystal, which could potentially lead to identification of a novel 
crystal form of quinine hydrochloride. 
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Having decided to use quinine hydrochloride dihydrate as the API for producing 
melt extrudates using Eudragit®EPO, this study can report that it was possible 
to produce melt extrudates with drug loadings of 10%, 30%, 50% and 70% w/w. 
The next objective then set out to characterise these melt extrudates with a 
view of describing the form of quinine hydrochloride present in these extrudates. 
In addition, characterisation was conducted on melt extrudate powders after 
exposing them the stress of temperature, humidity and time. The work 
presented in chapter 5, section 5.3.4.1 and 2 showed that it was possible to 
produce extrudate of Eudragit®EPO and quinine hydrochloride with drug 
loading at 10, 30, 50 and 70%. In addition, EPO10%, 30% and 50% QHD all 
demonstrated amorphous nature when analysed using PXRD. EPO70%QHD 
however showed crystallinity even when fresh. Interestingly, the PXRD 
diffractogram for EPO70%QHD did not match that of unprocessed hence 
suggesting the presence of the different crystal. This was mirrored by the DSC 
thermograph which showed a broad exotherm (onset 205oC) ascribed to 
recrystallisation. This is a significant observation which remains to be published. 
Although, the identification of this crystal was not in the scope of this thesis, it 
would be interesting to do so and lead to reporting of a novel crystalline form of 
quinine hydrochloride. It is also worth noting that even though the generalised 
amorphous halo shown for 30 and 50% drug loading represents the amorphous 
nature of the polymer, however the drug remains crystalline as shown by the 
DSC thermographs and HSM images. 
 
The final objective of chapter 5 presented in section 5.was to assess the taste 
masking efficacy of the melt extrudates using a dissolution method designed to 
mimic the oral mucosa. The most clinically relevant finding from this study 
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showed that the melt extrudates produced with drug loadings 30%, 50% and 
70% all released 5.6%, 5.7% and 5.4% quinine hydrochloride respectively 
within the first three minutes. The amount of drug released is less than 10% 
which is used as a benchmark in the AAPS/FIP taste masking guideline. It is 
worth pointing out that although this guideline primarily addresses 
orodispersible preparations, it is the only guideline currently available in the 
literature relating to taste masking assessment. Therefore, the melt extrudates 
have demonstrated successful taste masking. This is further supported using 
the electronic tongue where the sensor responses are not statistically different 
to water when samples are tested after three minutes. 
 
Another finding from the taste assessment showed that the EPO30%QHD and 
EPO50%QHD release profiles did not change with time, humidity or 
temperature. This observation mirrored the results also shown via PXRD 
diffractograms and DSC thermographs. EPO70%QHD however had two 
different release profiles depending on the storage conditions. In the first 
instance when these melt extrudate were stored at 0% relative humidity and 
25oC, the release rate matched that of the physical mixtures after seven days 
thus releasing 18% QHD after three minutes. In contrast the EPO70% QHD 
melt extrudate powders which were stored at 50% relative humidity and 4oC 
released 5.6% after seven days, a percentage that similar to the fresh samples. 
However, after fourteen days, the amount of quinine hydrochloride released at 
the three minutes sampling time was similar to the physical mixture therefore 
releasing 41.4% quinine hydrochloride. It appears that when stored to 50% 
relative humidity and 4oC, the EPO70%QHD is stable for up to seven days. At 
this stage it is unclear as to when the form of quinine hydrochloride reverts back 
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to resemble its untreated counterpart because analysis was only done to day 
seven and day fourteen. Therefore, further investigation is required between 
those days to establish this 
 
The work detailed in chapter 5, has highlighted that two factors are important 
when discussing taste assessment. These are 1) the proportion of API that is 
released within the residence time of the formulation within the oral cavity and 
2) the intrinsic taste of the API in question. At present, there is no consensus in 
the literature regarding both issues. A logical approach would suggest that the 
proportion of API released should vary in accordance with API. This is because 
each API has a difference detection threshold in humans. For example, human 
detection thresholds of quinine hydrochloride and caffeine are 0.0083±0.001mM 
and 1.2±0.12mM respectively. Therefore, the proportion of drug released should 
mirror the detection profile of the API. Using the example of the quinine and 
caffeine, quinine is one thousand time more detectable than caffeine which 
therefore 10% of quinine released should not be equated to 10% caffeine. This 
may not always be possible because unlike the APIs used in this study, in most 
cases the detection threshold of the drug under investigation is unknown. 
Therefore, it is reasonable to use 10% when considering in-vitro methods of 
taste assessment; however formulators should be prepared to adjust taste 
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A1 PREPARATION OF STANDARD SOLUTIONS 
All reference solutions were adapted from Insent TS5000Z (2008) manual. 
 A1.1 STANDARD REFERENCE SOLUTION 
0.0455g of tartaric acid was dissolved in about 900ml of deionised water. 
2.2452g of KCl was added to the tartaric acid solution and stirred until fully 
dissolved. The solution was transferred to a 1L volumetric flask and made up to 
the 1L mark using deionised water. 
A1.2 NEGATIVELY CHARGED MEMBRANE WASHING SOLUTION 
150ml of ethanol was added to 250ml of deionised water and stirred thoroughly. 
50ml of 1M hydrochloric acid solution was added to the ethanol and deionised 
water solution. Following thorough stirring the solution was transferred to a 
500ml volumetric flask and made to volume using deionised water. 
A1.3 POSITIVELY CHARGED MEMBRANE WASHING SOLUTION 
3.73g KCl was added to 250ml deionised water and stirred thoroughly. 150ml 
ethanol (99%) was added to the KCl solution and stirred thoroughly. 5ml of 1M 
KOH was added and again stirred thoroughly. The resulting solution was 
transferred to a 500ml volumetric flask and made to volume using deionised 
water. 
A1.4 SALTY REFERENCE SOLUTION 
0.00453g of tartaric acid was dissolved in about 900ml deionised water. 
22.368g of KCl was added to the tartaric acid solution and dissolved thoroughly. 





A1.5 UMAMI REFERENCE SOLUTION 
0.0458g of tartaric acid was added to about 900ml of deionised water and 
stirred thoroughly. 2.2525g of KCl was added to the tartaric acid solution. 
Following thorough stirring and full dissolution of KCl, 1.8694g of MSG was 
added to the KCl and tartaric acid solution and dissolved. The resultant solution 
was transferred to a 1L volumetric flask and made to mark using deionised 
water. 
A1.6 ASTRINGENT REFERENCE SOLUTION 
0.04427g of tartaric acid was dissolved in about 900ml of deionised water. 
2.4240g of KCl was added to the tartaric acid solution and stirred thoroughly. 
Finally, 0.4945g of tannic acid was added to tartaric acid – KCl solution. The 
resultant solution was transferred to a 1L volumetric flask and made to volume 
using deionised water. 
A1.7 BITTER (-) REFERENCE SOLUTION 
0.045g of tartaric acid was dissolved in about 900ml of deionised water. 2.24g 
of KCl was added to the tartaric acid solution and stirred thoroughly. Finally, 
100µl iso-α-acid was added and again stirred thoroughly. The resultant solution 
was transferred into a 1L volumetric flask and made to volume using deionised 
water. 
A1.8 BITTER (+) REFERENCE SOLUTION 
0.045g of tartaric acid was dissolved in about 900ml of deionised water. 2.24g 
of KCl was added to the tartaric acid solution and stirred thoroughly. Finally, 
0.04g quinine hydrochloride was added and again stirred thoroughly. The 
resultant solution was transferred into a 1L volumetric flask and made to volume 





A2 SCHEMATIC FOR PREPARATION OF F1 AND F2 FORMULATIONS 










A3.2 POSTER FOR PARTICIPANT RECRUITMENT 
 





We are carrying out a study to look at the taste of different 
amlodipine liquid formulations (a cardiovascular medicine) and are 
looking for some volunteers to help. 
If you are healthy and over 18– open wide and take part in our 
study! 
 
You will be asked to taste different samples for 5-20 seconds by 
2 methods and rate them on a scale. 
You will not be asked to swallow the liquid.  
Finding out which one tastes better could help children and older 
adults who need to take this medicine, but can’t swallow the 
tablets. 
If you would like to participate, or find out more about this study, 
please contact us:ucnvxdg@live.ucl.ac.uk or ucnvjk1@live.ucl.ac.uk  
and we will send you an information sheet. As a small thank you 
for your time and commitment, you will be entered into a draw 
to win a £10 gift voucher 
 
All data will be collected and stored in accordance with the Data Protection Act 1998. 
 
Principal Investigator: Dr Catherine Tuleu 
UCL School of Pharmacy 
29/39 Brunswick Square, London, WC1N 1AX 





A3.3 PARTICIPANT CONSENT FORM 
Participant’s Statement  
 
I       
 
 have read the notes written above and the Information Sheet, and understand what the study involves. 
 understand that I should not take part if I have had any dental care or medicinal treatment (except 
contraceptives) during the 15 days before the tests.  
 understand that if I decide at any time that I no longer wish to take part in this project, I can notify the 
researchers involved and withdraw immediately without penalty. 
 consent to the processing of my personal information for the purposes of this research study. 
 understand that the information I have submitted will be published as a report and I can request a 
copy by contacting the researchers. Confidentiality and anonymity will be maintained and it will not be 
possible to identify me from any publications. 
 understand that such information will be treated as strictly confidential and handled in accordance with 
the provisions of the Data Protection Act 1998. 
 agree that the research project named above has been explained to me to my satisfaction and I agree 
to take part in this study.  
 
Signed:         Date:       
 
Please complete this form after you have read the Information Sheet and/or listened to an explanation about the research.  
Title of Project: Amlodipine Palatability Assessment Study 
This study has been approved by the UCL Research Ethics Committee (Project ID Number): 4612/001 
 
Thank you for your interest in taking part in this research. Before you agree to take part, the person organising the 
research must explain the project to you. 
If you have any questions arising from the Information Sheet or explanation already given to you, please ask the 
researcher before you to decide whether to join in.  You will be given a copy of this Consent Form to keep and refer to 
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Abstract 
The first inter-laboratory testing of electronic taste sensing systems was performed 
within five participating centers, each working with the Insent (Insent Inc., Atsugi-Shi, 
Japan) e-tongue. Preparation of the samples for the comprised four experiments, 
shipping of the samples and evaluation of the results was performed at the University of 
Duesseldorf. The sensitivity (in this case the difference between lowest and highest 
sensor response) and slope of the regression line values, obtained within Experiment 1 
and 2, have been found to serve as applicable evaluation criterions for inter-laboratory 
comparability. Modified sensor responses could be attributed to aged sensors, but did 
not influence the results of either Experiment 3, dealing with the evaluation of film 
formulations, or Experiment 4, dealing with the evaluation of minitablet formulations, 
in a great amount. Presented PCA Score and Loading Scatter Plots as well as Euclidean 
distance patterns based on the raw sensor responses confirmed the comparable 





With regard to a better understanding of electronic taste sensing systems (e-tongue), the 
“e-tongue usergroup” was set up in 2012 on behalf of the European Paediatric 
Formulation Initiative (EuPFi). Besides theoretical knowledge, data experimentally 
obtained within this group should be discussed. First studies have now been set up to 
evaluate inter-laboratory comparability of Insent e-tongue results. The inter-laboratory 
testing was based on four different experiments, comprising the evaluation of 
concentration series as well as drug containing film and minitablet formulations. To 
ensure comparability, production of the samples and data evaluation was done in one 
center (University of Duesseldorf).  
2. Participants 
The Institute of Pharmaceutics and Biopharmaceutics at the University of Duesseldorf, 
(HHUD, Duesseldorf, Germany) guided the inter-laboratory experiment and was 
responsible for the sample preparation and the data evaluation. All investigated samples 
were shipped to the participating centers Novartis (Basel, Switzerland), the School of 
Pharmacy at the University College of London (London, England) and the company 
Insent Inc. (Intelligent Sensor Technology, Inc. Atsugi-Shi, Japan). Every center 
worked with the Insent taste sensing system (Atsugi-Shi, Japan). Novartis, the 
University College London and the company Insent used the system TS5000Z, while 
the University of Duesseldorf (HHUD) used the TS5000Z and the SA402B, both with 
different sensor sets. In total, the results of 5 participating centers were the basis of this 
study.  
Independent of the participating center, experiments with the TS5000Z were performed 
at ambient temperature. The samples measured with the SA402B at the HHUD were 
kept at 20 °C by water cooling. 
3. Materials and methods 
3.1 Chemicals 
Quinine hydrochloride was purchased by Caesar & Loretz (Hilden, Germany) and 
potassium chloride by Gruessing (Filsum, Germany). Each film formulation contained 
15 % (w/w) of the film forming agent hydroxypropyl methylcellulose (Pharmacoat® 
606, Harke Group, Mühlheim a. d. R., Germany), 10 % (w/w) ethanol (96 %, VWR 
international, Darmstadt, Germany), 7 % (w/w) of anhydrous glycerol and the coloring 




formulations A1 and B1 contained 3 % (w/w) of dimenhydrinate, and film formulations 
B1 and D1 were sweetened with 0.5 % of a 1:10 mixture of saccharin sodium:sodium 
cyclamate (both sweeteners purchased by Caesar & Loretz, Hilden, Germany). The 
minitablet formulations were prepared according to Stoltenberg based on the ready-to-
use tableting excipient Pearlitol® flash (provided by Roquette, Lestrem, France) 
(Stoltenberg, 2012). Minitablets A2, B2 and D2 contained 0.16 % (w/w) of zinc 
sulphate (Riedel-de Haen, Sigma-Aldrich, Seelze, Germany), minitablets A2, C2 and 
D2 contained 9.8 % of sodium chloride (analytical grade, VWR international, 
Darmstadt, Germany) and minitablets B2, C2 and D2 contained 18.5 % of a 1:10 
mixture of saccharin sodium:sodium cyclamate. 
The sample compositions reduced to the API and the taste-masking excipient(s) are 
summarized in Table 1. 
Table 1: Sample composition, reduced to the API and the taste-masking agents 
sample A1 B1 C1 D1 E1 F1 G1 
dimenhydrinate 100 mg 100 mg - - 100 mg 100 mg - 
saccharin sodium : sodium cyclamate 
(1:10) 
- 17 mg - 17 mg - 17 mg 17 mg 
sample A2 B2 C2 D2 E2 F2 G2 
zinc sulphate 20 mg 20 mg 20 mg - 20 mg 20 mg - 
saccharin sodium : sodium cyclamate 
(1:10) 
 23.1 mg 23.1 mg 23.1 mg - 23.1 mg 23.1 mg 
sodium chloride 12.25 mg - 12.25 mg 12.25 mg - 12.25 mg 12.25 mg 
 
3.2 Preparation of the film and tablet formulations 
To prepare the drug containing film formulations (film A1 and B1), dimenhydrinate 
(DMH) was dissolved in ethanol and added to a stirred water-glycerol mixture. To 
prepare film B1, the sweetener mixture was additionally added, while it was solely 
added to prepare film C1. To each of the solutions, the film forming agent was added 
stepwise. After 24 hours of continuous stirring, the viscous solutions were poured onto 
a release liner (Erichsen film applicator, Erichsen, Hemer, Germany) and casted 




The minitablets were compressed on a rotary die press (Pressima MX-Eu-B/D, IMA 
Kilian, Cologne, Germany) with 2 mm bi-concave punches. Prepared minitablets 
weighed 6.2 mg ± 0.26 mg. 
3.3 Electronic tongue measurements 
3.3.1 Standard and washing solutions 
Dependent on the incorporated artificial lipids, sensors should be dipped into either the 
(-)- or the (+)-washing solution. The (-)-washing solution was prepared by diluting 100 
mM hydrochloric acid with ethanol (30 % (w/w)) and used for sensors with negatively 
charged lipids. The (+)-washing solution was used for sensors with positively charged 
lipids and prepared by dissolving 100 mM potassium chloride and 10 mM potassium 
hydroxide in ethanol (30 % (w/w)). The standard solution, which served as cleaning and 
reference solution, was prepared by dissolving 0.3 mM tartaric acid and 30 mM 
potassium chloride in distilled water. 
3.3.2 General procedure 
Using the recommended measurement setup ABCABC (A, B, and C are representatives 
of sample beakers), the e-tongue measurement followed the standard procedure as 
described by (Woertz et al., 2010, 2011). The washing steps were conducted in the 
recommended (-)- or (+)-washing solution (see also section 3.3.3) as well as in the 
standard solution (preparation according to section 3.3.1). The whole measurement 
procedure was carried out 4 times in a row. Both, sensor responses and CPA (change of 
membrane potential due to adsorption) values were recorded.  
3.3.3 Specific procedure 
To measure the samples with all 7 sensors, two measurement cycles have to be 
performed. For the first measurement cycle, the outer sensor head was equipped with 
sensor SB2AC0 at position 1 and SB2AN0 at position 2. During the washing procedure 
these sensors dipped into the (-)-washing solution.  
After the first measurement cycle, the reference solution in the washing beakers was 
exchanged. For the second measurement cycle, the outer sensor head was then equipped 
with the sensors SB2AAE (position 1), SB2CT0 (position 2) and SB2CA0 (position 3), 




The sensors at the outer sensor head dipped into the (-)-washing solution, whereas the 
sensors at the inner sensor head dipped into the (+)-washing solution. 
3.4 Experiments 1 to 4 and sample preparation 
A solution of quinine hydrochloride (0.5 mM, 0.1985 g/l) served as external standard, 
which was placed in the first sample beaker position (position sample A) for every 
experiment. A serial dilution series of quinine hydrochloride was prepared in water 
(Experiment 1) and in an aqueous 10 mM KCl-solution (Experiment 2). For Experiment 
3, 20 films of each provided sample (A1-D1) and the according physical mixtures (E1-
G1) were dissolved in 100.0 ml of purified water at 37 °C in an ultrasonic bath. For 
Experiment 4, 20 minitablets of each provided sample (A2-D2) were stirred for 3 min in 
100.0 ml of purified water at 37 °C. To enable comparable filtration processes within 
the centers, the samples were immediately filtered through a paper filter, which was 
provided by the HHUD. The physical mixtures (E2-G2) were dissolved in 100.0 ml of 
purified water. 
3.5 Data evaluation 
The data was analyzed at the HHUD. For univariate evaluation and calculation of 
Euclidean Distances (Equation 1) based on the sensor signals, Excel 2010 (Microsoft, 
Redmond, US) was used.  
Equation 1: 𝑑 (p, q) = √∑ (𝑝𝑖 − 𝑞𝑖)2
𝑛
𝑖=1
     
The single sensor responses of the external standard solution were subtracted from the 
sensor responses of the different experiment samples. Multivariate statistics were 
performed with SIMCA-P 12.01 (Umetrics AB, Umea, Sweden). 
4. Results and Discussion 
4.1 Evaluation Experiment 1 and 2 (dilution series) 
A dilution series of quinine hydrochloride in water was analyzed to assess the 
performance of the Insent sensors, as it has already been shown by Woertz et al. that 
each sensor is sensitive towards changing quinine concentrations (Woertz et al., 2010). 
The model drug was moreover dissolved in aqueous KCl (10 mM), to judge about the 




were compared with regard to sensitivity (in this case the difference between the highest 
and the lowest sensor response), onset, log-linear range, slope and the corresponding 
coefficient of determination (R
2
) (Figure 1).   
 
Figure 1: Sensitivity, onset, log-linear range, slope and the corresponding coefficient of determination (R2) as 
indicators for sensor performance comparability. 
The results of the concentration series in water are summarized in Table 2 and 
highlighted in the figures therein. As expected, and independent of the evaluating center, 
the bitter sensors SB2AC0 and SB2AN0 show the highest sensitivity towards changing 
quinine concentrations. Considering the slope as further parameter to describe the 
sensitivity, sensor SB2AN0 can be defined as more sensitive towards changing quinine 
concentrations between 0.1 and 10 mM (Table 2, slope (mean ± s) = 42.3 ± 1.3). 
Although sensor SB2AC0 provides a slighter slope compared to sensor SB2AN0, it 
shows the larger log-linear range (0.001-10 mM, Table 2). Both findings are in good 
agreement to (Woertz et al., 2010). The other five sensors are comparably sensitive 
towards changing quinine concentrations, represented in similar sensitivity values as 
well as similar absolute slopes. Noteworthy in this context are the comparable responses 
of sensor SB2AE1, indicating a robust performance of this sensor type. Sensors 
SB2C00 of center 4 and 5 are marked with a * in Table 1, because the according sensor 
responses do not only increase with increasing concentrations like those of 1 to 3, but 
decrease again after reaching a concentration of 0.1 (center 4) or 1 mM (center 5). 
Contrary to the other sensor types, SB2C00 sensors also show differing log-linear 
ranges within the centers. 
Defining applicable evaluation criterions to judge about the inter-laboratory 




values have been selected for further investigation. Significance of different sensor 
behavior between the centers is proven based on the t-test for independent samples (α = 
0.05). In this context, sensitivity and slope values of each sensor in each center are 
compared with the corresponding average values. For inhomogeneous variations a 
correction of the t-value according to Welch has been considered. Moreover, the 
corresponding confidence intervals (α = 0.05) are calculated based on the mean 
sensitivity and slope values.  
Table 2: Sensitivity, onset, log-linear range, slope and the coefficient of determination (R2) as indicators for 
sensor performance; results are based on the concentration series in water; sensitivity and slope are 
highlighted in the figures on the right; the numbers in “sensor_center” represent the participant; the * 
indicates that according sensor responses do not only increase with increasing concentrations, but decrease 
again after reaching a concentration of 0.1 (SB2C00_4*) or 1 mM (SB2C00_5*); results were displayed with 
left up to right down scattered bares, if they were below mean ± CI (α = 0.05); results were displayed right up 
to left down scattered bars, if they were significantly different from the mean results within one sensor type 
according to the t-test for independent samples (α = 0.05); results were displayed with dotted bars, if they were 
below mean ± CI (α = 0.05) AND significantly different from the mean results within one sensor type 
according to the t-test for independent samples (α = 0.05). 
Both calculation methods recognized values tending towards and away from 0. As 
decreasing sensor performance is accompanied with values tending towards 0 (Pein et 
al., 2013), only those values have been highlighted in Table 2. Information, which can 
be obtained by the sensitivity values, confirms the assignment of the sensors. The slopes 
include however more specific information regarding sensor behavior (such as the 
orientation of the slope). SB2AAE and SB2CA0 of center 3, SB2C00 of center 4 and 
SB2C00 and SB2CT0 of center 5 behaved significant differently regarding both, 
sensitivity and slope values. While the reduced performance of the sensors of center 3 
could be correlated with the high period of use (18 months), the reduced performance of 
the other sensors could not be explained. 
The results of the concentration series aqueous KCl (10 mM) are summarized in table 3 
and highlighted in the figures therein. Sensors SB2AC0, SB2AN0, SB2AAE and 
SB2CA0 show comparable sensitivity and slope patterns compared with those listed in 
Table 2. These results fit the assignment of the sensors: SB2AC0 and SB2AN0 are 
dedicated to cationic bitter substances, SB2AAE to umami tasting compounds and 
SB2CA0 to sour substances. Thus, they should not be influenced by either potassium 
cations or chloride anions. In contrast, the performance of the salty sensor (SB2CT0) is 
significantly decreased. This behavior is also displayed by the astringent sensor 




al., 2010). Both sensors considerably lost their ability to differentiate between different 
concentrations of quinine hydrochloride. Their slopes decrease from -12.6 (±3.1) 
(SB2CT0) and -15.3 (±1.0) (SB2AE1) to -2.5 (±1.8) and -3.0 (±0.8) and their sensitivity 
values from 60.0 (±16.4) and 77.5 (±5.2) to 12.9 (±7.5) and 14.5 (±2.6). This behavior 
is additionally confirmed by the results of the linear regression. At least three 
concentrations have been used to calculate the coefficients of determination (R
2
), even 
if the sensor responses neither significantly increase nor decrease until a concentration 
of 1 or 10 mM is reached (which is indicated by brackets around the corresponding log-
linear ranges in Table 3). Especially for sensors SB2AE1 and SB2CT0, the resulting R
2 
values are below 0.90. However, no explanation can be provided for the non-
systemically changes of the responses of sensor SB2C00. 
Table 3: Sensitivity, onset, log-linear range, slope and the coefficient of determination (R2) as indicators for 
sensor performance; results are based on the concentration series in 10 mM aqueous KCl; sensitivity and slope 
are highlighted in the figures on the right; the numbers in “sensor_center” represent the participant; the * 
indicates that according sensor responses do not only increase with increasing concentrations, but decrease 
again after reaching a concentration of 0.1 (SB2C00_4*); results were displayed with left up to right down 
scattered bares, if they were below mean ± CI (0.05); results were displayed with dotted bars, if they were 
below mean ± CI (0.05) AND significantly different from the mean results within one sensor type according to 
the t-test for independent samples (α = 0.05). 
The reduced performance of SB2AAE and SB2CA0 of center 3 and SB2CT0 of center 
5 highlights the history of the sensors of center 3 as main influence.  
 
3.2 Evaluation of the film formulations (Experiment 3) 
Principle component analyses (PCA) were performed individually for each participating 
center, containing the information of all seven sensors. Moreover, a PCA was 
performed based on the merged information of all 5 centers, containing the information 
of 35 sensors. The corresponding PCA score and loading scatter plots are displayed in 
Figure 2. 
Figure 2: PCA maps of the results of Experiment 3, containing the information of 35 sensors (1) or 7 sensors 
(2-6). Each sample was measured in triplicate. Data was center scaled. A1 (black): films containing 
dimenhydrinate, B1 (red): films containing dimenhydrinate and sweetener, C1 (blue): placebo films, D1 (light 
green): films containing sweetener, E1 (yellow): dimenhydrinate, F1 (pink): dimenhydrinate and sweetener, 




The information of all dimenhydrinate containing samples is influenced by the 
responses of bitter sensors SB2AC0 and SB2AN0 (Figure 2.1: Loading Scatter Plot) 
and thus displayed on the right side of the PCA map 1. The information is mainly 
separated along principle component 1 (PC1:94.1 %), and only minor along PC2 
(4.7 %). Regarding the distances between the data points, the dimenhydrinate 
containing formulations A1 and B1 and the corresponding physical mixtures E1 and F1 
are detected comparably. While sweetener containing solutions (D1 and G1) are closer 
located, the placebo film sample (C1) is detected most differently compared to the 
dimenhydrinate containing samples. C1 is most distinctively recognized by sensors 
SB2AE1 and SB2CT0 (Figure 2.1: Loading Scatter Plot). 
The PCA Score and Loading Scatter Plots of center 2, 4 and 5 are almost identical 
(Figure 2). The Score Scatter Plot of center 1 varies only little, representing sample C1 
similar located as G1 regarding PC1. This might be due to the differing influences of 
sensors SB2C00 and SB2CA0 of center 1 (Figure 2.2: Loading Scatter Plot), if 
compared to those of center 2, 4 and 5. While the result of SB2CA0_1 complies with 
the reduced performance in Experiments 1 and 2, no such a correlation could be found 
for SB2C00_1. The PCA map of participant 3 is arranged mirror-inverted, although the 
results have been evaluated in the same manner as the results of the other centers. 
Moreover, scattered results for sample E1 are evident. These differing results could be 
due to the decreased sensor performance of sensor SB2AAE_3, SB2CT0_3 and 
SB2AC0_3, which have been proven as evident in Experiment 1 (Table 2) and 
Experiment 2 (Table 3). Moreover, sensor SB2AC0_3 is located in the same quadrant as 
sensor SB2AAE_3 (Figure 2.4: Loading Scatter Plot), which is not the case within the 
results of the other center. Nonetheless, the main information is comparable to those of 
the other centers: the dimenhydrinate containing samples are located at one side of the 
PCA map, while order and distance of the sweet and placebo samples as well as the 
information given on the x- and y-axes are the same as for each other PCA map. 
Similar findings are confirmed by calculating and evaluation of the Euclidean distances 
(according to Equation 1) based on the mean sensor values. The Euclidean distances are 
calculated originating from the placebo film formulation (C1) and show similar patterns 
for all participating centers (Figure 3). 
Figure 3: Euclidean distances, calculated based on the mean sensor values (left) and CPA values (right) 




films containing dimenhydrinate, B1: films containing dimenhydrinate and sweetener, D1: films containing 
sweetener, E1: dimenhydrinate, F1: dimenhydrinate and sweetener, G1: sweetener 
  
 
Interestingly, also the Euclidean distance patterns based on the mean CPA (change in 
membrane potential due to adsorption) values are comparable between the centers 
(Figure 3, right) but also to the patterns of the mean sensor values (Figure 3, left). 
CPA values have already been correlated with gustatoric impressions by (Kobayashi et 
al., 2010) and are a measure for the lipophilic character of the analyzed substances. The 
obtained Euclidean distance patterns based on CPA values could therefore refer to 
adsorption of dimenhydrinate as the main contributor for the signal. This assumption is 
proven by evaluating the original CPA values (Figure 4). These values are by default 
measured in the standard solution after measuring a sample solution (followed by a 
subsequent slight washing). Distinctly recognized by the CPA values of the three bitter 
sensors (SB2C00, SB2AC0 and SB2AN0) are those samples that contain 
dimenhydrinate (Figure 4). 
Figure 4: Mean CPA values based on the CPA values of the different centers (mean ± s).  A1 (black): films 
containing dimenhydrinate, B1 (red): films containing dimenhydrinate and sweetener, C1 (blue): placebo films, 
D1 (light green): films containing sweetener, E1 (yellow): dimenhydrinate, F1 (pink): dimenhydrinate and 






















































3.3 Evaluation of the minitablet formulations (Experiment 4) 
For evaluating the minitablet formulations, PCAs were also performed individually for 
each participating center and based on the merged information of all 5 centers  
(Figure 5).  
Contrary to the PCA maps of the film formulations, where around 95 % of the 
information is separated along the x-axes, PC1 of experiment 4 displays between 71-
85.4 %. Thus, also the separation of the samples along PC2 (13.2-26.3 %) has to be 
regarded for the sample evaluation. PCA map 1 displays E2, containing only dissolved 
zinc sulphate, furthest to the right, mainly influenced by the response of astringent 
sensor SB2AE1 and to a lesser extent by SB2CT0 (Figure 5.1: Loading Scatter Plot). 
On the left side of the PCA map, the samples can be divided into two clusters: one 
representing the samples containing only NaCl and sweetener (C2 and G2) and one 
representing the samples, containing zinc sulphate in combination with NaCl and 
sweetener (D2 and F2). While the minitablet formulation containing zinc sulphate and 
only sweeteners (B2) is located in the second cluster, minitablets containing zinc 
sulphate and only NaCl (A2) can be found next to pure zinc sulphate (E2). This leads to 
the assumption that the included sweeteners direct to the left, while zinc sulphate directs 
to the right side of the PCA map. However, none of the applied sensors can 
unequivocally be dedicated to one or the other cluster (Figure 5.1: Loading Scatter Plot). 
Figure 5: PCA maps of the results of experiment 4, containing the information of 35 sensors (1) or 7 sensors (2-
6). Data was center scaled. A2 (black): minitablets containing ZS and NaCl, B2 (red): minitablets containing 




























containing ZS, NaCl and sweetener, E2 (yellow): ZS, F2 (pink): ZS, NaCl and sweetener, G2 (dark green): 
NaCl and sweetener 
While the PCA maps within Experiment 3 are very comparable (Figure 2), this is less 
the case for the PCA maps within Experiment 4 (Figure 5). Nonetheless, the cluster 
structure can be recognized independent of the center, and thus provide comparative 
results. No reason for the drifting results for each sample measured in center 4 could be 
found.  
Calculating the Euclidean distances based on the mean sensor values lead to results 
summarized in Figure 6. In this case, the Euclidean distances are calculated originating 
from the zinc sulphate containing minitablet formulation (E2). The results support those 
of the PCA maps: Each center identified samples E2 and G2 on the one and B2, D2 and 
F2 on the other hand most likely to be similar. The decreased Euclidean distances of 
center 1 go along with the decreased scaling of the corresponding PCA map (Figure 5.2). 
Figure 6: Euclidean distances, calculated based on the mean sensor values (left) and CPA values (right) 
according to Equation 1. The Euclidean distances are calculated originating from pure ZS (E2). A2: 
minitablets containing ZS and NaCl, B2: minitablets containing ZS and sweetener, C2: minitablets containing 
NaCl and sweetener, D2: minitablets containing ZS, NaCl and sweetener, F2: ZS, NaCl and sweetener, G2: 
NaCl and sweetener 
 
 
In contrast to the patterns obtained from Experiment 3 (Figure 3), the patterns based on 
the mean CPA values of Experiment 4 are not comparable to the Euclidean distance 
patterns of the sensor signals (Figure 6). Moreover, the highest Euclidean distances are 
decreased from approximately 70 mV (Figure 3, right) to 15 mV (Figure 6, right). The 
decreased values are additional proof for adsorption being the main signal creating 
process in Experiment 3, as zinc sulphate is not lipophilic and thus does not result in 





















































Figure 7: Mean CPA values based on the CPA values of the different centers (mean ± s).  A2 (black): 
minitablets containing ZS and NaCl, B2 (red): minitablets containing ZS and sweetener, C2 (blue): minitablets 
containing NaCl and sweetener, D2 (light green): minitablets containing ZS, NaCl and sweetener, E2 (yellow): 
ZS, F2 (pink): ZS, NaCl and sweetener, G2 (dark green): NaCl and sweetener 
 
4. Conclusions 
The first inter-laboratory testing of Insent e-tongues has successfully been performed 
based on four experiments, which were conducted by five different centers. Experiment 
1 and 2, each based on a concentration series of quinine hydrochloride, served as some 
kind of additional sensor performance check. The resulting sensitivity (in this case the 
difference between lowest and highest sensor response) and slope of the regression line 
values have been found to serve as applicable evaluation criterions for inter-laboratory 
comparability. However, further investigations with other drugs than quinine 
hydrochloride are recommended for future studies to get more generalized information. . 
In Experiment 3 and 4, drug formulations were investigated and with regard to inter-
laboratory comparability of the results different evaluation methods have been applied 
and discussed. PCA Score and Loading Scatter Plots and Euclidean distance patterns 
based on the raw sensor responses appeared as valuable evaluation tools for the inter-
laboratory comparison. Varying PCA Score Scatter Plots between the centers were 
explained by the information of the Loading Scatter plots, which could be correlated 
with the results of Experiments 1 and 2. Information given by the CPA values enabled 
to dedicate adsorption of dimenhydrinate as main contributor for the results in 
Experiment 3. Although some (aged) sensors behaved differently in Experiment 1 and 2, 
the according sensors responses resulted in comparable PCA and Euclidean distances 
patterns in Experiment 3 and 4. In conclusion, participating e-tongues can be declared to 
perform comparably. 

































Modified sensor responses were found to be related to aged sensors. The supplier 
requires using only sensors that passed the routinely performed sensor check and the 
monthly required maintenance measurement. Both measures, considering defined 
substances in a defined concentration, fail, if the underlying information about the 
sensor response profiles differs from the measured one. These single point calibration 
procedures help to sort out weakly performing sensors. Thus, future work of the “e-
tongue usergroup” intends to develop more sophisticated methods to judge about the 
sensor performance in connection with the sensor age or history, which will be 
beneficial for the users. 
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